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“ – А я действительно похож на галлюцинацию. Обратите внимание на мой
профиль в лунном свете, – кот полез в лунный столб и хотел еще что-то
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готов молчать. Я буду молчаливой галлюцинацией, – замолчал.”
— Михаил Булгаков, Мастер и Маргарита
“The Unknown Mind” by Unknown Artist. Edited.
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Abstract
Mental and behavioural disorders introduce a significant burden on society,
estimated to account for 12% of the global burden of disease, with approxi-
mately 450 million suffering from them every day, and only a small number
of those getting any treatment. The situation will worsen with time, with
unipolar depressive disorders predicted by the World Health Organisation to
become the leading cause of disabilities by 2030.
Mental disorders affect primarily the mind and the brain, leading to patho-
logical changes in emotions or cognition. Although clinical manifestations
of different mental disorders may vary, Liddle et al. suggested five principal
symptom dimensions, including reality distortion, disorganisation, psychomo-
tor, mood and anxiety dimensions. For assessment of symptoms in clinical
practice, the structured clinical interview, alongside standard questionnaires
are used, but in many cases are not providing a reliable and objective diag-
nostic tool due to the complexity of the assessed phenomena.
Activity and motion analysis has the potential to be used as a diagnostic tool
for mental disorders. However, to-date, little work has been performed in
turning stratification measures of activity into useful symptom markers. The
research presented in this thesis has focused on the identification of objective
activity and behaviour metrics that could be useful for the analysis of mental
health symptoms in the above mentioned dimensions. Particular attention
is given to the analysis of objective differences between disorders, as well as
identification of clinical episodes of mania and depression in bipolar patients,
and deterioration in borderline personality disorder patients.
A principled framework is proposed for mHealth monitoring of psychiatric
patients, based on measurable changes in behaviour, represented in physical
activity time series, collected via mobile and wearable devices. The framework
defines methods for direct computational analysis of symptoms in disorganisa-
tion and psychomotor dimensions, as well as measures for indirect assessment
of mood, using patterns of physical activity, sleep and circadian rhythms.
An extensive mHealth software tracking system was constructed, and data
collected from over 100 individuals. Using the developed framework, the ac-
curacy of differentiation between healthy controls and bipolar disorder was
67%, healthy controls and borderline personality disorder 70%, and bipolar
vs. borderline personality disorder 80%. For identification of clinical states of
euthymia, mania and depression the accuracy of differentiation of euthymia
and mania was 80%, euthymia and depression 85% and mania and depression
90%, when using leave-one-out cross-validation. For personalised mood mod-
els, the mean absolute error of symptom scores estimation was in the range
of 1.36 to 3.32 points, this corresponds to the ranges reserved in psychiatric
questionnaires for a unique identifiable mood state (4-5 points).
Finally, the methods were applied to a new data set (schizophrenia patients
and matched controls) and were shown to be 95.3% accurate using leave-
one-out cross-validation at classifying the cohort. Both physiological as well
as activity features were relevant for classification of this cohort, and so the
hypothesis that heart rate added additional predictive power was tested. The
combination of HR and locomotor activity features provided almost a 10%
increase in classification accuracy above using locomotor features alone, and
almost a 17% increase over using heart rate based features alone.
The approach of computational behaviour analysis, proposed in this thesis,
has the potential for early identification of clinical deterioration in ambu-
latory patients, and allows for the specification of distinct and measurable
behavioural phenotypes, thus enabling better understanding and treatment
of mental disorders.
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Glossary
• Affect - the experience of feeling or emotion, usually indicated by facial, vocal or
gestural behaviour.
• Actigraphy - non-invasive method of capturing rest and activity patterns using
electronically recorded activity from a wearable unit (actigraph).
• Activity count - unit of activity measurement by an actigraph.
• Accelerometer - a device measuring g-force, including both acceleration and gravity
components.
• Bipolar disorder - a mental disorder characterised by periods of elevated and de-
pressed mood.
• Borderline personality disorder - a personality disorder characterised by unstable
mood, behaviours, relationships and self-perception.
• Catatonia - a state of motor immobility or stupor, often present in schizophrenia.
• Circadian rhythm - a biological process with oscillations of about 24 hours.
• Chlorpromazine - antipsychotic medication, primarely used in schizophrenia.
• Dynamic programming - a method of solving a complex problem by breaking it
down into a set of simpler sub-problems, and re-using solutions of those.
• Dysphoria - a severe state on unease or dissatisfaction.
• Entropy - a measurement of the disorder or randomness of a system.
• Euthymia - a relatively asymptomatic state in mood disorders.
• Impulsivity - a psychological construct, describing tendency to act on the spur of
the moment.
• Imputation - substitution of some value for missing data.
• Locomotor activity - a variety of methods animals or humans use to change their
location.
• Metabolic equivalent (MET) - measure of the intensity of physical activity, where
1 MET is the amount of energy produced by a person seated at rest.
• Mixed state - a state with simultaneous manifestation of symptoms of depression
and mania (usually in bipolar disorder).
• Negative symptom - in schizophrenia, a deficit of normal emotional reactions or
other behaviours.
• Sleep apnoea - a sleep disorder, characterised by pauses or severe shallowness in
breathing.
• Pieso-electric - an effect of accumulating electrical charge in material in response
to mechanical stress.
• Positive symptom - in schizophrenia, a symptom that can be described as behaviour
usually not present in normal people (such as hallucinations).
• Psychophysiology - branch of psychology, studying physiological bases of psycho-
logical processes.
• Psychomotor - a behaviour, represented in change of physical activity patterns
originated from mental processes.
• Schizophrenia - a mental disorder characterised by reality distortion.
• Schizoaffective disorder - a mental disorder characterised by the presence of symp-
toms of both schizophrenia and mood disorder.
• Stationarity - a property of a system, described by stability of statistical character-
istics over time.
• Symptom - a departure from a normal function noticeable by a patient (as opposite
to observed by clinician only).
• Syndrome - a combination of symptoms and signs, correlated with each other and
a specific disease.
• Transcendental - a phenomena, independent of experience.
• Unipolar depressive disorder - a mental disorder, characterised by a severe and
persistent low mood.
• Zeitgeber - an external stimulus that synchronises an organism’s biological rhythms
to 24 hour cycle.
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Chapter 1
Introduction
1.1 Motivation
Mental and behavioural disorders place a significant burden on society, estimated to
account for 12% of the global burden of disease, with one in four people experiencing
mental health problems during their lifetime and an estimated 450 million suffering from
them every day, although only a small fraction receive treatment, due to the lack of
diagnosis (Sayers, 2001). The situation is predicted to get worse with time, and according
to the World Health Organisation Global Burden of Disease report unipolar depressive
disorders will be the single leading cause of disabilities by 2030, from 3rd place in 2004
(Mathers et al., 2008).
In the United Kingdom (UK) mental disorders (including dementia) affect approx-
imately 8.7 million people with direct costs to the UK National Health Service (NHS)
of £22.5 billion per year (McCrone, 2008). This number is expected to increase to 9.88
million people, at a cost of £32.6 billion by 2026. Mental illness accounts for nearly half
of all ill health for people aged under 65, and the cost of lost employment is estimated
at £26.1 billion, with many people not in contact with NHS services and not receiving
any treatment (35% of those with depression and 51% with anxiety disorders) (Layard,
2012).
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Mental health issues are also associated with physical illnesses, with stress being
related to the common cold (Cohen et al., 1991) and delays in wound healing (Kiecolt-
Glaser et al., 1998). Mental health issues, in particular depression and bipolar disorder,
are also linked with obesity (McElroy et al., 2004), suggesting a range of well-known
co-morbidities, including cardiovascular problems, sleep apnoea and increased risk of
cancer and diabetes. A common complication of mental health illnesses is suicide. It is
estimated that by 2020 1.5 million people a year will commit suicide and up to 30 million
will attempt to do so (Bertolote and Fleischmann, 2002).
1.2 The problem of diagnosis
The diagnosis and management of mental disorders heavily depends on clinical judgement
(Lobbestael et al., 2010) and patients’ self-reports, making it a challenging task in situa-
tions when patients’ cognition is impaired. There is a high degree of similarity between
symptoms of different mental disorders (Green, 2006; Cannon et al., 1997) and in some
cases it is very difficult, even for a trained clinician, to distinguish between disorders with
similar manifestations and thus prescribe the correct treatment (Henry et al., 2001).
Collecting symptoms history is the key part of the diagnostic process, however assess-
ing history during interviews is difficult due to substantial recall bias (Ben-Zeev et al.,
2012). Numerous mental health scales have been suggested to bring objectivity into the
diagnostic and therapeutic process (Rush et al., 2008). But there is evidence, that re-
liance on such scales only may also lead to mistaken conclusions (Shedler et al., 1993), so
more objective diagnostic criteria may be necessary to create a reliable diagnostic system,
and potentially define better disorder boundaries, predictive of treatment response and
accurately capturing the mechanisms of mental dysfunction (Insel et al., 2010).
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1.3 The problem of deterioration
Most mental disorders, such as schizophrenia or bipolar disorder, are life-long conditions
often involving relapses and remitting, and cannot be cured completely (Lehman et al.,
2004; Geddes and Miklowitz, 2013). Treatment strategy in mental health focuses on
avoiding relapses, by starting treatment at the first signs of deterioration. And in many
cases, early warning signs can be detected long before the full relapse, enabling early
intervention for management of the disorder (Molnar et al., 1988; Klosterko¨tter et al.,
2001).
However, early warning signs of relapse are often missed by patients and clinicians
alike, identification of relapse signature in ambulatory patients is not routinely performed
in clinical practice, and if performed at all is often based on self-reports and affected
by compliance and recall bias issues (Miklowitz et al., 2012). A more systematic and
objective approach to management of psychiatric disorders with a focus on early warning
signs may therefore be useful in clinical practice.
From the treatment perspective, most psychiatric medications have quite severe side
effects. For example the most widely used mood stabiliser, lithium, may lead to tremor
and weight gain as side effects, and require careful dose adjustment to avoid poisoning
(Schou et al., 1970). Side effects of antipsychotic medication include sedation, weight
gain and sexual dysfunctions (Fleischhacker et al., 1994). Reducing the duration of
pharmacological treatment by providing it only when first signs of relapse are detected
would help to avoid unnecessary inconvenience for patients and improve compliance and
outcomes (Tandon et al., 2009; Miklowitz et al., 2012; Geddes and Miklowitz, 2013).
1.4 Approach of this work
Automated and objective assessment of mental health may provide more timely interven-
tions and prevent or decrease the severity of significant events. Since the classical work
of Lacey in 1959 (Lacey, 1959), psychophysiology has been a heavily debated approach to
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introduce objectivity into the diagnostic and psychotherapeutic process. Such measures
as physical activity, heart rate, electrodermal activity, skin temperature, muscle poten-
tials, as well as clinical indexes based on these measures and features derived from them,
may provide valuable information to assess the patients’ mental state (Cacioppo, 1991).
While there is some scepticism among practising clinicians about the possibility of
automating the diagnostic process (Steiner, 2011), psychophysiological measures are ex-
tensively used by researchers to analyse mental conditions, including aggression (Scarpa
and Raine, 1997), psychopathy (Rothemund et al., 2012), conduct problems (Lorber,
2004), schizophrenia (Wulff et al., 2012) and others. There are also recent examples of
activity-based biomarkers for predicting treatment response (McCall, 2015), thus poten-
tially establishing actigraphy as an important clinical tool in psychiatry.
However, most existing research focuses on small subsets of psychophysiological vari-
ables, collected in controlled laboratory settings (Hornero et al., 2006; Minassian et al.,
2010; Walther et al., 2014). In order to create a complete picture of the patients’ state,
longitudinal measurements capturing data from patients in normal living conditions may
be required. Such an approach would potentially allow continuous identification of clini-
cal state and deterioration in patients with mental health issues, and thus enable timely
intervention (Paradiso et al., 2010; Bardram et al., 2012).
This work proposes a multidimensional framework for continuous ambulatory assess-
ment of symptoms in mental health. The framework is based on evaluation of behaviour
patterns, extracted from physical activity recordings, collected using off-the-shelf wear-
able and mobile devices, so it is potentially suitable for prodrome identification and early
detection of deterioration in psychiatric patients.
1.5 Contributions
The main contribution of this work is in the introduction of a principled framework
for analysis of mental health symptoms, based on objective behavioural features. The
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framework is based on the five-cluster model of symptoms (Liddle, 2001) and suggests
objective measures for symptoms in psychomotor, disorganisation and mood clusters,
with a potential to extend to the remaining two clusters (reality distortion and anxiety)
by using physiological information, such as heart rate and electrodermal activity.
The framework integrates methods from physical activity research and sleep medicine
(including analysis of sleep and circadian rhythm disturbances). The analysis approach
is designed to deal with non-stationary human activity data by identifying and treating
independently subjects’ physiological states, such as sleep and wakefulness, using the
Hidden Semi-Markov Models, as well as using non-stationarity and duration of stationary
activity segments as features itself.
The multi-dimensional model allows for analysis and differentiation between similar
disorders, with bipolar disorder and borderline personality disorder addressed in this
work. It also allows for a more objective and complete description of clinical deterioration,
applicable across a wide range of disorders.
Novel activity analysis methods are introduced based on definitions of mental health
symptoms, including Multiscale Entropy-based activity disorganisation assessment, De-
trended Fluctuation Analysis of stationary activity segment durations, obtained using
the Bayesian Online Change Point Detection, and assessment of day-to-day activity pat-
terns variability by measuring the Dynamic Time Warping distance between successive
24-hour activity patterns. These analysis methods were shown to be useful in describing
clinically relevant changes in behaviour patterns, and in classification between healthy
controls, biploar disorder and borderline personality disorder, as well as healthy controls
and schizophrenia patients.
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Chapter 2
Automating symptoms assessment in
mental health
2.1 Brief history of physical activity and physiology in
assessment of mental health
2.1.1 The roots
Mental disorders affect primarily mind and brain, leading to pathological changes in emo-
tions or cognition. Unfortunately, until very recently there were no instruments to allow
us to look into a living brain for a better understanding of pathologies related to mental
health problems, to understand the etiology and processes behind mental disorders. And
since it is not possible to cut open a living human brain, in order to understand the
pathologies related to mental health problems researchers had to rely mostly on post-
mortem analysis, studies on animal models and psychopharmacological evidence (Liddle,
2001). Very limited possibilities to observe living human brain activity were provided
by EEG, and more recently a better resolution picture has become possible with imag-
ing techniques, such as PET and FMRI, marking a new era in neuroscience (Andreasen,
1988), but to date none of these methods are diagnostically specific.
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From a clinical perspective, there is still no way to look into the disorder-related
activity of a living brain and mind continuously and for an extended period of time, as
may be needed for analysis and assessment of symptoms for clinical intervention.
While direct observation of mind and brain is not really feasible, could we possibly rely
on secondary measurements, based on changes in physical activity, behaviours or bodily
processes, that are induced by changes in mental state? In other words, can we identify
measurable objective signs of a person’s mental health? And is there instrumentation
that would allow us assess these signs continuously and without imposing a significant
burden on the patient?
The first question brings us to a discussion of the relationship between the mind
and the body, originating from Greek philosophers - the so called "mind-body problem".
Plato believed, that the mind is completely independent from the body and the physical
world, so no information measurable from the body could help us with understanding
the mind. But already in the times of Plato many philosophers considered that the mind
and the body are tightly connected, and affect each other. Such conclusions were often
derived from observations of mind disorders. For example the treatise ”On the Sacred
Disease“ from the Hippocratic Corpus (Jones, 1923) describes epilepsy as based mostly on
physiological causes originating in the brain and manifesting itself with certain physical
phenomena, thus eliminating the transcendental component of mental illness:
“The hands are paralysed and twisted when the blood is still, and is not
distributed as usual. The eyes roll when the minor veins are shut off from
the air and pulsate. The foaming at the mouth comes from the lungs; for
when the breath fails to enter them they foam and boil as though death
were near.”
Hippocrates of Cos in his work “On Regimen in Acute Diseases” (Jones, 1923) takes
a step forward, linking lifestyle to both physical and mental health, and declaring that
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changes in behaviour can induce changes in health and mind.
These ideas were further developed by Diocles of Crystus and Galen, who described
in some case reports the physiological and behavioural manifestations of mental illness,
such as insomnia and irregular heart rate, probably providing a first documented example
of heart rate variability analysis in assessment of mental disorders (Jackson, 1969):
“I was called in to see a woman who was stated to be sleepless at night and
to lie tossing about from one position into another... After I had diagnosed
that there was no bodily trouble, and that the woman was suffering from
some mental uneasiness... I applied my hand to her wrist and noticed
that her pulse had suddenly become extremely irregular. This kind of pulse
indicates that the mind is disturbed.”
Similar ideas were expressed by Aristotle, who described emotions as psycho-physical
phenomena, for example anger as “seething heat in the region of the heart” (Aristotle,
1984). As with many other fields of science, the understanding of mind, cognition and
emotions remained relatively unchanged since antiquity until the 19th century, when the
concepts of cognition and emotions were developed further based on collected empirical
evidences.
The major step forward in the understanding of mind and behaviour was performed by
Charles Darwin, who postulated the evolutionary origin of emotional expression as mostly
acquired serviceable habit, however sometimes originating purely from the constitution
of the nervous system. In his work “The expression of the emotions in man and animals”
(Darwin, 1872) Darwin declared three principles of expression:
1. The principle of serviceable associated habits.
2. The principle of antithesis.
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3. The principle of actions due to the constitution of the nervous system,
independently from the first of the will, and independently to a certain
extent of habit.
These principles did not only declare the tight connection between emotions and
their physical manifestations, but also the evolutionary nature of emotions, the tight
interconnection of cognitive and affective actions and involuntary (not originating from
evolutionary causes or cognitive factors) actions, originating solely from the nervous sys-
tem.
On the other side of the ocean, probably the earliest modern attempt to associate
mental state and physical manifestation was performed by William James (James, 1884),
who postulated the theory of emotions, independently also developed by Carl Lange
(“James-Lange theory”). The theory suggested that emotions arise in response to specific
stimuli, which evoke physiological arousal, such as change of heart rate, electrodermal
activity or specific muscle reaction, and this arousal in turn leads to specific emotion.
The James-Lange theory was soon challenged by Walter Bradford Cannon and Philip
Bard (“Cannon-Bard theory”), who localised the centre of emotional expression in the
brain and verified that physiological changes follow the emotional activation and arousal
does not have to occur before emotion in a heartbreaking and disturbing to modern
sensibilities experiment on 52 cats (46 survived long enough to prove the theory) (Bard,
1928).
This is where the modern era in understanding the connection between body and
mind began. Most further research on interactions between mind and body, in particular
in the field of physiological reactions to psychological processes, was developed using
experimental methods, and in more narrow areas, such as psychophysiology, psychiatry,
and other specific areas of neuroscience and medicine.
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2.1.2 The modern era
The presence of the conceptual framework for linking bodily processes and mind has led
to intensified research in the field. The major driving force behind scientific progress was
the development of new medical instrumentation, which would allow analysis of certain
aspects of emotional activation with high accuracy and without placing a significant
burden on a person, and which made the application of experimental methods possible.
One of the earliest successful attempts to use physiology for the analysis of the mental
state led to the creation of the polygraph, invented in 1921 by John Augustus Larson
(Larson, 1923). It is probably the most controversial and widely adopted tool for forensic
psychiatry. A polygraph measures several physiological signs, such as blood pressure,
respiration and skin conductivity and allows the operator to differentiate between genuine
and deceptive answers by visualising physiological response to emotional activation.
Such an early and successful application of physiological methods to psychological
applications ignited significant interest, but the field of psychophysiology was defined
only in 1955 with the creation of “The Psychophysiology Newsletter” by Albert F. Ax
and the Society for Psychophysiological Research later in 1959. John I. Lacey, one of
the pioneers of psychophysiology in 1959 proposed the use of physiological measures as
a clinical tool for mental disorders, specifically in the psychotherapeutic process (Lacey,
1959). However, in the same paper he also expressed concerns about the usefulness of
simple physiological measures:
“...as far as present evidence goes, individual indicant concordance is so
low that single autonomic measures cannot be used to unequivocally rank-
order the "arousal-value" of different stimuli for a given individual, or the
arousability of different individuals”.
Despite the initial work on the introduction of physiological instrumentation in clinical
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psychiatry (Gerard, 1949; Altschule, 1953; Lacey, 1959), physiological measurements
were not widely adopted in the field. Research suggested a great degree of variability
in individual responses and difficulties in assessing the ground truth (mental state). A
good critical statement on the subject was provided by John M. Hinton in 1966 (Hinton,
1966), listing the five causes of inconclusive results in physiological assessment of mental
phenomena:
“First, the hypothesised relationship between the physiological and the
psychological state may be mistaken. Secondly, the physiological phe-
nomenon may be measured by an unreliable method. Thirdly, the psy-
chological state under consideration may be ill-defined or insusceptible to
accurate measurement. Even if the quality of the mental state could be
agreed, few would claim complete reliability for the various rating scales.
Nor can it be assumed that different subjects placed in the same experimen-
tal situations or given identical stimuli will experience equal psychological
changes. A fourth reason for inconsistent psycho-physiological relation-
ships is the influence of other variables besides the selected emotion upon
the bodily state. A fifth cause for the lack of uniformity in results is the
idiosyncrasies of the individual’s habitual state and his way of reacting.”
All these facts diminished the attention of clinical specialists from the field and left it
mostly as a playground for research, where novel data acquisition techniques and anal-
ysis methods were developed. With the improvement of medical instrumentation, data
analysis methods and introduction of new measurement modalities, some of the prob-
lems mentioned by Hinton were solved, making the longitudinal monitoring of activity
and physiology feasible, and potentially enabling the creation of personalised models of
psychophysiological response.
In particular, the introduction of non-invasive actigraphic units has enabled long-term
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assessment of sleep, physical activity and rest-activity cycles in research settings since
the early 90’s (Witting et al., 1990). In 1995 Martin H. Teicher noted that activity and
motion analysis has a good potential to be used as a diagnostic tool for mental disorders
(Teicher, 1995). However until now the problem has not been addressed properly in
clinical practice, due to difficulties introducing instrumentation for continuous physiology
assessment and low patient compliance with research-grade instrumentation.
2.1.3 The future
Personal activity monitoring devices have now become consumer products. Communica-
tion protocols allow continuous upload, visualisation and analysis of data in real time,
and algorithms have been developed to identify types of activity patterns from acceler-
ation data. Personal activity monitors now often integrate physiologic monitoring tools,
such as heart rate and electrodermal activity sensors, appropriate for estimation of av-
erage activity and energy expenditure (El-Amrawy and Nounou, 2015). This creates an
opportunity for a more complete and personalised assessment of physiological and be-
havioural correlates of mental symptoms, with the potential to overcome the difficulties
encountered by researchers and psychiatrists in previous years.
One of the enabling factors for the new increasing interest in applications of physio-
logical and behavioural monitoring for diagnostic and therapeutic process in psychiatry
was triggered by the large scale adoption of mobile devices and the rapid rise of wearable
technologies (Mohr et al., 2014). Most commercial companies on the market, such as
Fitbit and Jawbone, were launched less than 10 years ago (Fitbit was founded in 2007
and Jawbone UP lifestyle tracker in 2011). Despite the initial scepticism, fitness tracking
and the so-called "quantified self" approach were quickly adopted by a large number of
people.
The success of these devices was to a great extent based on the variety of actigraphy
data analysis techniques, developed by researchers during previous years, and the evidence
base on the importance of activity and sleep for people’s health (Ancoli-Israel et al.,
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2003; Faulkner and Biddle, 2013). However, in the past, research was constrained by
technological limitations, such as limited battery life and data storage capacity, with
the main results created around very coarse-grained analysis methods, such as minute-
by-minute sleep/wake segmentation, sedentary, light, moderate and vigorous physical
activity identification, or cosinor analysis of circadian rhythms. These analysis methods
were adopted by commercial device manufacturers. For the analysis of mental health,
more elaborate data analysis methods may be required (Agelink et al., 2002; Hauge et al.,
2011; Indic et al., 2011; Walther et al., 2014), and the rapid rise of commercially available
and inexpensive activity tracking solutions enables researchers to conduct large scale
studies, which are necessary to validate the effectiveness of these methods in ambulatory
settings.
Furthermore, given the gradual introduction of physiology and environment sensors
(heart rate, electrodermal activity and ambient light) into the "quantified self" technolo-
gies toolkit, as well as capabilities of mobile phone sensors to capture social activity
patterns, many of the problems mentioned in Section 2.1.2 can be solved now by using
simple and commercially available multi-sensor solutions. There is a growing need for
the development and validation of new sensor fusion-based analysis methods, which are
capable of using the great amount of diverse data collected from mobile and wearable
sensors. In the field of psychiatry, these data need to be translated into clinically useful
and useable information, helping both patient and clinical specialist to better understand
the problem and improve the management of disorders (Prociow et al., 2012; Torous
et al., 2015; Naslund et al., 2015).
Using this information, and benefiting from the wide penetration of activity and phys-
iology monitoring tools, integrated into smart phone applications and wearable devices
(Migo et al., 2014), it may be possible to address the problem of continuous activity
and physiology monitoring for the early identification of symptoms and clinical states of
psychiatric patients.
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2.2 Diagnostic criteria for mental disorders
Mental health problems are very complex phenomena, often with poorly understood
etiology, unclear diagnostic criteria and blurred boundaries between different conditions.
Frequently, the very definition of a disorder has a historic origin and it is debatable if
such a definition is correct and such a separate diagnostic entity exists (Dahl, 1985; Maj,
1998; Angst et al., 2003). The main reference for the diagnosis of psychiatric disorders is
the “Diagnostic and Statistical Manual of Mental Disorders” by the American Psychiatric
Association, with the fifth edition released in 2013 (American Psychiatric Association,
2013) (DSM-5). The DSM-5 defines a mental disorder as follows:
"A mental disorder is a syndrome characterised by clinically significant
disturbance in an individual’s cognition, emotion regulation, or behaviour
that reflects a dysfunction in the psychological, biological, or developmen-
tal processes underlying mental functioning. Mental disorders are usually
associated with significant distress or disability in social, occupational, or
other important activities. An expectable or culturally approved response
to a common stressor or loss, such as the death of a loved one, is not a
mental disorder. Socially deviant behaviour (e.g., political, religious, or
sexual) and conflicts that are primarily between the individual and soci-
ety are not mental disorders unless the deviance or conflict results from a
dysfunction in the individual, as described above."
It can be seen that the definition of a mental disorder is based on socially unac-
ceptable disturbances in behaviour, resulting in a disability and not caused by socially
approved external factors. The definition includes a large amount of contextual and sub-
jective information, making the diagnostic process a challenging task, especially given
that cognition and insight are often impaired in psychiatric patients.
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In order to understand the problem in better detail, let us take a look at three typical
examples of mental disorders (which are the focus of this thesis), affecting different aspects
of emotions, cognition and behaviour, including:
• Bipolar disorder, characterised by instability in mood with variations between
very depressed and highly exited states with intermediate euthymic periods, usually
on a time scale of months or years.
• Borderline personality disorder, manifesting itself in impulsivity of behaviour
and instability of interpersonal relationships, self-image and affect.
• Schizophrenia, characterised by severe disturbance in cognition, such as presence
of delusions, hallucinations, and disorganisation in thinking or behaviour.
These three disorders represent important classes of serious mental illnesses in the
DSM-5 classification (American Psychiatric Association, 2013), affecting predominantly
mood, behaviour and cognition. In order to provide the reader with a better understand-
ing of complexity of behavioural phenomena characterising these mental illnesses, the
complete DSM-5 diagnostic criteria for those are provided in the next chapters.
2.2.1 Bipolar disorder
Excluding the earliest definitions of bipolar disorder by Avicenna (Gruner, 1970) and Gao
Lian (Carpenter, 1990), the first modern attempts to describe the bipolar disorder belong
to Jules Baillarger (Baillarger, 1880) and Jean-Pierre Falret (Falret, 1854), followed by
Emil Kraepelin, who defined the term “manic depressive psychosis” (Kraepelin, 1987).
Carl Gustav Jung has described the bipolar disorder without psychotic episodes and has
contributed to our modern understanding, where bipolar type I (with psychotic episodes)
and type II (without psychotic episodes) are defined as distinctly separate (Jung, 1921;
Angst and Marneros, 2001).
The lifetime prevalence of bipolar disorder ranges from 0.3% to 1.5% depending on
country (Weissman, 1996), some studies estimating it as high as up to 5% (Akiskal
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et al., 2000), with sex ratios almost equal (Weissman, 1996). Rapid cycling (at least four
alterations of depression and mania per year) appears in 20% of patients during the course
of the disorder and mixed states occur in 40% of bipolar patients (Akiskal et al., 2000).
The lifetime risk of suicide attempts in bipolar disorder is 29.2% (Chen and Dilsaver,
1996) or up to 20–30 times greater than that for the general population (Pompili et al.,
2013).
The DSM-5 (American Psychiatric Association, 2013) defines the following diagnostic
criteria of bipolar disorder. For simplicity, only the bipolar type I is presented here, given
that type II diagnostic criteria are essentially the same, but with relaxed requirements for
symptoms manifestation and duration of episodes. The DSM-5 approaches the diagnosis
of bipolar disorder from the perspective of the presence of manic and depressive episodes,
matching certain criteria.
2.2.1.1 Manic episode
A manic episode in the DSM-5 (American Psychiatric Association, 2013) is defined as
follows, with at least one manic episode in a lifetime required for the diagnosis of bipolar
disorder (type I):
A. A distinct period of abnormally and persistently elevated, expansive,
or irritable mood and abnormally and persistently increased goal-
directed activity or energy, lasting at least 1 week and present most
of the day, nearly every day (or any duration if hospitalisation is
necessary).
B. During the period of mood disturbance and increased energy or activ-
ity, three (or more) of the following symptoms (four if mood is only
irritable) are present to a significant degree and present a noticeable
change from usual behaviour:
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1. Inflated self-esteem or grandiosity.
2. Decreased need for sleep (e.g., feels rested after only 3 hours of
sleep).
3. More talkative than usual or pressure to keep talking.
4. Flight of ideas or subjective experience that thoughts are racing.
5. Distractibitilty (i.e., attention too easily drawn to unimportant
or irrelevant external stimuli), as reported or observed.
6. Increase in goal-directed activity (either socially, at work or
school, or sexually) or psychomotor agitation (e.e., purposeless
non-goal-directed activity).
7. Excessive involvement in activities that have a high potential
for painful consequences (e.g., engaging in unrestrained buying
sprees, sexual indiscretions, or foolish business investments).
C. The mood disturbance is sufficiently severe to cause marked impair-
ment in social or occupational functioning or to necessitate hospi-
talisation to prevent harm to self or others, or there are psychotic
features.
D. The episode is not attributable to the physiological effects of a sub-
stance (e.g., a drug of abuse, a medication, other treatment) or to
another medical condition.
2.2.1.2 Major depressive episode
A major depressive episode is defined in the DSM-5 (American Psychiatric Association,
2013) as follows:
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A. Five (or more) of the following symptoms have been present during
the same 2-week period and represent a change from previous func-
tioning; at least one of the symptoms is either (1) depressed mood or
(2) loss of interest or pleasure.
1. Depressed mood most of the day, nearly every day, as indicated
by either subjective report (e.g., feels sad, empty, or hopeless) or
observation made by others (e.g., appears tearful).
2. Markedly diminished interest or pleasure in all, or almost all,
activities most of the day, nearly every day (as indicated by either
subjective account or observation).
3. Significant weight loss when not dieting or weight gain (e.g., a
change of more than 5% of body weight in a month), or decrease
or increase in appetite nearly every day.
4. Insomnia or hypersomnia nearly every day.
5. Psychomotor agitation or retardation nearly every day (observ-
able by others; not merely subjective feelings of restlessness or
being slowed down).
6. Fatigue or loss of energy nearly every day.
7. Feelings of worthlessness or excessive or inappropriate guilt
(which may be delusional) nearly every day (not merely self-
reproach or guilt about being sick).
8. Diminished ability to think or concentrate, or indecisiveness,
nearly every day (either by subjective account or as observed by
others).
9. Recurrent thoughts of death (not just fear of dying), recurrent
suicidal ideation without a specific plan, or a suicide attempt or
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a specific plan for committing suicide.
B. The symptoms cause clinically significant distress or impairment in
social, occupational, or other important areas of functioning.
C. The episode is not attributable to the psychological effects of a sub-
stance or another medical condition.
2.2.2 Borderline personality disorder
Borderline personality disorder was initially described by Theophile Bonet in 1684 as well
as Charles H. Hughes and Irving C. Rosse and was called “borderline insanity” (Ritschel
and Kilpela, 2014). The modern definition of the borderline personality disorder origi-
nates from Emil Kraepelin, who called it “excitable personality” (Kraepelin, 1921) with
features, closely resembling the modern definition by the DSM-5 (American Psychiatric
Association, 2013).
Borderline personality disorder affects about 1-2% of people, but introduces a sig-
nificant burden on healthcare systems due to patients’ behaviour patterns, including
self-harm and suicidal tendencies. The suicide rate among patients is very high, with
up to 10% of patients committing suicide (Lieb et al., 2004). The borderline personality
disorder was considered to be more prevalent in women (70%) (Widiger and Weissman,
1991), however more recent findings indicate no gender bias (Grant et al., 2008; Sansone
and Sansone, 2011).
In DSM-5, the borderline personality disorder belongs to a long list of personality
disorders, including the paranoid, schizoid, schizotypal, antisocial, borderline, histrionic,
narcissistic, avoidant, dependant, obsessive-compulsive and others. The diagnostic cri-
teria include affective, cognitive, behavioural and interpersonal relationship symptoms
(Lieb et al., 2004; American Psychiatric Association, 2013):
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A pervasive pattern of instability of interpersonal relationships, self-image,
and affects, and marked impulsivity, beginning by early adulthood and
present in variety of contexts, as indicated by five (or more) of the fol-
lowing:
1. Frantic efforts to avoid real or imagined abandonment.
2. A pattern of unstable and intense interpersonal relationships charac-
terised by alternating between idealisation and devaluation.
3. Identity disturbance: markedly and persistently unstable self-image
or sense of self.
4. Impulsivity in at least two areas that are potentially self-damaging
(e.g., spending, sex, substance abuse, reckless driving, binge eating).
5. Recurrent suicidal behaviour, gestures, or threats, or self-mutilating
behaviour.
6. Affective instability due to a marked reactivity of mood (e.g., intense
episodic dysphoria, irritability, or anxiety usually lasting a few hours
and only rarely more than a few days.
7. Chronic feelings of emptiness.
8. Inappropriate, intense anger or difficulty controlling anger (e.g., fre-
quent displays of temper, constant anger, recurrent physical fights),
9. Transient, stress-repeated paranoid ideation or severe dissociative
symptoms.
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2.2.3 Schizophrenia
Schizophrenia is one of the most controversial and debated psychiatric disorders. The
historical record of schizophrenia starts in the 19th century and there is very little evidence
of earlier documented schizophrenia cases, or recognition of it as a separate disorder. The
definition of schizophrenia was developed by a number of contributors, including Benedict
Augustin Morel and Emil Kraepelin, and the term “schizophrenia” was coined by Eugen
Bleuler in 1908 (Tsoi et al., 2008).
The risk of developing schizophrenia over one’s lifetime is around 0.3-2.0%, with males
about 1.4 times more likely to develop schizophrenia then females (Tandon et al., 2008).
Schizophrenia is usually diagnosed first based on so called “positive symptoms”, involving
severely distorted perception of reality (Tandon et al., 2009), so the social functioning of
patients with schizophrenia is severely impaired with high costs to society.
The exact definition and diagnostic criteria of schizophrenia are the subjects of heated
debates, sometimes going as far as suggesting abandoning the existing concept (Greene,
2007). The diversity of schizophrenia symptoms has led to the definition of subtypes, in-
cluding catatonic, disorganised, paranoid and others, however this definition is often ques-
tioned (Helmes and Landmark, 2003; Regier, 2007). The DSM-5 considers schizophrenia
to be a part of a broad schizophrenia spectrum of disorders, defined by such abnormal-
ities as delusions, hallucinations, disorganised thinking, abnormal motor behaviour and
negative symptoms (American Psychiatric Association, 2013). The diagnostic criteria for
schizophrenia are:
A. Two (or more) of the following, each present for a significant portion
of time during a 1-month period (or less if successfully treated). At
least one of these must be (1), (2), or (3):
1. Delusions.
2. Hallucinations.
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3. Disorganised speech (e.g., frequent derailment or incoherence).
4. Grossly disorganised or catatonic behaviour.
5. Negative symptoms (e.g., diminished emotional expression or
avolition).
B. For a significant portion of the time since the onset of the distur-
bance, the level of functioning in one or more major areas, such as
work, interpersonal relations, or self-care, is markedly below the level
achieved prior to the onset (or when the onset is in childhood or ado-
lescence, there is failure to achieve the expected level of interpersonal,
academic, or occupational functioning).
C. Continuous signs of the disturbance persist for at least 6 months.
This 6-month period must include at least 1 month of symptoms (or
less if successfully treated) that meet Criterion A (i.e., active-phase
symptoms) and may include periods of prodromal or residual symp-
toms. During these prodromal or residual periods, the signs of the
disturbance may be manifested by only negative symptoms or by two
or more symptoms listed in Criterion A present in an attenuated form
(e.g. odd beliefs, unusual perceptual experiences).
D. Schizoaffective disorder and depressive or bipolar disorder with psy-
chotic features have been ruled out because either 1) no major de-
pressive or manic episodes have occurred concurrently with the active-
phase symptoms, or they have been present for a minority of the total
duration of the active and residual periods of the illness.
E. The disturbance is not attributable to the physiological effects of a
substance (e.g., abuse of drugs or medication) or another medical
condition.
23
F. If there is a history of autism spectrum disorder or a communication
disorder of childhood onset, the additional diagnosis of schizophrenia
is made only if prominent delusions or hallucinations, in addition to
the other required symptoms of schizophrenia, are also present for at
least 1 month (or less if successfully treated).
2.2.4 Summary: dimensional perspective
As we can see from the DSM-5 requirements, the diagnostic criteria for many mental
disorders consist of a complex combination of factors, including a person’s symptoms,
behaviours, cognitive functions, personality traits, physical signs, syndrome combinations,
and durations of the above, necessary for the differentiation of abnormal behaviour from
normal life patterns.
The narrow definition of diagnostic criteria and the wide variety of possible symp-
tom combinations has led to a large number of diagnostic categories, with many pa-
tients demonstrating signs of several mental disorders. The high levels of psychiatric
comorbidity (30%-50%) is sometimes argued to be a by-product of the diagnostic sys-
tem, artificially splitting complex clinical conditions (Maj, 2005). One of the reasons for
designing the fifth version of DSM was the introduction of a dimensional approach to
diagnosis. The new DSM-5 grouping of disorders is based on eleven indicators, including:
shared neural substrates, family traits, genetic risk factors, specific environmental risk
factors, biomarkers, temperamental antecedents, abnormalities of emotional or cognitive
processing, symptom similarity, course of illness, high comorbidity, and shared treatment
response.
Similarly, there are attempts to simplify the analysis of mental symptoms, that are
often based on ambiguously defined psychological or behavioural constructs. Symptoms
may be organised into several principle dimensions of psychopathology. The work of
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Table 2.1: The major clusters of mental symptoms (Liddle, 2001).
Dimension Syndrome Symptom cluster
Reality distortion Reality distortion Delusions, Hallucinations
Disorganisation Disorganisation Formal thought disorder, Inappropriate
affect, Disorganised or bizarre behaviour
Psychomotor Psychomotor poverty Flat affect, Poverty of speech,
Decreased voluntary motor activity
Psychomotor excitation Labile affect, Pressure of speech,
Motor agitation
Mood Depression Low mood, Low self-esteem, Hopelessness,
Suicidality, Somatic symptoms
Elation Elevated mood, Elevated self-esteem
Decreased need for sleep
Anxiety Anxiety Feelings of unease, fear or dread,
Overactivity of the sympathetic nervous
system
Liddle et al. (Liddle, 2001) suggests five major dimensions, as described by Table 2.1,
which can be used to define a complete symptoms assessment framework. We can see that
certain aspects of behaviour, affect, motor activity, sleep, and activity of the sympathetic
nervous system contribute to the broader dimensional picture of symptomatology and in
turn are principal diagnostic features for bipolar disorder, borderline personality disorder
and schizophrenia as defined above.
While some of the dimensions, such as reality distortion, are mostly subjective and
require a clinical interview for proper assessments, and also assume a good knowledge of
a patient’s history, there are many areas where objective measurement could be of sig-
nificant benefit for symptom identification and analysis, and improve the clinical picture
of disorder. Furthermore, a growing body of evidence suggests the importance of certain
symptoms, such as sleep, circadian rhythms (Afonso et al., 2013; Taillard et al., 1993;
Wulff et al., 2010) or day time motor activity (Minassian et al., 2010; Burton et al., 2013)
in some mental disorders, despite not being included in the DSM-5 diagnostic criteria for
particular illnesses.
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2.3 Diagnostic and assessment tools
2.3.1 Clinical interview
The Structured Clinical Interview for DSM Disorders (SCID) is the main diagnostic ex-
amination defined by the DSM-IV (American Psychiatric Association, 2000) (the DSM-5
version is under development at the time of writing). There are two main versions, for the
Axis I (SCID-I), addressing principal disorders, such as schizophrenia or bipolar disorder,
and Axis II (SCID-II), addressing personality disorders, as well as specific versions for
research, clinical trials and different subject populations (First et al., 1996; First et al.,
1997; First et al., 2002; First et al., 2007). Depending on the individual the interview can
take from 15 minutes to several hours and can be administered by a trained mental health
professional or a non-clinical research assistant. The SCID includes several modules that
could be administered depending on a patient’s circumstances. The inter-rater agreement
of SCID diagnosis has Cohen’s kappa values of 0.61 to 0.83 for the Axis I disorders and
0.77 to 0.94 for the Axis II disorders (Lobbestael et al., 2010).
2.3.2 Questionnaires
Alongside clinical interviews, questionnaires remain the main tool for assessment of pa-
tient state in research and clinical settings. Questionnaires are used to assess various
aspects of well-being and different dimensions of symptoms. The Handbook of Psychi-
atric Measures (Rush et al., 2008) provides 275 rating methods both for diagnosis and
assessment of outcomes. The main benefit offered by questionnaires over the standard
clinical interview is the improvement of repeatability and reliability of patient assessment.
However, it was reported that “objective” scales are unable to distinguish between the
illusory mental health, demonstrated because of psychological defence mechanisms, and
genuine mental health status as identified by clinical judgement (Shedler et al., 1993).
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2.3.3 Web-based questionnaires
Given the pervasive use and the laborious transcription process involved in the use of
paper questionnaires, for most psychiatric scales an attempt is made to create a form for
electronic assessment. Electronic delivery also facilitates temporal analysis of reported
measures and could be particularly useful for assessment of patient outcomes and self-
management. In some cases, implementation of particular tools exists in a standardised
form at a country level, such as the Patient-Reported Outcome Measure Information Sys-
tem (PROMIS)1, developed by the US National Institutes of Health (NIH) and covering
the areas of physical, mental, social and global health.
One of the leading examples of integrating the patient-reported outcomes in clinical
practice in the UK is the True Colours Self-Management System2, adopted by the Oxford
Health NHS Foundation Trust. The system provides capabilities for online and mobile
text-based completion of questionnaires, periodic reminders and patient dashboard, and
the visualisation of assessment results in a graphical form. The True Colours system is
actively used in clinical practice and research (Miklowitz et al., 2012; Rosa et al., 2014).
Despite the fact that self-reporting is useful for the self-management of mental disor-
ders and for the provision of timely communication of symptoms to clinical specialists,
the frequency of assessment and the amount of captured information is not sufficient to
allow for the prediction of patient deterioration (Moore et al., 2012). Increasing frequency
may lead to diminished compliance, with demonstrated response rates of 88% for weekly
and 81% for daily mood prompts (Miklowitz et al., 2012) in research settings.
There is research ongoing to address this compliance issue, for example through the use
of virtual agents technology, integrating both assessment and therapy using a realistic
animation of a therapist, providing emotional feedback to a patient. The Help4Mood
project3 aimed to facilitate the recovery of patients, suffering from major depression at
home using a novel system that monitors patients’ health through sensors (Perez-Diaz
1http://www.nihpromis.org/
2https://oxfordhealth.truecolours.nhs.uk/www/en/
3http://help4mood.info/, FP7 project number 248765
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de Cerio et al., 2012), questionnaires and diaries, which are integrated with a virtual
agent, providing a therapeutic response. The therapeutic agent implementation (Wolters
et al., 2013; Breso´ et al., 2014) was validated in two small scale studies in different
configurations, one involving 5 patients for 7 days and the second involving 4 patients
for 15 days. The system usage was on average 94.2% for the first study and 87% for
the second study, providing a marginal improvement over the web-based questionnaire
approach. Note, that sensors data were not used in these studies.
2.3.4 Mobile phone based systems
The benefits of using web-based patient-reported outcome measures could be further
increased by collecting such data on mobile devices. However, in many cases psychiatric
questionnaires were not designed with small user interfaces in mind, making them difficult
to use, and alternative measures need to be introduced, providing patients with short and
concise questions, which are accessible on small screens.
The additional benefit created by the usage of mobile phones for psychiatric assess-
ment, compared to desktop computers, is the availability of sensors for the continuous
assessment of activity, behaviour (acceleration and location changes) and interpersonal
relationship (calls, texts, social networking and voice) patterns.
Although such usage of mobile phone sensors still has not reached clinical practice,
a number of research projects have demonstrated the potential benefit of mobile phone
sensors for the assessment of different psychological phenomena. For example the Emo-
tionSense mobile platform4, used for momentary ecological assessment in social psychol-
ogy research (Rachuri et al., 2010; Lathia et al., 2013), included capabilities for capturing
mood using surveys, as well as collecting data from mobile phone sensors and analysing
voice for emotional expression.
Other early examples of integrated mobile assessment and intervention using mobile
4http://emotionsense.org/, funded by the EPSRC Ubhave Project
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and wearable technologies include the ICT4Depression project5, developing the Mood-
buster mobile application, which facilitates Cognitive Behaviour Therapy (CBT) for treat-
ment of depression. Monitoring of symptoms was performed in a paradigm of Ecological
Momentary Assessments (EMA), by providing daily mood rating requests (Santos et al.,
2012). A wearable sensor glove for EDA, respiration and ECG was developed as part
of the project and medicine intake was also monitored (Silva et al., 2012; Arau´jo et al.,
2012). All information was provided back to the patient via smart phone app and web-
site (van de Ven et al., 2012; Warmerdam et al., 2012). The Moodbuster technology was
validated in small scale technology trials in Sweden and the Netherlands (Warmerdam
et al., 2012). The trial in Sweden was performed with 24 depressed student participants
scoring 5 or more on the PHQ-9 depression scale (Kroenke et al., 2001) and diagnosed
with major or minor depression. The Moodbuster treatment was provided for 6 weeks
and a significant decrease in PHQ-9 score post treatment was observed (ICT4Depression
Consortium, 2013b). The study in the Netherlands was performed with 23 depressed
subjects recruited mostly via media advertisement, and the 10-item Kessler’s psychologi-
cal distress scale (Kessler et al., 2002) was used to identify subjects eligible for the study
(scoring above 20). The Beck Depression Inventory second edition (BDI-II) (Beck et al.,
1988) was used to assess the treatment response and significantly lower post-treatment
scores were found (ICT4Depression Consortium, 2013a).
The MONARCA project6 focused mostly on behavioural and physiological monitor-
ing, attempting to solve the task of predicting depressive and manic episodes in bipolar
disorder patients (Bardram et al., 2012). The monitoring system included a mobile phone
(Osmani et al., 2013), wrist-worn activity monitor, sock-integrated physiological sensor
for GSR and HR (Gravenhorst et al., 2013), and a stationary EEG measurement system.
Physiological information from the sensors was combined with behavioural data from the
mobile phone, such as GPS location traces, phone usage patterns, voice and motion anal-
5http://www.ict4depression.eu/, FP7 project number 248778
6http://www.monarca-project.eu/, FP7 project number 248545
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ysis results (Gruenerbl et al., 2014). The MONARCA smart phone platform was piloted
in small-scale trials in Austria (10 bipolar patients) and Denmark (12 bipolar patients),
both collecting data for approximately 3 months. The study in Denmark was focused on
the assessment of the system’s usability and found that patients demonstrated similar
adherence to paper based and mobile data collection (Bardram et al., 2013). The study
in Austria focused on the recognition of clinical states, broadly defined as a mood scale
with 7 items, from depressive to manic, assessed using the Hamilton Depression Rating
Scale (HAMD) (Hamilton, 1960) and Young Mania Rating Scale (YMRS) (Young et al.,
1978) and achieved 76.4% recognition accuracy using fusion of location, acceleration and
voice features. For state change detection (novelty detection), the accuracy was as high
as 97.4% (Grunerbl et al., 2014; Gruenerbl et al., 2014) on testing set with three-fold
cross-validation.
2.3.5 Wearable devices
While smart phones provide a potentially powerful tool for monitoring changes in be-
haviour, psychological state (Bardram et al., 2012; Santos et al., 2012; Lathia et al.,
2013) and treatment delivery, they lack the capability for assessing physiology and sleep.
This is why wearable devices are often considered for the analysis of mental state. Wear-
able devices can take different forms, starting from conventional wrist-worn bracelets to
smart textile clothing solutions. The above-mentioned ICT4Depression and MONARCA
projects included design of wearable instrumentation as dedicated work packages, with
ICT4Depression focusing on the development of a “smart glove” (measuring EDA and
blood volume pulse) (Silva et al., 2012; Arau´jo et al., 2012) and MONARCA using a
“smart sock” (measuring EDA and acceleration) approach (Kappeler-Setz et al., 2011;
Gravenhorst et al., 2013). Help4Mood also incorporated eZ430-Chronos smart watch
(Texas Instruments, US) as one of the system components (Perez-Diaz de Cerio et al.,
2012). However, none of the projects described above reported clinically useful results
using the in-house developed instrumentation.
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The OPTIMI project7 used a different approach, focusing mostly on physiological
assessment, and aiming to develop behavioural and physiological monitoring tools to
detect potential early signs of stress and depression, using EEG, ECG, activity moni-
toring, voice analysis, cortisol measurements and electronic diaries (Botella et al., 2011).
However, the reported results included evaluation of the EEG headset only. It was vali-
dated for usability with 10 healthy participants with positive feedback (Zaragoza´ et al.,
2011). An accuracy of 94.2% was reported for detecting depression (BDI-II score of 14
or higher) using α-band absolute power, β-band absolute power, θ-band absolute power,
C0-complexity, largest Lyapunov Exponent and Lempel-Ziv complexity features and with
three-fold cross-validation on 25 female volunteers (Zhang et al., 2013).
A textile multi-sensor monitoring system for patients with bipolar disorder was de-
veloped by the PSYCHE project8 (Paradiso et al., 2010; Javelot et al., 2014). The
developed “sensor shirt” included ECG, respiratory rate and acceleration sensors to per-
form physiological assessment. The main activities of the project mostly concentrated
on the development of tools and methods for the analysis of ECG and identification of
mood states (Valenza et al., 2014b; Valenza et al., 2014a), so validation of the technology
was performed in controlled conditions with 8 bipolar patients. However, only 3 subjects
participated in the evaluation of mood detection during unstructured activity, with a
reported accuracy of euthymic state recognition as high as 82.4% (Valenza et al., 2015).
In the framework of the same project small scale experiments were performed with EDA
analysis (10 bipolar patients for 20 minutes) (Greco et al., 2012; Greco et al., 2014) and
voice analysis (11 bipolar patients) (Guidi et al., 2014) and significant differences were
identified between mood states.
7http://www.optimiproject.eu/, FP7 project number 248544
8http://www.psyche-project.org/, FP7 project number 247777
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2.4 Discussion and conclusions
Psychiatric questionnaires and clinical interviews are the gold standard for the evaluation
of clinical states in mental health. However, there are some issues with objectivity and
inter-rater agreement of such assessments (Lobbestael et al., 2010). To evaluate the pres-
ence of specific symptoms we may also collect information using accepted physiological
measurements, which are known to be correlated with these symptoms. Such measure-
ments, important in the context of mental disorders, may include physical, cardiac and
electrodermal activity (Cacioppo et al., 2007). Despite the fact, that only limited correla-
tions were reported previously, combining measures from different monitoring modalities
and with a focus on assessing specific symptoms and not disorders per se, may provide a
way to improve diagnosis and management of mental disorders.
Physical activity: Actigraphy information can be obtained using mobile phones or
body mounted accelerometry measurement devices, located on the wrist, hip or waist,
depending on research settings. Changes in physical activity and sleep structure have
been shown to correlate with a range of short and long term medical conditions, from
cardiac problems to mental health issues (Foster and Wulff, 2005; Wirz-Justice, 2007a;
Wulff et al., 2010). Usage of actigraphy for sleep-wake assessment was first proposed in
1982 by Webster et al. (Webster et al., 1982) and usage of body-mounted actigraphs for
analysis of sleep and circadian rhythms in mental disorders, such as schizophrenia, was pi-
oneered in 1990 by Witting et al. (Witting et al., 1990) and has been widely adopted since
then. Recent models of actigraphs may include high-precision micro-electro-mechanical
sensors (MEMS) for tri-axial acceleration measurement and allow for very precise auto-
mated classification of activity (Zhang et al., 2012), opening up the possibility for the
development of powerful actigraphy analysis methods.
Heart rate: The heart rate is controlled by both the sympathetic nervous system
(SNS) and parasympathetic nervous system (PNS) (Appelhans and Luecken, 2006; Lor-
ber, 2004). In the context of mental disorders, the heart rate is especially important
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for analysing problems related to emotional regulation and was proposed as an objective
measure of emotional arousal (Lacey and Lacey, 1974). HR derived features, such as heart
rate variability (HRV) (Appelhans and Luecken, 2006; Friedman and Thayer, 1998), are
useful in the analysis of such conditions as depression (Carney et al., 2001), aggression
(Scarpa and Raine, 1997), anxiety (Lang et al., 1998) and psychopathy (Hare and Quinn,
1971). Heart rate data may be collected using different modalities, including electrocar-
diogram (ECG), blood pressure monitors, audio acquisition devices (such as electronic
stethoscopes) and pulse oximeters. Portable (Holter) ECG monitoring devices are most
widely used for cardiac function assessment and HRV analysis, due to their capability in
the detection of normal beats for HRV calculation (Task Force of the European Society
of Cardiology the North American Society of Pacing Electrophysiology, 1996) and good
temporal resolution. A study by Lu et al. (Lu et al., 2008) indicates that pulse oximetry
can also be used to extract some measures of heart rate variability.
Electrodermal activity: Unlike the heart rate, electrodermal activity is influenced
only by the SNS (Lorber, 2004; Fowles, 2007). EDA is measured by obtaining skin
conductivity and is usually split into the tonic and phasic parts, where tonic is a reference
level and phasic corresponds to the reaction to a certain stimulus (Boucsein, 2012). The
phasic EDA signal can be further analysed to extract response features, such as frequency,
amplitude, rise time, recovery time and other metrics. Although the primary use of EDA
is related to emotion regulation research (Birket-Smith et al., 1993; Scarpa and Raine,
1997) and psychopathy (Fung et al., 2005), it is also used in studies of schizophrenia
(O¨hman, 1981; Dawson et al., 2010).
A number of projects were started in the last decade to evaluate the potential of phys-
iological measurements for use in mental health assessment, described in Table 2.2. These
projects mainly benefited from the development of consumer-grade activity monitoring
devices, such as mobile phones and commercial fitness trackers, as well as advances in
electronic miniaturisation, enabling the development of wearable physiological sensors.
However, the existing studies suffer from a number of shortcomings, including:
33
Table 2.2: Summary of publications on physiology and activity in analysis of mental disorders.
Study description Study type Participants Results
Treatment of depression using Questionnaires Major depression, 2 cohorts Only usability
virtual agents, Help4Mood 1) 5 subjects, 7 days evaluated
(Breso´ et al., 2014) 2) 4 subjects, 15 days
Recognition of emotions using Smart phone voice, Healthy subjects 58.7-84.7%%
mobile phone sensors, EmotionSense bluetooth and 12 subjects, 24 hours accuracy of emotion
(Rachuri et al., 2010) accelerometer recognition (no CV)
Evaluation of blood pulse volume Blood pulse volume Healthy subjects R2 > 90% comparing
sensor, ICT4Depression 10 subjects, 5 minutes to reference signal
(Silva et al., 2012)
Evaluation of localised EEG sensor, EEG Healthy subjects Visual EEG
ICT4Depression (Arau´jo et al., 2012) 1 subject evaluation
Evaluation of mobile phone Blood pulse volume Depression Only usability
based mood intervention, and ECG 23 subjects, 6 weeks evaluation
ICT4Depression
(ICT4Depression Consortium, 2013a)
Evaluation of mobile phone Blood pulse volume Depression Only usability
based mood intervention, and ECG 25 subjects, 6 weeks evaluation
ICT4Depression
(ICT4Depression Consortium, 2013b)
Evaluation of mobile phone for mood Smart phone Bipolar disorder Patient-specific
monitoring, MONARCA accelerometer 9 patients, 3 months correlation between PA
(Osmani et al., 2013) and mood reported
Technical feasibility of mobile Galvanic skin Bipolar disorder Only feature
galvanic skin response sensors, response 11 patients, 7 months differences reported
MONARCA (Gravenhorst et al., 2013) (3-4 30 minute sessions) (p-values)
Evaluation of smart phone sensors Smart phone GPS, Bipolar disorder 76% mood recognition
for identification of mood, accelerometer 12 patients, 12 weeks accuracy (no CV)
MONARCA (Grunerbl et al., 2014) and sound
Evaluation of smart phone Questionnaires Bipolar disorder 29% increase of
questionnaires for identification of 12 patients, 12 weeks compliance reported
mood, MONARCA (Bardram et al., 2013) comparing to paper
Technical feasibility of wearable Galvanic skin Healthy subjects 88% of reference
galvanic skin response sensors, response (sock) 8 subjects, 21 minutes signal responses
MONARCA (Kappeler-Setz et al., 2011) detected
Technical feasibility of wireless Smart phone, smart Healthy subjects Only usability
sensor network for mood watch, key ring, numbers and durations evaluated
monitoring, Help4Mood belt and bed motion not reported
(Perez-Diaz de Cerio et al., 2012) sensors
Evaluation of a system for stress Wearable motion, ECG, Healthy subjects Only usability
detection, OPTIMI (Zaragoza´ et al., 2011) stationary EEG and 12 subjects, 1 day evaluated
microphone
Depression detection using EEG, EEG Healthy and depressed 94.2% accuracy
OPTIMI, (Zhang et al., 2013) volunteers (3-fold CV)
25 subjects, 1 month
Mood states detection using HRV, ECG Bipolar disorder Only feature
PSYCHE (Valenza et al., 2014a) 8 subjects, 2 nights differences reported
(p-values)
Mood states detection using EDA, EDA Bipolar disorder > 76% state
PSYCHE (Greco et al., 2012) 3 subjects, 75 days recognition accuracy
(2-5 20 minutes sessions) (5-fold CV)
Mood states detection using EDA, EDA Bipolar disorder and controls Mixed results
PSYCHE (Greco et al., 2014) 20 subjects, 75 days reported for
(1-2 20 minutes sessions) different subjects
Mood states detection using speech Speech Bipolar disorder and controls Only intra-subject
analysis, PSYCHE (Guidi et al., 2014) 30 subjects, 2 days analysis of voice
features performed
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• The small number of participants and limited duration of data collection.
• The lack of a principled framework, connecting new results and previous research
findings.
• The use of experimental technology without considering long-term usability.
• The results are often mixed and hard to generalise due to the use of custom data
collection tools and analysis methods.
• The participants are often from specific research cohorts, e.g. specialist clinic set-
tings.
There is a clear need for development of a more solid evidence base in the objective
assessment of mental health. It is necessary to validate if the existing monitoring tools
are appropriate for long term monitoring, and can be used in clinical populations. There
is also a need for better understanding of the complex picture of individual symptoms
and the provision of more personalised care. Large scale and long term behavioural
data may allow for the creation of individual phenotypes and the identification of more
objective boundaries between different disorders, that address underlying pathologies and
are predictive to treatment response.
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Chapter 3
The Automated Monitoring of
Symptoms Severity (AMoSS) study
3.1 Motivation and study organisation
3.1.1 Objectives
As has been mentioned in Chapter 2, the key limitations of objective mental health
research studies produced so far include the small number of subjects, limited duration
of data acquisition, and difficulties in translating results into clinical practice due to the
usage of research-grade data collection instrumentation, which is not completely suitable
for continuous use in ambulatory settings. The most important collaborative research
projects, aiming to demonstrate the benefits of mobile technology for mental health,
including the ICT4Depression, MONARCA and PSYCHE, were working with cohorts of
10-20 subjects and collected up to 3 months of data (Warmerdam et al., 2012; Bardram
et al., 2012; Valenza et al., 2015).
In order to overcome these difficulties and create a more solid evidence base for the
introduction of behaviour monitoring in clinical practice, the Automated Monitoring of
Symptoms Severity (AMoSS)1 study was designed, with a protocol written by Athanasios
1http://conbrio.psych.ox.ac.uk/the-amoss-study
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Table 3.1: Projects using mobile and wearable technologies in mental health applications. Many
projects were focused on technology development in a framework of European collaborative re-
search, and included multiple separate validation studies with different numbers of participants.
Project Number and type of participants Study duration
AMoSS 50 bipolar disorder, 1 year
30 borderline personality disorder,
50 healthy controls
MONARCA Study 1: 10 bipolar disorder 3 months
Study 2: 12 bipolar disorder
PSYCHE Study 1: 8 bipolar disorder patients Up to 1 day
Study 2: 10 bipolar disorder patients
Study 3: 11 bipolar disorder patients
OPTIMI Study 1: 10 healthy participants Up to 1 day
Study 2: 25 depression
ICT4Depression Study 1: 24 depression Up to 6 weeks
Study 2: 23 depression
Help4Mood Study 1: 4 depression Up to 7 days
Study 2: 5 depression
Tsanas and Kate Saunders (not published) (Clifford et al., 2015) with technical contri-
butions from the author of this thesis. The AMoSS study protocol includes collection of
data from bipolar disorder (N=50), borderline personality disorder (N=30) and healthy
control subjects (N=50) for a duration of one year, representing a substantial advance
in both study duration and number of participants compared to previous research (see
Table 3.1). The study was approved by the local NHS research ethics committee (REC
reference 13/EE/0288) and all participants provided written informed consent.
The AMoSS study was designed to improve the understanding of bipolar and bor-
derline personality disorders and to explore new ways of ambulatory monitoring and
self-management in mental health. The study used off-the-shelf consumer-grade moni-
toring tools in parallel with research-grade instrumentation to acquire high-quality and
long-term physiological and behavioural data from patients and controls. The objectives
of the study were (Clifford et al., 2015):
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• Primary objectives: To measure objective differences in activity
and physiological measures, between healthy controls and people with
bipolar disorder and borderline personality disorder, and associate
these with the symptom severity which is quantified using the patients’
self-reported assessments.
• Secondary objectives: Secondary objectives of the research include
answering the following questions:
– What are the minimal number of sensors required towards our
goals in order to obtain accuracy (sensitivity and specificity) of
at least 90%?
– Can we identify, in advance, patterns in the data that are associ-
ated with deterioration in mental state? This will be determined
by exploratory analysis at the end of the study.
– What is the acceptability of the overall monitoring approach, and
regarding specific sensors for each participant? We will also ob-
tain implicitly the acceptability of each sensor by the frequency
that participants set specific sensors off.
The primary study objective was dictated by the need for better clinical understand-
ing of bipolar and borderline personality disorders, where diagnostic criteria may not
allow for a simple delineation between two. Identification of reliable objective behaviour
features associated with specific symptoms of these disorders, as well as prevalence of
these behaviours in clinical populations, allows building personalised models of deterio-
ration, that would account for inter-person variations in euthymic state and symptoms
manifestation during clinical episodes.
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3.1.2 Recruitment of participants
Participants for the study were recruited by research staff at the Department of Psychia-
try of the University of Oxford, at the Warneford psychiatric hospital. Healthy controls
were recruited through advertisement and from previous study cohorts. Bipolar disor-
der patients are recruited from the OXTEXT-1 study cohort (Armstrong et al., 2015).
Borderline personality disorder patients were recruited both from previous research co-
horts and by advertisement; due to the prevalence of the disorder in clinical populations,
the borderline personality disorder participants were predominantly female, so in order
to balance the cohorts, numbers of participants in bipolar disorder and healthy cohorts
were increased by comparison with the borderline, and a higher proportion of female
participants were recruited to these groups.
3.1.2.1 Demographics and clinical characteristics
All participants of the study were monitored in an ambulatory environment. Patients
received treatment and many were medicated, however all were relatively stable at the
time of recruitment. Recruitment and data collection for the study is still ongoing, so the
healthy and clinical groups are not yet complete. Due to this fact the AMoSS data set
may be unbalanced, for example it can be seen that age, weight and BMI are significantly
different between healthy and bipolar disorder cohorts (see Table 3.2).
Table 3.2: Demographic characteristics of the AMoSS study participants. Superscripts indicate
that the distributions are different with p < 0.05 according to the Wilcoxon rank sum test. BD,
BPD and HC superscripts refer to bipolar disorder, borderline personality disorder and healthy
controls.
Healthy controls Bipolar disorder Borderline personality
disorder
Number of participants 32 43 22
Gender 23 females 28 females 19 females
Age (Mean±SD) 33.12±11.54 BD 38.37±11.68 HC 33.05±10.90
Height (Mean±SD) 169.78±8.37 169.47±9.28 167.05±7.57
Weight (Mean±SD) 69.19±13.09 BD 79.09±18.15 HC 77.64±19.47
BMI (Mean±SD) 23.99±4.04 BD 27.44±5.47 HC 27.90±7.18
39
3.1.3 Data collection
The AMoSS study is multifactorial by design and includes a phase for preliminary assess-
ment, where key data including occupational and personality characteristics are collected.
The phase of objective data collection includes a 12-week period (with the option to con-
tinue for one year) of continuous activity data collection using Galaxy S3 or S4 smart
phone (Samsung, Korea), Fitbit One commercial activity tracker (Fitbit, US), weekly
detailed and daily short mood questionnaires, and a week of high intensity data collec-
tion, including high frequency acceleration, ECG, body temperature, blood pressure and
a short mood questionnaire on the phone up to 10 times a day (see Table 3.3).
The data collection strategy aimed to capture longitudinal data if possible, but in the
same time include all modalities that may be important for identification of symptoms
of analysed mental disorders, as based on the prior art discussed in Chapter 2. Therefore
for long-term monitoring (from 3 months and up to a year) off-the-shelf devices were used
that have a proven history of compliance (Fitbit One and smart phone).
In the same time the quality of data collected with such devices is not validated, and
the number of signals is limited. Therefore during a shorter period of time, with duration
constrained by characteristics of data collecting devices, research-grade instrumentation
were also used, such as GENEActiv accelerometer.
ASRM, QIDS-16SR and GAD-7 questionnaires were delivered with a weekly fre-
quency, as these questionnaires require recollection of last week behaviours to provide
mood scoring. Mood Zoom questionnaire was designed to provide a low-overhead insight
into momentary subject emotional state suitable for SMS delivery and was delivered on
a daily basis.
Some phenomena, such as sleep, require additional information for assessment, such
as bed time segmentation. Such segmentation in research settings is usually provided
by sleep logs, however Fitbit One includes a simple button press capability for bed time
identification, so sleep logs were not used in this study to reduce burden on participants
with Fitbit-based bed time reporting compliance described later in this thesis.
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Table 3.3: Monitoring modalities of the AMoSS study. During the high intensity week par-
ticipants were instructed to use a number of physiological sensors, in addition to usual mobile
and wearable devices and the Mood Zoom questionnaire was also administered with increased
frequency.
Instrument Signals Data collection
True Colours QIDS-SR16 (depression) Continuously administered for the period of
questionnaires ASRM (mania) study, delivered weekly
GAD-7 (anxiety)
EQ-5D (quality of life)
Mobile phone Tri-axial acceleration Continuously for the period of study,
sensors Light level variable sampling rate
Battery level
Geolocation
Calls and texts
Mobile phone Mood Zoom (mood) Once a day for the period of study,
questionnaires 10 times a day during the high intensity
week
Fitbit, commercial Steps Continuously for the period of study,
fitness tracker Floors one minute resolution, manual (button
Sleep analysis press) bed time annotation
Bed time annotation
GENEActiv wrist-worn Tri-axial acceleration High intensity week and optional at other
accelerometer Light level times, 10-50Hz sampling rate for a duration
Body temperature of 10-28 days
Shimmer ECG ECG High intensity week, up to 48 hours ECG
at 125Hz
Proteus patch HR High intensity week, HR every 10 minutes,
Body temperature physical activity every 5 minutes
Physical activity
Omron home blood Blood pressure High intensity week, 3 times a day
pressure monitor Heart rate
Omron temperature Body temperature High intensity week, 3 times a day
probe (ear or oral)
The data acquisition platform was designed to use a custom AMoSS mobile appli-
cation on an Android smart phone as the main data acquisition instrument, providing
a data entry interface for users and transferring the collected data to mobile back-end
servers, running Linux, Apache, MySQL and PHP (LAMP) software stack and providing
protected file storage for all study data (Palmius et al., 2014).
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To ensure data security, study participants and clinical assistants were located outside
of the protected internal network, where back-end servers were placed and which only
research personnel has access to. The data were uploaded to the internal network as
anonymised and only clinical assistants have access to participant’s identities, stored at
the Warneford psychiatric hospital (Oxford, UK).
To ensure compliance with data collection, participants were offered to keep study-
provided smart phones if continued the study for more than one year. The back-end
platform provided research personnel with status of data collection for each participant,
so that in case of interrupted data transfers the participant could be contacted directly
to identify and resolve the issue.
Note, that the study participants did not keep sleep log to reduce the study burden
on participants. All data collection modalities selected for the study required minimal
user interaction, however together could potentially cover a broad spectrum of possible
symptoms, and thus account for inter-subject variability in disorder manifestations.
3.1.3.1 Mobile phone application
The key component of the study is a mobile platform for the acquisition of data from
mobile phone sensors and Mood Zoom questionnaire (AMoSS mobile application) (see
Figure 3.1). The mobile application collects data from the mobile phone accelerometer
(tri-axial), light sensor, battery, coarse location information (obtained by proximity of
cell towers and Wi-Fi access points, unless the user has enabled GPS explicitly), as well
as phone calls and text messages (addressee, direction and length). All information that
may lead to the identification of participants by researchers is eliminated at the stage of
mobile phone data acquisition according to the following rules:
• For location data, during the application installation a random seed was generated
for latitude (range of ±90◦) and longitude (range of ±180◦), and subsequently
subtracted from all collected data, so location has an unknown at the analysis
stage offset from the real measured location, defined by the seed.
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a. b. c.
Figure 3.1: User interface of the AMoSS mobile application. Figure a) shows the main ac-
tivity visualisation screen, b) shows the Mood Zoom questionnaire prompt and c) presents the
application configuration options.
• For phone calls and texts, the real addressee number is replaced with a MD5 hash,
thus eliminating the possibility of identification, but at the same time preserving
the addressee’s uniqueness, and content of text messages or calls was not collected.
Users agreed with the applications terms of use during installation and required to
sign consent form in order to receive credentials to start using the application. The design
and functionality of the mobile application were evaluated in 3-months study on healthy
volunteers (students) to ensure that the data collection will not undermine usability of
smart phones (such as battery life) and ensure data transfer reliability to avoid significant
data traffic charges. But no formal comparison were performed between smart phone
characteristics with and without AMoSS mobile application.
From the software architecture point of view, the mobile application is organised into
a number of asynchronous modules, to facilitate continuous data collection and upload,
even if the application itself is not running in the foreground on a user’s phone. The
following key software components are included in the application:
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• User interface: Provides visualisation of the last 7 days of collected activity data,
an interface for submission of Mood Zoom questionnaire responses and a screen for
application configuration (see Figure 3.1).
• Background sensors data collection service: The service runs continuously on
the mobile phone and collects data from the accelerometer, light sensor, and battery,
as well as geolocation data, information about calls and texts and responses from
the Mood Zoom questionnaire. All data are saved on the phone’s local file system
in CSV format for up to 30 days or until uploaded to the AMoSS server.
• Background data upload service: The service performs a buffered asynchronous
upload of collected data as zip-compressed CSV files and manages the application
connectivity. Due to the large amount of data collected (5-10 MB per day per
participant) and to protect participants from excessive mobile data payments, server
uploads are only performed when a Wi-Fi connection becomes available.
• Events scheduler: The scheduler handles the key application events, such as
activation of the Mood Zoom questionnaire and repeated data upload attempts.
3.1.3.2 Server side interface
The main design goal of the server side interface was to provide a simple and flexible
infrastructure for acquiring and storing data from mobile phone sensors, as well as other
types of data collected during the study (Palmius et al., 2014) (see Figure 3.2). The server
interface was implemented using the LAMP open-source software stack and included the
following components:
• Web Server: Apache web server version 2.2.22 with HTTPS support (Rescorla,
2000) and PHP module for implementation of File Server functionality. For im-
proved security, the server is accessible only on an encrypted (HTTPS) connection.
• Authentication Server: A basic access authentication facility using user identifier
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Figure 3.2: Architecture of the AMoSS smart phone data acquisition platform. The password-
protected internal computing resources are highlighted in orange. Participants access the internal
network using provided smart phones with in-house developed AMoSS application.
and password (Franks et al., 1999). Each user is assigned a unique study identifier
(user name) and a specially generated strong password. The study identifier and
password need to be specified within the mobile application to establish a secure
server connection.
• File Server: A custom PHP scripts infrastructure for unidirectional file transfer
(data upload only). Once uploaded, data files are transferred to a secure server
area, not accessible by the Apache web server.
The key factor for implementation of server side interface was the limited availability
of supporting infrastructure and implementation resources. Therefore a "low-tech" ap-
proach to the implementation was taken, where uploaded data were stored in files, thus
simplifying server backups and data management by researchers. This approach in the
same time allows for a good horizontal scalability as data from different clients may be
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stored on different file servers and API server can be easily migrated to a facility with
automatic load balancing, such as Amazon Elastic Beanstalk. However, for the analysis
purpose the data need to be decompressed and converted from CSV to a format with
direct data access (Matlab data files used in this thesis), which may need significant
computational resources. Source code for all platform components is stored in private
Bitbucket Git repositories.
Only users recruited for the study or clinical study administrators are allowed to
upload data to the server and only researchers within the internal network can access the
uploaded data files. Additionally, a set of support scripts was developed for the creation
of new users, generation of strong alphanumeric passwords, conversion and re-sampling
of data.
3.2 Data analysis subset
Data collected by the AMoSS project are diverse and not all signals listed in Table 3.3
are used in this thesis. Since the main focus of this work is the identification of objective
features to continuously assess patients’ symptoms, the main emphasis was given to
accelerometry, as the least invasive data acquisition tool, and capable of characterising a
broad range of symptomatic behaviours (Teicher, 1995).
The selected subset of signals is described in Table 3.4, including the objective mea-
sures of physical activity and subjective questionnaire-based ground truth assessment
of symptoms. Note, that the ground truth of mental state is represented by subjective
assessment of symptoms, however it is the current state-of-art in diagnostics of mental
disorders, and shifting towards more objective assessment is the purpose of this thesis.
In the following sections a detailed description is provided for each of the selected
data sources.
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Table 3.4: Monitoring modalities of the AMoSS study selected for this research, including
subjective ground truth (questionnaires) and objective measures of activity and behaviour.
Signals Purpose
BIS-11 (impulsivity) score Ground truth for identification of trait
impulsivity related behaviour features
QIDS-SR16 (depression), Ground truth for identification of clinically
ASRM (mania) and GAD-7 (anxiety) significant mood episodes in recent two week
questionnaires period
Mood Zoom questionnaire Ground truth for short-term (day-to-day) mood
changes
Fitbit bed time annotation Ground truth for development of automated
bed/wake segmentation algorithms
GENEActiv acceleration and light High-quality dataset for identification of
level features, specific for behaviour of diagnosed
patients vs. healthy controls
Phone acceleration, light level, Long-term rich dataset for identification of
battery level, calls and texts clinically significant mood episodes
3.2.1 Questionnaires
3.2.1.1 Impulsivity assessment
Impulsivity is widely acknowledged as an important characteristic of many mental disor-
ders and clinical states (Swann, 2009). Impulsivity is generally considered to be a "trait"
characteristic, describing the habitual behaviour patterns independently on mental state,
however there were very few studies of impulsivity in mania or depression. The Inter-
national Society for Research on Impulsivity suggests four measurement tools, including
the Barratt Impulsiveness Scale (BIS-11) (Barratt and Patton, 1995), Balloon Analogue
Risk Task (BART) (Lejuez et al., 2002), Cued Go No-Go (Marczinski and Fillmore,
2003) and Immediate and Delayed Memory Tasks (IMT/DMT) (Dougherty et al., 2002).
In the AMoSS study, the impulsivity assessment (BIS-11) is performed once during the
enrolment process to identify the following personality traits:
• Attentional impulsiveness which assesses task-focus, intrusive thoughts, and
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racing thoughts.
• Motor impulsiveness which assesses the tendency to act on the spur of the mo-
ment and consistency of lifestyle.
• Non-planning impulsiveness which assesses careful thinking and planning and
enjoyment of challenging mental tasks.
It can be seen that the contributing factors describe human behaviour on multiple
scales, from seconds (attentional) to minutes and hours (motor) and days (non-planning),
and are strongly linked to physical activity or behaviour. Therefore continuous analysis
of physical activity recordings has the potential to characterise a person’s impulsivity by
analysing both day-time activity patterns and rapid changes in activities (for example
frequent changes between sedentary and moderate activities).
The AMoSS study includes healthy, bipolar disorder and borderline personality dis-
order participants, all having different profiles of impulsivity, as we can see from Figure
3.3. For the bipolar disorder patients increased impulsiveness is expected during manic
episodes and for the borderline personality disorder patients it is a persistent distinctive
trait characteristic.
3.2.1.2 Weekly mood questionnaires
The presence of clinical episodes of mania and depression in bipolar patients in am-
bulatory settings is usually assessed with questionnaires. The AMoSS study uses the
QIDS-SR16 for the assessment of depression (Rush et al., 2003), ASRM for the assess-
ment of mania (Altman et al., 1997) and GAD-7 for the assessment of anxiety (Spitzer
et al., 2006). The questionnaires are delivered on a weekly basis using the True Colours
Self-Management System2, via email or mobile text message.
As we can expect and see from Table 3.5, mood scores vary between the disorder and
control groups. However, according to DSM-5 diagnostic criteria symptoms are often
2http://truecolours.nhs.uk/
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a. b.
Figure 3.3: Boxplots of BIS-11 impulsivity scores of the AMoSS study participants, where
TOTL refers to the total score, and MOTR, ATTN, NPLN are the motor, attentional and non-
planning 2nd order factors respectively. BD, BPD and HC refer to biploar disorder, borderline
personality disorder and healthy controls.
required to be present for a certain period of time and to exceed a specific threshold (see
Table 3.6), to become a clinically significant episode.
Questionnaire-based weekly mood scores are used as the main ground truth for the
identification of bipolar disorder episodes, so compliance with questionnaires is of special
importance in this study. As we can see from Table 3.5, compliance among the AMoSS
study participants varied considerably, however the mean time between responses is not
significantly different between healthy and disorder cohorts at a level of p < 0.05 using
the Wilcox rank sum test.
Table 3.5: Scores and compliance of AMoSS study participants to QIDS-SR16, ASRM and
GAD-7 web-based questionnaires. Superscripts indicate if (and with which) the average value of
a given patient distribution is significantly different at a level of p < 0.05 using the Wilcox rank
sum test.
Healthy controls Bipolar disorder Borderline personality
disorder
QIDS-SR16 (Mean±SD) 2.24±2.06 BD BPD 8.01±3.99 HC BPD 13.85±4.09 HC BD
ASRM (Mean±SD) 1.29±2.22 BD BPD 2.74±2.21 HC 2.61±2.10 HC
GAD-7 (Mean±SD) 1.26±1.43 BD BPD 5.96±4.40 HC BPD 11.87±4.94 HC BD
Response rate, days (Mean±SD) 7.26±5.03 7.60±3.31 8.27±3.39
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Table 3.6: Diagnostic thresholds of weekly mood questionnaires, mood disturbance should persist
for a minimum duration of time to be considered a clinically significant episode (see DSM-5
(American Psychiatric Association, 2013)).
Questionnaire Score range Interpretation
QIDS-SR16 0-5 No depression
6-10 Mild depression
11-15 Moderate depression
16-20 Severe depression
21-27 Very severe depression
ASRM 0-5 Less likely mania
6-25 Higher probability of mania
GAD-7 0-4 Minimal anxiety
5-9 Mild anxiety
10-14 Moderate anxiety
15-21 Severe anxiety
From Figure 3.4 it can be seen that compliance pattern remains stable for each partici-
pant for the duration of the study. The relatively high variance in inter-response intervals
is explained mostly by participants who stop responding to questionnaires after a period
of time, as illustrated by Figure 3.4. It must be also noted, that according to the opinion
of the AMoSS clinical team, compliance can be a function of the clinical state, i.e. the
patient may stop responding during a manic or depressive episode.
50
Figure 3.4: Weekly QIDS-SR16 depression scores collected from the AMoSS study participants,
demonstrating compliance to email mood prompts. All questionnaires are delivered simultane-
ously, so similar results are observed also for ASRM and GAD-7 responses. The colour of the
plot indicates a score as described by the colour bar on the right side of the plot.
3.2.1.3 Daily mood questionnaires
Mood questionnaires, delivered on a weekly or bi-monthly basis are reliable and validated
clinical instruments, however they may suffer from recall bias in determining the actual
objective historic values of measured phenomena (Ben-Zeev et al., 2012). Therefore daily
assessment of mood may be useful and included in the AMoSS study protocol. Daily
mood assessment was performed using the Mood Zoom questionnaire, implemented as a
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part of the AMoSS mobile application.
The Mood Zoom questionnaire assesses self-rated mood on six dimensions, namely,
anxiety, elation, sadness, anger, irritability and energy, using a 7-item Likert scale, rating
each state from "Not at all" applicable to "Very much" applicable. Mood Zoom does
not have a diagnostic purpose and is intended to provide a more detailed assessment of
mood, irrespective of the underlying disorder, as we can see from Table 3.7.
Table 3.7: Scores and compliance to Mood Zoom questionnaires of AMoSS study participants.
Numbers from 1 to 7 correspond to grades of Likert scale with a lower grade representing the
lower subjective experience level. Superscripts indicate that the distributions are different with
p < 0.05 according to Wilcoxon rank sum test.
Healthy controls Bipolar disorder Borderline personality
disorder
Angry (Mean±SD) 1.39±0.59 BD BPD 1.94±1.20 HC BPD 2.45±0.84 HC BD
Anxious (Mean±SD) 1.74±0.82 BD BPD 2.86±1.39 HC BPD 4.07±1.36 HC BD
Elated (Mean±SD) 2.71±1.45 2.40±1.10 2.86±1.10
Energetic (Mean±SD) 3.50±1.09 BD BPD 2.92±0.94 HC 2.89±0.87 HC
Irritable (Mean±SD) 1.68±0.69 BD BPD 2.47±1.17 HC BPD 3.13±1.25 HC BD
Sad (Mean±SD) 1.56±0.73 BD BPD 2.48±1.27 HC BPD 3.76±1.21 HC BD
Response rate, days (Median±IQR) 0.92±0.51 1.05±0.64 1.01±0.69
The Mood Zoom is delivered using the AMoSS smart phone application, and the
user is notified about the submission time via the phone alarm, so compliance may be
different compared to email-based notifications of weekly questionnaires. From Table 3.7
and Figure 3.5 we can see that the median inter-response interval is not significantly
different between groups and the variance can be explained mostly by participants who
stopped responding at some point of the study.
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Figure 3.5: Mood Zoom sadness self-rating collected from the AMoSS study participants. Ac-
cording to the application’s design, all Mood Zoom questions have to be answered to enable
submission of results, so compliance is the same for all mood dimensions. The colour of the plot
indicates the score as described by the colour bar on the right side of the plot.
3.2.2 Objective behaviour assessment
Objective assessment of behaviour in this work is based on the analysis of data from
accelerometers embedded in mobile phones and GENEActiv wrist-worn devices. Activity
measurement using accelerometers (e.g. actigraphy), is an inexpensive and easy-to-use
approach, frequently used in sports medicine (Swartz et al., 2000), for sleep (Sadeh,
2011) and circadian research (Ancoli-Israel et al., 2003). Measurement results depend
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on device location on the human body. For sleep and circadian rhythms analysis (and
also in this project), the non- dominant wrist was selected as the preferred location of
the accelerometer (Steenari and Aronen, 2002; Berger et al., 2008), but no significant
difference in analysis results were reported between dominant and non-dominant wrists,
as well as if worn on the waist (Sadeh et al., 1994).
Accelerometers measure changes in speed, typically using piezo-electric sensors. Ac-
celerometer hardware is constantly evolving, with many devices on the market being
from an older generation, offering non-directional measurement of acceleration in arbi-
trary units (counts) rather than SI units (m/s2). Such devices suffer from technological
limitations, including a limited amount of data storage, low sampling rates (below 0.1
Hz) and non-linearity of acceleration measurements. Results of activity measurement in
such devices are usually collected in epochs of several seconds or minutes (Roebuck et al.,
2013). Activity data are often post-processed and available as zero-crossing timestamps
(frequency of movement), time-above-threshold (duration of movement) or periodic inte-
gration information (intensity of movement) (Hersen, 2006).
Modern micro-electro-mechanical system (MEMS) accelerometers (used by this project),
are capable of precise tri-axial acceleration measurement. Such accelerometers only re-
cently started to be used in research (te Lindert and Van Someren, 2013) and allow for a
reliable automated classification of activity, with the study of Zhang et al. demonstrating
99% classification accuracy of walking, running, household and sedentary activities in a
study with 60 healthy participants in laboratory and outdoor environments (Zhang et al.,
2012). Modern accelerometers usually integrate a set of sensors, including a tri-axial ac-
celerometer and others (such as light, temperature and pulse rate), however for simplicity
the word “actigraph” or “accelerometer” will be used to refer to such devices.
In this work, the main focus is on physical activity data, obtained from GENEActiv
(Activinsights Ltd, UK) accelerometers (see Figure 3.6) and Galaxy S3 or S4 mobile
phone sensors, that are described in detail in the following sections.
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3.2.2.1 Wrist-worn accelerometer
The GENEActiv accelerometer is a waterproof research-grade device, suitable for contin-
uous 24x7 use and includes a tri-axial accelerometer, light sensor and body temperature
sensor with operating characteristics presented in Table 3.8. Collected data are stored in
internal memory and can be uploaded for analysis using a specialised cradle.
a. b.
Figure 3.6: GENEActiv acceleromenter, a) presenting the physical design and b) the orientation
of acceleration measurement axes. Adapted from (Activinsights Ltd., 2012).
The GENEActiv accelerometer provides a very high quality physical activity mea-
surement with configurable sampling frequency (frequencies of 50, 25 and 10 Hz are used
in the study). The period of assessment using GENEActiv is limited by the internal
memory capacity, and participants need to return the device to study administrators to
upload the collected data. Therefore the duration of the GENEActiv assessment is lim-
ited to 10-28 days, depending on the configured sampling frequency, with one or more
assessment sessions performed per participant during the period of the AMoSS study.
The AMoSS study participants are instructed to use the accelerometer continuously,
unless taken off due to a medical procedure or similar. However, not all participants
follow the instruction and devices were often taken off at night or not worn during the
day time. During the non-wear time the accelerometer measures 1g acceleration (gravity)
and it affects (decreases) the cumulative daily activity measurements. Figure 3.7 presents
the average daily acceleration for all GENEActiv sessions, with gravity subtracted. We
can see that decreased daily acceleration values (dark blue) usually appear closer to the
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Table 3.8: Operating characteristics of GENEActiv accelerometer (Activinsights Ltd., 2012)
and integrated sensors.
Parameter Value
Sampling rate 10-100 Hz
Record duration 45 days @ 10 Hz, 7 days @ 100 Hz
Battery life 2 months
Operating temperature 5 to 40 deg C
Accelerometer type MEMS 3-directional
Accelerometer range +/− 8 g
Accelerometer resolution 3.9 milli g
Light sensor type Silicon photodiode, 400 to 1100 nm
Light sensor range 0 to 3000 Lux
Light sensor resolution 5 Lux
Temperature sensor type Linear active thermistor
Temperature range 0 to 60 deg C
Temperature resolution 0.25 deg C
Other features Event button, Water-resistant to 10 m
end of the measurement session, as participant compliance decreases towards the end of
assessment.
The information, collected with GENEActiv accelerometers, potentially allows iden-
tification of objective differences in activity between participant groups, but may not be
enough to capture a large number of clinically significant disorder episodes for two main
reasons:
• According to the DSM-5 diagnostic criteria, symptoms of depression need to be
present for at least two weeks for a clinically significant depressive episode to be
detected (or one week for a manic episode).
• In bipolar disorder, disorder episodes are relatively infrequent, and even in rapid
cycling bipolar (approximately 10% of patients) episodes may happen up to four
times a year.
Patients in the AMoSS study are well-managed and the probability of capturing an
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episode, while assessing a randomly selected continuous 10-28 day period is quite low.
Therefore to capture clinically significant episodes of bipolar disorder in well-managed
patients, such as our study cohort, we need to acquire at least one year of data, so that
periods of euthymia and deterioration are both present in collected information. Due to
usability issues of research-grade instrumentation (Teicher, 1995), such data acquisition
is practically possible only with consumer-grade devices.
Figure 3.7: GENEActiv activity data collection sessions. Each bar represents a single assess-
ment session. The colour of the plot represents the mean daily acceleration in units of g at sea
level, after removing 1 G as the background gravitational field, with deep blue indicating a very
low level of activity, such as non-wear or sedentary time.
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3.2.2.2 Mobile phone
Of all consumer devices with the potential to record accelerometry, none is more ubiq-
uitous than the mobile phone, therefore this work focused mostly on the data collected
with mobile phone sensors. For continuous long-term physical activity and behaviour
assessment in the AMoSS study, Android smart phones were used, making it possible to
capture and analyse clinically significant mood episodes.
Participants were given Samsung Galaxy S3 or S4 mobile phones with pre-installed
in-house developed AMoSS mobile application, continuously collecting data from phone
accelerometer, light sensor, coarse geolocation, as well as time, direction and duration of
phone calls and text messages. All participants used the study-provided mobile phone as
their primary one.
Key phone sensors characteristics are presented in Table 3.9 and sampling frequencies
for all signals are variable and defined by Android platform at run time.
Table 3.9: Operating characteristics of Samsung Galaxy mobile phone sensors.
Parameter Value
Sampling rate variable up to 10 Hz
Record duration unlimited
Battery life depends on usage (1 day typical)
Accelerometer type LSM330DLC (MEMS 3-directional)
Accelerometer range ±2 g
Accelerometer resolution 0.1 milli g
Light sensor type CM36651 (CMOS RGB)
Light sensor range 0 to 121240 Lux
Light sensor resolution 1 Lux
AMoSS mobile application runs in background, providing instrument for truly ambient
behaviour monitoring, where non-use of mobile phone is also a useful source of information
about participants’ behaviour. However, although participants were encouraged to use the
study-provided mobile phone as their primary one, not all participants did so. Another
issue for mobile phone data collection is data missingness due to sensor failure. Due to
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the specifics of the Android platform, data collection is performed in a non-deterministic
environment and there are several main reasons for missing data from phone sensors:
• Any mobile application can be terminated by the Android platform if phone re-
sources (such as memory) are needed by other applications with a higher priority
(for example those running in the foreground and interacting with the user). In
such situations data collection may stop for an unspecified period of time until the
application is restarted.
• The acceleration sampling rate may decrease or sampling may stop completely in
response to external events, for example the sampling rate decreases during periods
of phone non-movement to reduce power consumption.
• The user may uninstall the AMoSS application, stop using it, or the internal phone
SD card may become full, preventing the phone from saving data collected from
the sensors.
Although the AMoSS project clinical team handled issues such as phone damage or
accidental uninstallation, it was not possible to eliminate all problems, partially because
the developers did not have access to participants’ devices. Therefore the phone data
collection in the AMoSS project is prone to intermittent interruptions, with frequency and
duration influenced partially by phone usage patterns. Figure 3.8 presents all acceleration
data collected from the study participants as a percentage of seconds with at least one
sample for each day.
We can see that the percentage of missing data varies both between subjects and
within the data collection period of each specific subject. Very rarely a single subject
would have a data acquisition period with 100% samples collected. This emphasises the
need for pre-processing methods, capable of generating an evenly sampled time series by
imputing missing values with a reasonable default.
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Figure 3.8: Acceleration data collected from a smart phone. Each dot represents a day and the
colour of the plot represents the proportion of seconds during a day with at least one sample of
acceleration, deep blue indicating a very low sampling rate or missing data.
3.3 Summary
The AMoSS data set includes ground truth information about the subjects’ mood, to-
gether with physical activity, physiology and behavioural information, which is helpful in
identifying clinically significant episodes of disorder. Given the sample size, the number
and granularity of collected physiological data, research cohort composition, and the du-
ration of the study, AMoSS stands as one of the most advanced and detailed data sources
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for longitudinal behavioural assessment of psychiatric disorders.
The composition of the AMoSS data set makes possible the identification of objec-
tive differences between cohorts using the captured physical activity patterns, as well
as the identification of activity features that would be predictive to clinical symptoms
and disorder episodes. The data subset selected for this thesis consists of accelerometer
recordings from wearable research-grade devices and the in-house developed smart phone
application, together with self-rated mood scores as described by Table 3.4.
The ground truth of emotional state (representing clinical state for our study pop-
ulation) is represented by subjective assessment with ASRM, QIDS-16SR and GAD-7
questionnaires, validated for diagnostic accuracy for assessment of mania, depression and
anxiety (Altman et al., 1997; Rush et al., 2003; Spitzer et al., 2006). However, the as-
sessment of physical activity, sleep or other behaviours with questionnaires is known to
be inaccurate (Sabia et al., 2014; Busschaert et al., 2015), therefore leading to limited
agreement between even perfectly measured subjective and objective data.
GENEActiv accelerometer is widely used for assessment of physical activity and sleep,
and is one of the most (independently) validated devices on the market (te Lindert and
Van Someren, 2013; Rowlands et al., 2014a; Rowlands et al., 2014b; Schaefer et al.,
2014; Hildebrand et al., 2014; Troiano et al., 2014; Chapman et al., 2015). However,
the quality and quantity of collected data vary between participants, with one to three
GENEActiv recordings per participants, each of 10 to 21 days, and up to 12 months
of mobile phone data (depending on recruitment date) with variable sampling rate and
missing data periods.
The factors may be limiting for the presented research and were taken into account
in the data analysis strategy presented in the next chapters.
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Chapter 4
Data pre-processing methods
4.1 The problem of data quality
The AMoSS data set is diverse and includes different types of information, from self-rated
mood questionnaires to continuously collected data from sensors, which are not necessarily
evenly sampled. In this work several data analysis methods were applied to these data,
extracting different behaviour features. As noted by Enders (Enders, 2006), data quality
is not an inherent characteristic of a data set, but is largely defined by analysis methods,
each suggesting a different understanding of data quality and potentially different pre-
processing strategies. The quality issues specific to our subset are described in Table 4.1,
focusing on two main classes of data - questionnaires and sensor measurements.
Data quality issues in the context of questionnaires were discussed by Bowling (Bowl-
ing, 2005) with a focus on different modes of questionnaire administration. Many common
problems, such as interviewer bias or incomplete responses in the AMoSS study were
eliminated by the electronic mode of questionnaire delivery and specific design, which
only allowed the submission of complete responses. The remaining issues, including the
missing values (non-response) and recall bias, are addressed later in this chapter.
In the case of sensor values, data may suffer from missingness or absence (due to non-
wear or sensor failure), noise (inherent characteristic of any sensor) and measurement
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Table 4.1: The sources of data quality issues in AMoSS data.
Questionnaires Sensors
Missing values Non-response to questionnaires Non-wear time for wearable sensors,
interrupted data collection due to
sensor failure
Noise Typos Noise is often a feature of sensor
hardware
Bias Recall bias, subjective bias Sensor measurement bias may be created
(often disorder-specific) by imprecise sensor calibration and
hardware heterogeneity
bias (due to poor factory calibration of a sensor). These issues were analysed extensively
in the literature, specifically in the case of accelerometers, and a number of approaches
are proposed and described below (Lo¨tters et al., 1998; Catellier et al., 2005; Gietzelt
et al., 2008; Curone et al., 2010; van Hees et al., 2013; van Hees et al., 2014).
4.2 Noise and bias removal
4.2.1 Questionnaires
In the case of AMoSS questionnaires, sources of noise and bias include erroneous responses
(typos) and subjective bias, such as recall bias or disorder-specific bias in responses, as
noted also by Hinton (Hinton, 1966). For example, the important clinical characteristics
of the borderline personality disorder is the identity disturbance, characterised by illogical
or incoherent thought, feeling and behaviour, that could affect the objectivity of self-
assessment in questionnaire responses (American Psychiatric Association, 2013).
Noise and recall bias could be eliminated by using a second source of observations,
which is not always possible in practice. However, the AMoSS study includes collection
of objective data from sensors, and one of the analysis goals of this work is to identify
behaviour correlates of mood based on these data. Therefore the problem of biased
questionnaire responses is partially addressed by this work by using the alternative source
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of behaviour observations.
4.2.2 Accelerometer measurements
While accelerometers are calibrated during manufacturing, there is still the possibility of
systematic error in some devices (calibration error). The accelerometer calibration error
may include a bias and scaling error for each measurement axis separately, as represented
by the offset of accelerometer samples during inactivity periods from a 1 g sphere of a
perfectly calibrated device (see Figure 4.1).
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Figure 4.1: GENEActiv accelerometer data plot of a sample subject. Green dots represent
accelerometer samples during inactivity periods (identified as described in this section), black
circles are projections of a 1 g sphere of perfectly calibrated device measurements and red cross
represents the centre of mass. Accelerometer calibration error may include a bias and scaling
error for each measurement axis separately.
The principal framework for addressing this issue is called auto-calibration and in-
cludes identification of non-wear episodes, where measured acceleration should be equal
to 1 g. Accelerometer measurements during these periods are located on the boundary
of a 3-dimensional ellipsoid, with some offset and scaling on each of 3 axes (van Hees
et al., 2014). The offset and scaling errors are removed by identifying adjustment fac-
tors for every plane, to transform measurements to a perfect sphere with a zero offset
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(Lo¨tters et al., 1998; Gietzelt et al., 2008; Curone et al., 2010; van Hees et al., 2014).
Such a procedure allows the identification of the calibration error directly from captured
ambulatory recordings. For GENEActiv accelerometers it was validated by van Hees et
al. (van Hees et al., 2014) and includes the following steps:
1. For every time window of 10 seconds in each data record the standard deviation
and the average acceleration per axis are extracted.
2. Only time windows for which the standard deviation is < 13 milli g (empirically
derived) in all three axes are retained.
3. For all retained measurements at times t, axis-specific calibration is defined as
s
′
i(t) = di + si(t)ai, where si(t) and s
′
i(t) are acceleration before and after auto-
calibration, di is the offset and ai is the gain factor for axis i.
4. Parameters of the model di and ai are optimised by minimising the average calibra-
tion error (the difference between 1 g and the euclidean norm for each measurement)
using a least squares approach.
The sensor noise is then removed by filtering the transformed accelerometer measure-
ments as described in Section 4.4. Average accuracy improvement after sensor calibration
process was 0.0097± 0.0060 g (Mean±SD).
4.3 Dealing with missing data
The choice of strategy for dealing with missing data depends on the underlying assump-
tions on data missingness. The principal framework for dealing with missing values was
developed by Rubin (Rubin, 1976) and describes three missing data scenarios:
• Missing Completely At Random (MCAR): The probability of a missing value is
unrelated to both observed and unobserved values.
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• Missing At Random (MAR): The probability of a missing value is unrelated to the
missing values itself only.
• Missing Not At Random (MNAR): Missingness depends on the missing data.
Traditional strategies for dealing with missing values, including the arithmetic mean
imputation, regression imputation, stochastic regression imputation and the last obser-
vation carried forward, will provide an unbiased estimate only for MCAR data (Enders,
2006). The approaches that would work under both MCAR and MAR assumptions in-
clude the Maximum Likelihood (ML) and Multiple Imputation (MI) (Rubin, 1976; Schafer
and Olsen, 1998; Enders, 2006). However, in many (if not all) practical cases the missing
data are related to both observed and unobserved values. In such cases the approach for
dealing with missing data would depend on the model of data missingness.
In order to understand the nature of data missingness, a separate experiment may
need to be performed that require participants to recall the reason for not wearing a
certain sensor or not responding to a questionnaire. Due to resource constraints such
activity was not performed in the framework of AMoSS study.
4.3.1 Questionnaires
For subjective mood questionnaires, extensive analysis of mood time series with a focus on
forecasting was performed by Moore (Moore et al., 2012; Moore et al., 2014). Forecasting
methods, as well as imputation, use the known time series data to predict unknown
values, so forecasting methods may be also used to deal with missing data. Several
forecasting methods were investigated by Moore et al., including the unconditional mean,
last value carried forward, exponential smoothing and Gaussian Process regression. It
was demonstrated that the unconditional mean provides a better forecast in almost half
of all analysed mood time series (Moore et al., 2012), so it was selected as the imputation
strategy for this study.
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4.3.2 Accelerometer measurements
For wearable sensors, the main reason for data missingness is the non-wear time, where the
data readings are constant as opposed to no data during sensor failure. The identification
of missing data periods for GENEActiv and other wearable accelerometers was extensively
analysed in the literature (Lo¨tters et al., 1998; Catellier et al., 2005; van Hees et al., 2011;
van Hees et al., 2013). Proposed methods of non-wear episodes detection are based on
identification of inactivity periods, where the standard deviation of the signal is below a
certain threshold. This work adopts the method used by da Silva et al. (da Silva et al.,
2014) and van Hees et al. (van Hees et al., 2013), where for each 30 minute window, the
window is classified as non-wear time if for at least two axes the standard deviation of
acceleration is below 13 milli g and the signal range is below 50 milli g.
In human activity time series, data imputation is a difficult problem due to the fact
that data may be missing during specific activities, such as bathing or excercise (MNAR
assumption). Catellier et al. demonstrated that data missingness depends on the time of
the day and day of the week, therefore a simple imputation strategy is not appropriate
(Catellier et al., 2005). Sabia et al. (Sabia et al., 2014) and van Hees et al. (van Hees
et al., 2011) used arithmetic mean imputation, however took for averaging only data from
the same time of day, thus incorporating global knowledge into the data model. In this
work, following the approach of Sabia et al. and van Hees et al., non-wear time was
imputed with data from the same time of day, and of the same recording, averaged across
the surrounding 5 days, thus preserving local signal characteristics.
4.4 Averaging and dimensionality reduction
Modern accelerometers include tri-axial micro-electro-mechanical systems (MEMS) sen-
sors for three-dimensional acceleration measurement with sub-second time resolution.
However, for analysis, these measurements are usually converted into a uni-axial repre-
sentation, measuring cumulative activity for a certain period of time.
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4.4.1 Euclidean Norm Minus One (ENMO)
Focusing on the day-time activity analysis, van Hees et al. (van Hees et al., 2013)
performed comparison of different summary activity metrics, derived from tri-axial ac-
celerometers, and analysed the correlation between activity measurement results and
direct energy expenditure measurements. The analysed summary metrics included:
• Simple Euclidean norm (EN).
• Euclidean norm minus one, with negative numbers rounded to zero (ENMO).
• Euclidean norm of the high-pass filtered signal (HFEN).
• Euclidean norm of low-pass filtered signal minus one (HFEN+).
The ENMO and HFEN+ were found to explain most variance in daily PAEE, and
ENMO was argued to be the preferred metric in both free-living and robot experiments,
and was subsequently used in large-scale physical activity studies (da Silva et al., 2014;
van Hees et al., 2014). This study used the ENMO as the preferred data representation
for day-time activity analysis for compatibility with previous research, and to retain the
frequency-dependent information that could be eliminated by filtering.
4.4.2 Epoch-based “activity counts”
A large number of actigraphs on the market are older generation devices, usually offer-
ing non-directional measurement of acceleration in arbitrary units (counts) rather than
gravity units (g). Results of activity measurements in such devices are usually integrated
over epochs of several seconds to create so called ’activity counts’ (Hersen, 2006).
Many activity analysis methods are developed and validated for such epoch based
’activity counts’ data, specifically for sleep analysis, therefore it is important to ensure
the compatibility of data formats between modern and traditional devices. For tri-axial
GENEActiv accelerometers, te Lindert (te Lindert and Van Someren, 2013) developed
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a procedure for converting the raw acceleration into activity counts, compatible with
Actiwatch (CamNTech, UK) format, and validated it in sleep analysis settings. The
procedure includes the following steps:
1. Palmar-dorsal (z) axis of GENEActiv data is selected.
2. Band-pass filter (3-11 Hz, Butterworth order 5) is applied to the data.
3. The resulting signal is rectified and divided into 128 equally spaced bins between 0
and 5 g at the natural sampling frequency (25 or 50 Hz).
4. Within each second, peak value is detected and assumed to be the second count
value.
The procedure was validated in a study with 15 healthy adults and demonstrated
agreement between the Actiwatch and GENEActiv scored sleep/wake epochs with kappa
values of 0.83±0.07, and better agreement of analysis results between two simultaneously
worn GENEActiv accelerometers, compared with two simultaneously worn Actiwatch
accelerometers. This data format, however, may not perfectly represent the subject’s
physical activity due to the processing of palmar-dorsal axis, therefore in this study
“activity counts” were used for sleep analysis only.
4.5 Activity segmentation
Non-stationarity is one of the key characteristics of human activity and physiology,
driven by either exogenous impulses (such as sleep-wake routine, structured working days,
alarms, human interaction, etc.), or intrinsic changes in state variables such as mental
activity, blood pressure, heart rate, endogenous activity level and level of consciousness
due to sleep and circadian rhythms.
Analysis of non-stationarity is especially important in the context of ambulatory hu-
man behaviour, where data are collected from a range of mobile and wearable sensors
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and non-stationarities describe changes in physiological states, habitual activities or the
influence of external factors. Time-related information about transitions between such
states is valuable for the assessment of subjects’ daily routine, for analysis of sleep and
circadian rhythms (Aritake-Okada et al., 2010). Different analysis methods may also be
applied to data captured during different physiological states, such as sleep and wake-
fulness, therefore such states need to be identified (Blackwell et al., 2005; Tracy et al.,
2014).
Time series segmentation allows the identification of semi-stationary states within
a complete recording. Depending on the states of interests, a number of methods for
activity segmentation were proposed in this study, which were helpful for identifying high
level states of sleep and wakefulness, as well as transitions between activities within these
states, as described in the next sections.
4.5.1 Stationary activity segments
One approach for the analysis of non-stationarity of physical activity is splitting the entire
recording into stationary segments (each representing a certain behaviour or physiological
state) and analysing their duration distribution. Change point detection plays a critical
role in the identification of stationary segments.
In order to select the best method of change point detection to be applied to human
locomotor activity data, we first evaluated a number of methods on a synthetic data set,
created using the physiological heart rate model of McSharry-Clifford (McSharry et al.,
2002). The heart rate is known to be correlated with physical activity (Freedson and
Miller, 2000), so it is to be expected that segments duration distributions are similar
between both. The best performing method was then applied to human data.
4.5.1.1 Recursive Mean Difference Maximisation (RMDM)
This algorithm was proposed by Bernaola-Galva`n (Bernaola-Galva´n et al., 2001) to study
the scaling behaviour of the human heart rate and aims to recursively maximise the
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difference in mean values between adjacent segments. It was applied to physiological
signals, including inter-beat intervals of the human heart (Bernaola-Galva´n et al., 2001)
and DNA analysis (Haiminen et al., 2007; Bernaola-Galva´n et al., 2012).
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Figure 4.2: The first step of RMDM algorithm. The input signal in normalised units (top
plot), together with the Student’s t-statistic for the difference of mean between the left and right
subsignals (bottom plot) and the candidate change point at tmax (red dashed line).
Given the input signal S = {x1, x2, ..., xN} of length N , a sliding pointer is moved from
left to right, splitting the signal into S1 = {x1, x2, ..., xj} and S2 = {xj+1, xj+2, ..., xN},
where j is the position of the pointer (Figure 4.2). For each point, the means of the left
and right signals are calculated as
µ1 =
1
N1
∑
xi∈S1
xi, µ2 =
1
N2
∑
xi∈S2
xi. (4.1)
The difference between the means is calculated using the Student’s t-statistics
t(S1, S2) =
∣∣∣∣(µ1 − µ2)√σP
∣∣∣∣ , (4.2)
where σP is the pooled variance, defined as
σP =
N(V (S1) + V (S2))
(N − 2)N1N2 (4.3)
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and V (S) is the sum of squared deviations of the data in the signal S:
V (S) =
∑
xi∈S
(xi − µ)2. (4.4)
The Student’s t-statistic is calculated as a function of the position j in the timeseries
and a candidate change point jmax is selected, where t(j) reaches the maximum tmax.
The significance level P(τ) of the change point is calculated as P(τ) = {tmax ≤ τ},
where P(τ) could not be obtained in a closed analytical form and was numerically ap-
proximated by Bernaola-Galva`n as
P(τ) =
{
1− I[ ν
ν+τ2
](δν, δ)
}γ
, (4.5)
where γ = 4.19lnN − 11.54, δ = 0.40, N is the length of the signal, ν = N − 1 is the
number of degrees of freedom, and Ix(a, b) is the incomplete beta function. Note, that
the probability of the change point depends only on the length of the original signal and
the selected significance level τ (usually set to 0.95). The dependency of the length of
time series on the selected significance threshold is illustrated by Figure 4.3.
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If the difference in means is significant, the signal is split into two segments (if the
means of the new segments are significantly different from the means of adjacent seg-
ments) and the above procedure is repeated for each new segment while significance
holds. Note that a weak stationary requires both the mean and variance to be constant
and so this technique does not segment non-stationary changes due to shifts in variance.
4.5.1.2 Bayesian Blocks (BBLOCKS)
The Bayesian Blocks algorithm was proposed by Scargle et al. (Scargle et al., 2013) and
provides a dynamic programming approach for change point detection. The algorithm
uses a piecewise constant signal model and performs optimal fitting of model to data.
The algorithm requires fitness of segments to be additive, so that
F [P(S)] =
Nsegments∑
k=1
f(Sk), (4.6)
where F [P(S)] is the total fitness of the segmentation P of the signal S and f(Sk) is
the fitness of the segment k, calculated as
f(Sk) =
(
∑
N xi)
2
4
∑
N σ
2
i
, (4.7)
where N is the number of data points within a segment, xi is the individual data
point and σi is the expected error of the data point measurement. Note, that in our case
of unknown error of data point measurement and normalised signal, the expected error
is taken as σ = 1.
The optimal segmentation is defined as the one with the maximum fitness, and is
calculated using a dynamic programming approach. The algorithm starts with a sub-
signal, including only one data point xi=1, where only one segmentation is possible. In
each step, a new datum xi=i+1 is added to the signal and fitness of all new possible
segmentations is calculated for each j = {1, ..., i} as
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Figure 4.4: The results of BBLOCKS algorithm. The input signal in normalised units (top
plot, black) and the resulting segmentation (top plot, red), together with iterative estimation of
the segment fitness function (bottom plot, black), where the maximum fitness indicates the last
change point (bottom plot, red).
F ji [P({x1, ..., xi})] = Fmaxj−1 + f({xj, ..., xi})− γ, (4.8)
where the definition of variables is the same as for the Equations 4.6 and 4.7 and γ
represents prior on the expected number of segments. The change point j is identified at
the maximum of F ji [P({x1, ..., xi})] (see Figure 4.4).
The process continues for all data points of the signal and the sequence of j values at
the i = N defines the detected change points in the signal S.
4.5.1.3 Bayesian Online Change Point Detection (BOCPD)
A Bayesian Online Change Point Detection algorithm was proposed by Adams and
MacKay (Adams and MacKay, 2007) and further developed by Turner et al. (Turner
et al., 2009). The method iteratively estimates the probability distribution of segment
lengths using the Bayesian inference technique (Figure 4.5).
The method was originally proposed for conjugate-exponential models, where exact
inference can be performed. In this work BOCPD was applied to normally distributed
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Figure 4.5: The results of BOCPD algorithm. The input signal in normalised units (top plot,
black) and the resulting segmentation (top plot, red), together with iterative estimation of segment
length probability distribution (bottom plot, black), where the maximum indicates the most likely
segment length (bottom plot, red).
data with unknown mean and variance. In this case the conjugate prior distribution takes
the form of Normal-inverse-Gamma distribution
f(x, σ2|µ, ν, α, β) =
√
ν
σ
√
2pi
βα
Γ(α)
(
1
σ2
)α+1
exp
(
− 2β + ν(x− µ)
2
2σ2
)
(4.9)
with µ, ν, α and β hyperparameters (Bishop, 2006).
On each step of the algorithm, a new datum xi=i+1 is added to the analysed signal.
The posterior predictive probability of new datum has the form of a non-standardised
Student’s t-distribution (Murphy, 2007) with 2α degrees of freedom, the centre at µ and
scale parameter equal to β(ν+1)
αν
is given by
pi
(r)
i = t2α(xi|µi,
βi(νi + 1)
αiνi
), (4.10)
where r is the segment length, pi(r)i is the posterior predictive probability of segment
length r at data point i.
In order to calculate the probability of the change point, we should take into account
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that with each new datum the segment length may only increase (segment continues) or
become zero (change point detected). The growth probabilities are calculated as
P (ri = ri−1 + 1, x1:i) = P (ri−1, x1:i−1)pi
(r)
t (1−H(ri−1)) (4.11)
and the change point probabilities are calculated as
P (ri = 0, x1:i) =
∑
ri−1
P (ri−1, x1:i−1)pi
(r)
i H(ri−1), (4.12)
where r is the current segment length and H(r) is a hazard function, defined as
H(r) = 1/λ, where λ is a free parameter of the algorithm, representing the expected
segment length.
Finally, the hyper-parameters are updated according to
µi+1 =
νiµi + xi
νi + 1
,
νi+1 = νi + 1,
αi+1 = αi + 0.5,
βi+1 = βi +
νi(xi − µi)2
2(νi + 1)
,
(4.13)
as defined in the conjugate Bayesian analysis of the Gaussian distribution (Murphy,
2007) and the process repeats for the remaining data of the analysed signal.
4.5.1.4 Change point detection quality evaluation
Given that the number of change points detected by an algorithm can be less or exceed
the number of true change points, and a correctly detected change point may be within
the tolerance δ from a true change point, we used a modified confusion matrix to evaluate
the change point detection accuracy, where
• True Positive (TP) is a detected change point within the tolerance δ from a true
change point (each true change point can have only one detected change point),
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• False Negative (FN) is a true change point without a detected change point within
the tolerance δ,
• False Positive (FP) is a detected change point outside of any true change point
tolerance interval δ and
• True Negative (TN) does not have a meaningful interpretation, so is always 0.
4.5.1.5 Artificial change point data
In order to identify true change points we must use an objective time series where we be-
lieve the change points are (almost) perfectly annotated. While there is no available open
data set with annotated human activity measured by an accelerometer, there is a phys-
iological model available for the generation of realistic heart rate time series (McSharry
et al., 2002). The heart rate is known to be correlated with physical activity (Trost,
2001) and thus the HR model can be used to evaluate the performance of segmentation
algorithms.
The McSharry-Clifford (McSharry et al., 2002) algorithm (RRGEN) generates realistic
24-hour RR-tachograms using a model of cardiovascular interactions and transitions be-
tween physiological states. It incorporates short range variability due to Mayer waves and
respiratory sinus arrhythmia, as well as long range transitions in physiological states by
using switching distributions extracted from real data. Ten different 24-hour tachograms
were generated from the model together with true change points of model parameters.
All algorithms were evaluated for a range of free parameter values, experimentally
selected to cover a wide range of algorithm accuracy. For RDMD the significance level
was set to P(τ)={0.5, 0.6, 0.7, 0.8, 0.85, 0.9, 0.93, 0.95, 0.98, 0.99}. For BBLOCKS
algorithm the free parameter was set to γ={0.02, 0.1, 0.2, 0.4, 0.7, 1, 2, 4, 10, 20} and for
BOCPD the expected segment length was set to λ={5, 6, 7, 8, 10, 20, 60, 100, 200, 300},
experimentally selected to cover a wide range of algorithm performance. Performance
of the algorithms was estimated using the number of correct detections (TP) and the
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Figure 4.6: Performance of change points detection algorithms on artificial 24-hour tachograms.
All algorithms were tested with one, five and ten second change point detection tolerance level
and for a range of free parameter values.
number of incorrect detections (FP).
4.5.1.6 Evaluation results
The results for a range of free parameter values and different detection thresholds are
presented in Figure 4.6 and Table 4.2. All algorithms demonstrated different forms of de-
pendency between free parameter and change point detection accuracy, influenced by the
selected change point detection tolerance level. The RMDM algorithm performance was
lower compared to Bayesian methods in all cases. The BOCPD method performs better
for exact change point detection and BBLOCKS demonstrated performance improvement
with increased change point detection tolerance.
Notably, the BOCPD algorithm performance is less sensitive to the selected change
point detection tolerance level, as well as free parameter settings. As the main goal of
the identification of stationary segments was to detect impulsive behaviours, represented
by short interruptions of continuous activities, the results of change point detection with
best tolerance (one second) were considered as the most important. BOCPD algorithm
also demonstrated arguably the best performance with one second change point detection
tolerance and using the expected segment length of 60 seconds (see Table 4.2, selected in
magenta colour).
Although the evaluation of the algorithms was performed on HR time series, only
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Table 4.2: Performance of change points detection algorithms on artificial 24-hour tachograms.
All algorithms were tested with one, five and ten second change point detection tolerance level and
for a range of free parameter values. Best performance results for each algorithm and tolerance
are selected in bold text.
Change point detection accuracy
RMDM BBLOCKS BOCPD
P(τ) TPR (%) FPR (%) γ TPR (%) FPR (%) λ TPR (%) FPR (%)
One second tolerance
0.50 0.16 0.91 0.02 0.74 0.97 5.00 0.14 0.90
0.60 0.16 0.91 0.10 0.42 0.95 6.00 0.19 0.88
0.70 0.15 0.91 0.20 0.32 0.91 7.00 0.23 0.85
0.80 0.15 0.90 0.40 0.25 0.85 8.00 0.26 0.83
0.85 0.14 0.90 0.70 0.23 0.82 10.00 0.29 0.80
0.90 0.14 0.89 1.00 0.21 0.80 20.00 0.31 0.76
0.93 0.12 0.89 2.00 0.18 0.79 60.00 0.30 0.75
0.95 0.10 0.88 4.00 0.11 0.80 100.00 0.28 0.76
0.98 0.06 0.88 10.00 0.05 0.78 200.00 0.26 0.77
0.99 0.04 0.87 20.00 0.03 0.78 300.00 0.25 0.78
Five seconds tolerance
0.50 0.74 0.58 0.02 1.00 0.96 5.00 0.56 0.59
0.60 0.73 0.56 0.10 0.96 0.89 6.00 0.68 0.56
0.70 0.73 0.54 0.20 0.90 0.75 7.00 0.74 0.52
0.80 0.71 0.52 0.40 0.84 0.51 8.00 0.78 0.48
0.85 0.71 0.50 0.70 0.78 0.38 10.00 0.82 0.43
0.90 0.69 0.46 1.00 0.74 0.31 20.00 0.83 0.36
0.93 0.63 0.42 2.00 0.63 0.25 60.00 0.80 0.35
0.95 0.52 0.39 4.00 0.44 0.23 100.00 0.77 0.35
0.98 0.33 0.33 10.00 0.19 0.19 200.00 0.74 0.36
0.99 0.21 0.31 20.00 0.09 0.20 300.00 0.72 0.37
Ten seconds tolerance
0.50 0.89 0.49 0.02 1.00 0.96 5.00 0.74 0.46
0.60 0.88 0.47 0.10 1.00 0.88 6.00 0.83 0.46
0.70 0.88 0.45 0.20 0.99 0.73 7.00 0.88 0.43
0.80 0.87 0.42 0.40 0.97 0.43 8.00 0.91 0.40
0.85 0.86 0.39 0.70 0.94 0.25 10.00 0.93 0.35
0.90 0.85 0.34 1.00 0.91 0.16 20.00 0.93 0.29
0.93 0.78 0.27 2.00 0.79 0.06 60.00 0.90 0.26
0.95 0.66 0.23 4.00 0.54 0.04 100.00 0.88 0.25
0.98 0.41 0.15 10.00 0.23 0.02 200.00 0.86 0.25
0.99 0.27 0.13 20.00 0.11 0.03 300.00 0.85 0.25
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having limited correlation with the locomotor activity time series analysed in further
research, the BOCPD model was earlier evaluated on other types of data (Adams and
MacKay, 2007) and can be applied to any distribution from conjugate-exponential family.
Based on this evaluation, the BOCPD algorithm with the expected segment length τ = 60
seconds was selected for the physical activity data segmentation.
4.5.2 Sleep and wakefulness time (L5/M10)
The basic approach for sleep and wakefulness segmentation, widely used in actigraphic
studies (Witting et al., 1990; Wirz-Justice et al., 2010; Ortiz-Tudela et al., 2010; Wulff
et al., 2012), is the identification of the least active 5 hours (H5) and most active 10
hours (H10) of activity for each day, where H10 activity data approximately represents
the period when the subject is awake and active, and H5 correspond to the (assumed)
sleep period (see Figure 4.7).
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Figure 4.7: Example segmentation of L5 and M10 periods. Activity time series in black, dark
grey regions represent the most active 10 hours and light grey the least active 5 hours of activity.
Red lines shows the beginning and end of the analysis period.
The identification was performed by analysing a window of 24 hours and alternating
search for H5 and H10 intervals. After the H5 or H10 interval was identified, a new window
was analysed starting at the beginning of the just identified interval and the searched for
H10 or H5 respectively, according to the following equations
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H10(i) = argmax
i
i+|H10|∑
i
xi,
H5(i) = argmin
i
i+|H5|∑
i
xi,
(4.14)
where xi is the data point within H10 or H5 interval and |H10| and |H5| are the
numbers of data points within these intervals (depend on sampling frequency).
4.5.3 Bed/wake time segmentation
Analysis of sleep is an important area of physical activity research, and particularly
relevant for mental disorders (Littner et al., 2003; Van de Water et al., 2011). Analysis of
sleep offers methods for calculation of such important behaviour measures as sleep onset
latency or total sleep time (among others), but requires precise segmentation of bed and
wake times not offered by simple L5/M10 segmentation.
In research settings, to identify the times of going to bed and waking up, diaries and
manual bed time segmentation are traditionally used (Wulff et al., 2006). But in long-
term studies, such as the AMoSS project, the use of diaries is difficult due to compliance
issues. In the AMoSS study the bed time annotation was performed by manually pressing
the Fitbit button when going to bed and after waking up. If the button was pressed,
the operating mode of Fitbit changed and sleep analysis was performed by identifying
sleep and wake episodes using a proprietary algorithm. The output of the proprietary
algorithm was not used because there has been no published scientific validation of the
algorithm, and the manufacturer may change the algorithm from device to device without
informing the user. This invalidates the notion of scientific repeatability.
Furthermore, overall compliance to Fitbit data collection was at a level of 60%, and
for about 60% of all nights when Fitbit was used there was bed time annotation, equating
to about 36% of nights with sleep analysis, with no significant difference between study
groups using Wilcoxon rank-sum test, as presented in Table 4.3, and with the following
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Table 4.3: Compliance of AMoSS study participants to Fitbit activity data collection (% days
worn) and manual (button press) bed time annotation (% nights annotated of days worn). De-
mographic characteristics are presented in Table 3.2. No significant difference between study
groups identified using Wilcoxon rank-sum test.
Healthy controls Bipolar disorder Borderline personality
disorder
% days worn (Mean±SD) 0.60±0.47 0.59±0.67 0.74±0.48
% nights annotated (Mean±SD) 0.72±0.39 0.61±0.58 0.61±0.27
main issues:
• The participants forgot to press the button when going to bed or waking up. In
such cases sleep analysis for the night was not performed by the Fitbit algorithm.
• The button was accidentally pressed during the day, leading to sporadic erroneous
sleep annotation.
• The button was pressed too early before going to bed or too late after waking up,
leading to overestimation of sleep time.
This created a problem in analysis of sleep from GENEActiv activity recordings and
using Fitbit bed time annotation, as in many cases no Fitbit bed time annotation were
present during the period of GENEActiv data collection. Author couldn’t find any pub-
lished algorithm for automatic identification of bed time from activity data. Since no
published algorithm was available for sleep/wake segmentation using GENEActiv data, a
novel approach was designed in this thesis based on Hidden Markov Models and validated
using existing Fitbit bed time annotation, where available. Note, that Fitbit annotation
suffers from compliance and bias issues, therefore only annotations that were physio-
logically plausible, with bed time more then 4 hours but not exceeding 16 hours were
selected.
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4.5.3.1 Hidden Markov Models
Hidden Markov Models (HMM) provide a fundamental framework for automatic state
identification in real-world processes, as well as estimation of process parameters based
on captured data. An HMM is a statistical model, with a system switching between
states which are not directly known to an external observer, and available only through
indirect observations that are generated with a state-defined probability. The complete
HMM model is defined by (Rabiner, 1989):
1. N , the number of states in the model, with individual states denoted as S =
{S1, S2, ..., SN} and the state at time t as qt.
2. M , the number of distinct observation symbols per state, with individual symbols
denoted as V = {v1, v2, ..., vM}.
3. A, the state transition probability distribution A = {aij} where
aij = P [qt+1 = Sj|qt = Si], 1 ≤ i, j ≤ N. (4.15)
4. B, the observation symbol probability distribution B = {bj(k)} in state j where
bj(k) = P [vk at t|qt = Sj], 1 ≤ j ≤ N, 1 ≤ k ≤M. (4.16)
5. pi, the initial state distribution pi = {pii} where
pii = P [q1 = Si], 1 ≤ i ≤ N. (4.17)
Given the HMM model λ = (A,B, pi) specified by N,M,A,B and pi, the observa-
tions O = O1O2...OT are generated at times t = 1, 2, ..., T . In the case of continuous
observations Equation 4.16 takes the form
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bj(O) =
M∑
m=1
cjmN [O, µjm, Ujm], 1 ≤ j ≤ N (4.18)
where O is the continuous vector of observations, cjm is the mixture coefficient for
mth mixture in state j and N is the probability density function (usually Gaussian) with
mean vector µjm and covariance matrix Ujm.
The computational power of HMM is based on the capability of solving the so-called
“Three Basic Problems” (Rabiner, 1989):
Problem 1: Given the observation sequence O and a model λ, how do we compute
P (O|λ), the probability of the observation sequence, given the model?
Problem 2: Given the observation sequence O and a model λ, how do we choose the
corresponding state sequence Q which best explains observations?
Problem 3: How do we adjust the model parameters λ to maximise P (O|λ)?
The solution for Problem 1 is provided by the dynamic programming algorithm known
as the “Forward-Backward Procedure”, based on inductively calculating the forward vari-
able α, defined as
αt(j) = P (O1O2...Ot, qt = Sj|λ) (4.19)
and includes the following steps:
1. Initialisation:
α1(i) = piibi(O1), 1 ≤ i ≤ N. (4.20)
2. Induction:
αt+1(j) =
[
N∑
j=1
αt(j)aij
]
bj(Ot+1), 1 ≤ t ≤ T − 1, 1 ≤ j ≤ N. (4.21)
3. Termination:
P (O|λ) =
N∑
j=1
αT (j) (4.22)
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To solve Problem 2 it is required to specify the “optimal” state sequence criterion,
usually defined as maximising the P (Q|O, λ), i.e. finding the single best state sequence
for the given model and observations. The problem is solved using the Viterbi algorithm
(Rabiner, 1989), using the best score variable δ, the highest probability along the single
path at time t which accounts for the first t observations and ends in state Si
δt(j) = max
q1,q2,...,qt−1
P [q1, q2, ..., qt = i, O1O2...Ot|λ], (4.23)
δt+1(j) = [max
i
γt(j)aij]bj(Ot+1). (4.24)
Using the best score variable δ and tracking array ψt(j) the procedure for finding the
best state sequence includes the following steps:
1. Initialisation:
δ1(i) = piibi(O1), 1 ≤ i ≤ N (4.25a)
ψ1(i) = 0. (4.25b)
2. Recursion:
δt(j) = max
1≤i≤N
[δt−1(i)aij]bj(Ot), 2 ≤ t ≤ T, 1 ≤ j ≤ N (4.26a)
ψt(i) = argmax
1≤i≤N
[δt−1(i)aij], 2 ≤ t ≤ T, 1 ≤ j ≤ N. (4.26b)
3. Termination:
p∗ = max
1≤i≤N
[δT (i)] (4.27a)
q∗T = argmax
1≤i≤N
[δT (i)]. (4.27b)
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4. Backtracking:
q∗t = ψt+1(q
∗
t+1), t = T − 1, T − 2, ..., 1. (4.28)
Problem 3 was not relevant to this work, so the solution for it is not discussed here.
4.5.3.2 Explicit Duration Hidden Semi-Markov Models
The main limitation of the classical Hidden Markov Model described above is the absence
of explicit modelling of time spent in each state. It could be introduced by non-zero self-
transition probability, however in such cases state duration distributions are limited to an
exponential form. The extension of HMM to allow independently (from state transitions)
modelling duration of each state is called the Explicit Duration Hidden (Semi-)Markov
Model (EDHMM). In the EDHMM, the model λ is extended with (usually Gaussian)
per-state duration distribution
pi(d) = N (d, µi, σ2i ) (4.29)
with mean µi and standard deviation σ2i for state i. For computational reasons, the
maximum state duration is usually limited by D, the maximum duration within any
state, and self-transitions are not allowed.
Solutions to the problems described in the previous section keep the same form for
the EDHMM, but for each state transition i → j we essentially consider a number of
possible previous states, each defined by a pair {Si, dk}, where Si is the previous state
and dk is the time spent in this state (1 < dk < D).
4.5.3.3 Model for bed/wake segmentation
The model for bed/wake segmentation was defined with two states (“in bed” and “not in
bed”), continuous observations, and explicitly specified state duration probability distri-
butions, specified based on bed and wakefulness times.
The activity features, selected as hidden state observations, included the mean level of
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log-activity at time t (in units of activity counts described in Section 4.4.2) and duration
of the stationary activity segment to which the time t belongs. The time granularity was
selected as 2 minutes due to computational limitations. The stationary activity segments
were identified using the Bayesian Online Change Point Detection method, as described
in Section 4.5.1.
Fitbit bed time annotation was used to estimate parameters of HMM, including the
state duration distributions pi(d) and observation probability distributions bj(O). The
resulting observation distributions for “in bed” and “not in bed” ’ states are presented in
Figure 4.8.
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Figure 4.8: Probability distributions of bed- and wake- time activity observations and state
durations, identified based on Fitbit bed/wake segmentation.
4.5.3.4 Segmentation results
Bed/wake segmentation was performed using the proposed Hidden Markov Model and
the accuracy of segmentation evaluated using manual Fitbit bed/wake annotation ground
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truth. Although the accuracy of Fitbit manual bed time segmentation is questionable,
manual bed time logging is the state-of-art method in sleep research (Lauderdale et al.,
2008). HMM segmentation quality is affected by the missingness of activity data, there-
fore the annotations with the amount of missing data exceeding 2 hours (the empirically
identified threshold) were removed. The resulting accuracy of bed and wake time detec-
tion is presented in Figures 4.9 and 4.10.
Figure 4.9: Bed and wake time estimation error for each subject, representing offset of HMM-
estimated state change comparing to Fitbit reference. On each box, the central mark is the
median, the edges of the box are the 25th and 75th percentiles, the whiskers extend to the most
extreme data points not considered outliers, and outliers are plotted individually.
The bed times were estimated with an error of −34.77±80.30 (Mean ± SD) and wake
times with an error of 12.36 ± 76.84 (Mean ± SD) minutes, compared to the reference
Fitbit segmentation, reflecting the issue of negative bias for manual bed time annotation
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Figure 4.10: Bed and wake time estimation error, representing offset of HMM-estimated state
change comparing to Fitbit reference.
and positive for wake time annotation, mentioned in Section 4.5.3. The reported bed
time accuracy identification using sleep reports is 0.80 hours (Lauderdale et al., 2008),
therefore the achieved results are within the range acceptable for sleep studies.
4.6 Summary
The AMoSS data set is diverse, often unevenly sampled and suffers from data missingness
due to levels of participant compliance and technical difficulties of implementing data
collection instrumentation. This chapter proposed data pre-processing approaches, based
on previous research findings in the field of ambulatory activity monitoring, to prepare
the AMoSS data set for further analysis, keeping in mind the types of applied analysis
methods.
Accelerometer-based ambulatory observation of physical activity also captures a very
complex non-stationary signal, where non-stationarities themselves contain potentially
useful information about subjects’ behaviour. In order to perform a meaningful analysis
on large volumes of such data, automated methods were proposed in this chapter, which
would be helpful in extracting physiological states and identifying segments of data with
similar statistical characteristics, as well as non-movement periods or continuous exercises
sessions.
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Chapter 5
Symptoms analysis framework
5.1 Objectivity of symptoms
Accelerometer-based data collection allows the characterisation of long-term physical ac-
tivity and behaviour, including the two main human physiological states, wakefulness and
sleep, as well as transitions between these states (circadian rhythm). For the purpose
of psychiatric symptoms assessment a number of objective measures can be extracted
from actigraphic recordings that allow the description of behaviours associated with spe-
cific symptoms of mental health. Some symptoms can be directly mapped to actigraphic
measures, based on the DSM-5 diagnostic criteria for certain disorders (for example psy-
chomotor poverty or decreased need for sleep in mania), but in many cases there are no
obvious symptom measures based on objective data.
The framework proposed by Liddle and described in Table 5.1 is helpful in formulating
a comprehensive set of clinically important objective measures of mental health, which can
be potentially useful for a broad range of mental illnesses and are based on recordings
of long term physical activity or physiology. Measures could be suggested for clusters
of symptoms, and it can be seen that some clusters can be assessed using just physical
activity data, while others may require physiological information, and only the dimension
of reality distortion is difficult to assess by non-invasive sensors.
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Table 5.1: The major clusters of mental symptoms (Liddle, 2001). Clusters where sensor-
based objective measurements of symptoms are possible using actigraphy are selected in green,
and clusters where other sensors can be used are in magenta.
Dimension Syndrome Symptom cluster
Reality distortion Reality distortion Delusions, Hallucinations
Disorganisation Disorganisation Formal thought disorder, Inappropriate
affect, Disorganised or bizarre behaviour
Psychomotor Psychomotor poverty Flat affect, Poverty of speech,
Decreased voluntary motor activity
Psychomotor excitation Labile affect, Pressure of speech,
Motor agitation
Mood Depression Low mood, Low self-esteem, Hopelessness,
Suicidality, Somatic symptoms
Elation Elevated mood, Elevated self-esteem
Decreased need for sleep
Anxiety Anxiety Feelings of unease, fear or dread,
Overactivity of the sympathetic nervous
system
Three key dimensions specifically relevant to bipolar and borderline personality dis-
orders are disorganisation, psychomotor and mood, and include symptoms potentially
measurable with continuous actigraphic recordings. The main interest of this research is
therefore in defining the objective ambulatory symptom measures for these dimensions,
to complement or substitute questionnaires and interview observations.
In the next sections features are proposed which are potentially relevant to these symp-
toms, based on existing physical activity, sleep and circadian rhythm research. Novel
methods of analysis are also described that could be useful specifically in the area of
mental health. The proposed features are logically organised into two categories, in-
cluding day-time behaviour and sleep characteristics and three dimensions, including the
psychomotor, disorganisation and mood.
Note, that the features are defined based on hypothesis of what the expected be-
haviours look like, and data mining approaches not explored in this work. Such ap-
proaches as neural networks, although very powerful, may require large amounts of train-
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ing data, and often produce results difficult to interpret by clinical specialists.
5.2 Experimental foundations
Several studies have attempted to identify and measure clinically relevant aspects of
behaviour in mental health, with the ultimate goal of creating behavioural markers of
specific disorders and clinical states. Most existing research has used physical activity
analysis techniques, where several established usage scenarios exist in exercise and sleep
medicine, so analysis methods are already available for use in mental health research.
These studies covered a wide range of disorders and focused on different analysis
methods, mostly addressing only subsets of activity measures in psychomotor and disor-
ganisation symptom dimensions, or focusing on sleep and circadian rhythms. However, a
small number of studies also attempted to create a principled multi-dimensional frame-
work for the assessment of mental health, similar to the approach proposed in this work.
5.2.1 Psychomotor symptoms
Psychomotor symptoms are prominent features of many disorders, including the bipolar
disorder, schizophrenia and clinical depression, and may be easily measured with levels of
day-time physical activity. A number of studies have looked at activity levels in mental
health, using different analysis methods and in different clinical conditions.
Walther et al. (Walther et al., 2009) performed activity analysis of paranoid (N=35;
age 39.6±9.64 years), catatonic (N=12; age 45.5±12.19 years) and disorganised (N=13;
age 36.23±10.26 years) schizophrenia subtypes. Activity was monitored for 24 hours with
2 seconds resolution and data collected during sleep removed from the main analysis.
Three activity parameters were extracted, including:
1. Mean number of activity counts per hour (Activity Level, AL).
2. Percentage of epochs with non-zero activity (Mobility Index, MI).
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3. Mean duration of periods with zero activity (Mean Immobility Period, MIP).
General linear models were created for AL, MI and MIP as dependent variables and
schizophrenia subtype, age, gender, type of medication, chlorpromazine equivalents, num-
ber of episodes and duration of illness as predictors. Only schizophrenia subtype and type
of anti-psychotic were found to have significant association with the dependent variables.
Minassian et al. (Minassian et al., 2010) performed activity analysis of manic bipo-
lar disorder patients (N=28; age 34.1±13.3 years), schizophrenia patients (N=17; age
36.7±12.4 years) and healthy controls (N=21; age 30.3±9.5 years). The activity mea-
surement experiment was performed on subjects, placed in a novel environment for 15
minutes. Manic bipolar disorder patients were found to have significantly higher levels of
motor activity compared to both schizophrenia and healthy controls.
Hauge et al. (Hauge et al., 2011) analysed differences in activity between schizophre-
nia, major depression and healthy controls in two settings, including a) one minute epochs
with 5 hours recorded length and b) one hour epochs with two weeks of recording. The
study included schizophrenic patients (N=24; age 47.4±11.1 years), depressed patients
(N=25; age 42.9±10.7 years) and control group (N=32; age 38.2±13.0 years). The data
were analysed and several characteristics were calculated and compared between groups,
including the mean activity level, standard deviation (SD), root mean square successive
difference (RMSSD), RMSSD/SD, Sample Entropy (m = 2, r = 0.2) and Fourier analysis.
For 5 hours recordings, both schizophrenia and depression mean activity levels were
significantly lower compared to healthy controls, standard deviation was significantly
higher in depression, RMSSD/SD ratio significantly higher in both depression and schizophre-
nia and Sample Entropy significantly lower in depression. For two week recordings, mean
activity levels in both schizophrenia and depression were significantly lower compared
to healthy controls, SD of activity was higher in depression compared to both controls
and schizophrenia, RMSSD was higher in depression compared to schizophrenia and
the RMSSD/SD ratio was significantly lower in schizophrenia compared to healthy con-
trols. In another study on the same data (Berle et al., 2010), it was also identified that
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schizophrenia patients have significantly lower intra-daily variability and higher inter-
daily stability of activity patterns.
In a systematic review of physical activity correlates of schizophrenia, Vancampfort
et al. (Vancampfort et al., 2012) identified that lower physical activity is associated
with the presence of negative symptoms. A systematic review of activity monitoring in
patients with depression by Burton et al. (Burton et al., 2013) identified decreased day
time activity in depression (increased post-treatment), and no difference in night time
activity level (but decreased activity level and increased sleep efficacy post-treatment).
5.2.2 Disorganisation symptoms
Behaviour disorganisation is one of the observable features of many mental disorders,
and initially came up as a separate syndrome in factor-analytic studies of schizophrenia
(Liddle, 1987; Ventura et al., 2000), but no objective behaviour measures of disorgani-
sation are used in clinical practice. Among other aspects, disorganisation syndrome is
characterised by impulsive behaviour (Kiehl et al., 2000; Ouzir, 2013), where structural
organisation of activity is impaired on different temporal scales. Impulsive behaviours
were extensively analysed in the context of bipolar disorder, borderline personality dis-
order, as well as schizophrenia and other mental illnesses (Henry et al., 2001; Lieb et al.,
2004; Swann, 2009; Ouzir, 2013).
In actigraphic studies, disorganisation symptoms are often analysed together with
psychomotor symptoms, for example in the previously described study of Hauge et al.
(Hauge et al., 2011) a number of structural activity measures are included together with
simple activity level characteristics.
Walther et al. (Walther et al., 2014) performed analysis of disorganisation symptoms
using actigraphy on schizophrenia spectrum disorder patients (N=100; age 39.2±11.1
years) with data sampled every 2 seconds for 60 minutes. A partial autocorrelation
function was computed and for each set of data the longest lag was extracted, where the
partial autocorrelation function was significant at p < 0.05. Reduced lags were found to
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be associated with positive symptoms, disorganisation and excitement, and a negative
syndrome was associated with reduced mean activity level.
To analyse abnormalities of structural activity organisation in bipolar disorder, Indic
et al. (Indic et al., 2011) proposed the actigraphic Vulnerability Index (VI) to distinguish
between a) high and low risk of mood disorders, b) bipolar disorder patients and healthy
controls and c) clinical states in bipolar disorder patients. The vulnerability index was
designed to assess multi-scale behaviour of physical activity amplitude and calculated
using the following steps:
1. Continuous wavelet analysis of 7 days of activity was performed on a range of time
scales from 0.2 to 26 hours.
2. Gamma distribution was fitted into the amplitude of wavelet transform in scales
from 0.2 to 2 hours.
3. The Vulnerability Index was defined as VI =
∫ 2
0.2
γ(s)ds.
The index was validated on actigraphy data from three studies. Study 1 included
healthy young adults with the potential risk of bipolar disorder, assessed using the Gen-
eral Behaviour Inventory (GBI) (Depue et al., 1989), and divided into high and low deciles
with low (N=35; age 20.9±2.3 years) and high risk (N=35; age 22.3±3.0 years). Study
2 included type-I bipolar disorder diagnosed subjects (N=15; age 46.8±12.4 years) and
healthy controls (N=15; age 46.7±14.1 years). Study 3 included type-I diagnosed sub-
jects (N=51; age 43.8±10.5 years) monitored for 3 days during maniac, major depression
and recovery states. The VI was shown to be associated with increasing risk of bipolar
disorder and mood states of patients. Mean VI increased linearly across the groups, rank-
ing major depression < minor depression < euthymia < minor mixed-states < hypomania
< major mixed-states < mania (goodness of fit was not reported).
Other types of activity (non-locomotor) were also shown to be useful in the analysis of
mental health. In non-actigraphic studies, an eye movement analysis model in schizophre-
nia was utilised on 88 healthy controls and 88 schizophrenia patients and was found to be
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capable of achieving accuracy of 87.8% in separation between schizophrenia subjects and
controls on 34 9-month retest subjects, 36 novel schizophrenia cases and 52 control sub-
jects (Benson et al., 2012). Analysis of activity disorganisation in schizophrenia was also
performed using user-generated time series (Hornero et al., 2006), where 20 schizophre-
nia patients and 20 control subjects were instructed to press a button as randomly as
possible. It demonstrated classification with 80% sensitivity and 90% specificity using
Limpel-Ziv complexity measure, 90% sensitivity with 60% specificity with Approximate
Entropy and 70% sensitivity with 70% specificity using the Central Tendency Measure
using 2-fold cross-validation. A significant difference between schizophrenia and normal
control groups (p < 0.0001) was also found using chirological (hand) testing with 100 hos-
pitalised schizophrenia patients and 50 healthy control subjects (Pomrock and Ginath,
1982).
5.2.3 Mood symptoms (sleep and circadian rhythms)
The recent review paper of Kahn, Shappes and Sadeh (Kahn et al., 2013) described the
bi-directional links between sleep and emotions, and concludes that almost all character-
istics of sleep, including duration, quality and REM sleep characteristics (Benca, 1992;
Benca et al., 1997) may influence emotional state, and emotional state may in turn affect
sleep, however this connection is complex and varies between different subject groups. For
example, sleep deprivation is known to negatively affect positive mood and increase nega-
tive mood intensity (Franzen et al., 2008). But at the same time reduced sleep duration is
characteristic of manic states and one of the diagnostic criteria of mania in bipolar disor-
der (American Psychiatric Association, 2013), and total sleep deprivation shows clinical
effect in depressed bipolar patients (Smeraldi et al., 1999). Similarly, the effect of stress
and anxiety on sleep duration can be bi-directional, mediated by the individuals’ coping
style producing a “turn on” response leading to decreased sleep time and increased sleep
latency or a “shut off” response to stress leading to withdrawal and increased sleep dura-
tion (Sadeh et al., 2004). For low mood, excessive sleepiness is an important predictor of
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depression (Mayers and Baldwin, 2015; American Psychiatric Association, 2013).
While the influence of sleep on emotions is relatively well understood from the phe-
nomenological perspective, in recent years evidence has emerged of tight connections
between disrupted circadian rhythms and mood disorders (Wulff et al., 2010; McClung,
2013; Benedetti and Terman, 2013). Evidence exists of a direct correlation between mood
and the severity of rhythm disruption (Wirz-Justice, 2006), chronobiology-inspired suc-
cessful treatment strategies (Bromundt et al., 2013) and a solid theoretical framework
connecting the circadian system and mood (McClung, 2013). The most recent publi-
cations suggest that sleep- and circadian rhythm-associated pathways can be promis-
ing therapeutic targets for bipolar disorder (Bellivier et al., 2015) and may be used as
biomarkers to predict responses to SSRIs treatment in depression (McCall, 2015).
Jones et al. (Jones et al., 2005) assessed both circadian activity and sleep patterns
in remitted bipolar disorder. The study included bipolar disorder patients (N = 19; age
44.37 ± 13.1 years) and age- and gender-matched controls (N = 19; age 46.89 ± 14.82
years). The data were collected for 7 day with 15 seconds resolution and significant
differences in circadian characteristics were found (IS and IV), but there was no difference
in sleep indices.
Sleep in remitted bipolar disorder was studied by Geoffroy et al. (Geoffroy et al.,
2014) on remitted bipolar patients (N = 26; age 53.5±11.49 years) and matching healthy
controls (N = 29; age 54.1 ± 9.11 years). The data were collected for 21 days with 1
minute resolution. Patients demonstrated significantly longer sleep latency, sleep dura-
tion, poorer sleep efficiency, a higher fragmentation index, poorer inter-daily stability and
more variability in sleep characteristics.
Wulff et al. (Wulff et al., 2010) analysed activity, light exposure and melatonin
of schizophrenia outpatients (N = 20; age 38.8 ± 8.6 years) vs. unemployed controls
(N = 21; age 37.5 ± 9.6 years). The data were collected for 6 weeks with a 2 minutes
resolution. Analysis of data included sleep characteristics and non-parametric circadian
rhythm analysis. All schizophrenia patients had significant sleep and circadian rhythm
99
abnormalities, including phase shifts, non-24 hour periods or highly irregular and frag-
mented sleep.
5.2.4 Multi-dimensional approach
While the above studies attempted to discover objective markers of certain clinical states,
many studies analysed only a few selected activity features, and did not define or follow a
principled approach for identifying a comprehensive set of objective diagnostic measures
of mental disorders. The principled framework for analysis of mental health symptoms
would need to be based on the accepted in clinical practice diagnostic markers (Ameri-
can Psychiatric Association, 2013), as well as take into account the possible measurable
symptom correlates arising from the known interactions between emotional states and
behaviours or physiology.
In attempting to identify behaviour disorder markers from first principles, i.e. ob-
served symptoms, Prociow et al. (Prociow et al., 2012) followed the approach similar to
the one adopted by this thesis, suggesting new measures and sensors based on clinical
syndromes of bipolar disorder, however he only described a system and did not validate
it via a study involving patients.
A principled framework was also proposed in the framework of the PSYCHE project
(Paradiso et al., 2010), but results of the project indicated a greater focus on sensor
technology for the acquisition of physiological signals, rather than identifying behaviour
features that are correlated to known symptoms of mental health and capable of improving
diagnosis (Valenza et al., 2013).
The study by Gru¨nerbl et al. (Grunerbl et al., 2014), used a similar principled ap-
proach in the MONARCA project, analysing mood in bipolar disorder using objective
features, including phone call features, speech and voice characteristics, as well as acceler-
ation and location changes captured from mobile phone sensors. The study demonstrated
an accuracy of 76% in clinical state change identification for bipolar patients (10 sub-
jects and 17 state changes) with the model trained on 66% of samples and tested on the
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remaining 33%.
5.2.5 Discussion
Day-time activity patterns are available for direct observation during clinical interview
and important aspects of day-time behaviour are mostly defined by two factors of the
5-factor model of psychopathology, including activity disorganisation or psychomotor
poverty and excitation. The interview, however, covers only a short period of time that
does not necessarily represent a true clinical picture of patients’ states, thus suggesting
the need for a longitudinal objective assessment.
Sleep characteristics are recognised diagnostic criteria for mania and depression, and
have been demonstrated to be important in other psychiatric conditions, contributing to
the mood dimension of symptoms. However, objective sleep assessment is not usually
performed as a part of clinical diagnostic assessment of mood disorders, and sleep is not
objectively assessed on a regular basis, while known as contributing to relapse prodromes
(Scott, 2011).
All together, the activity-based symptoms, including day-time activity patterns and
sleep, represent a substantial proportion of DSM-5 diagnostic criteria for many disorders,
and contribute to three out of five dimensions of psychopathology (Liddle, 2001), thus
forming an important part of the clinical picture. Despite that, there are no attempts at
objective assessment of physical activity in the current clinical practice of mental health.
5.3 Psychomotor symptoms cluster
Psychomotor symptoms cluster represents levels of activity of a person during periods of
wakefulness, and, therefore from the analytical perspective are relatively easy to evaluate.
For longitudal continuous data collection however, the question amounts to selecting the
characteristics of activity that are important from the clinical perspective.
The most extensive analysis of the influence of physical activity on health was per-
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formed within the framework of public health research (Troiano et al., 2008; Tudor-Locke
et al., 2010; van Hees et al., 2011), therefore the activity measures accepted in public
health studies are also used in this work.
5.3.1 Distribution-based measures of activity level
A traditional approach for the analysis of activity levels is to use distribution-based
measures, for example the average level of ENMO, as was performed in the study of a
Brazilian cohort with 8974 subjects (da Silva et al., 2014) and in the Whitehall II study
with 3975 participants (Sabia et al., 2014).
Physical activity of longer duration or a higher intensity may equally contribute to
a higher value of the average level of ENMO activity. In order to distinguish between
these scenarios, a distribution could be fitted into the activity data and parameters of
this distribution used as activity level measures. Following the approach of Indic et al.
(Indic et al., 2011), a Gamma distribution was used in this work, and shape k and scale
θ parameters were selected as activity measures.
5.3.2 Metabolic equivalent based measures of activity intensity
The metabolic equivalent (MET) is a unit of energy consumption, where 1 MET = mean
measured resting energy expenditure during lying down, calculated for adults as oxygen
consumption V˙ O2 = 3.5mL O2 · kg−1 · min−1 by Hildebrand et al. (Hildebrand et al.,
2014). In epidemiological studies, activities with values of
• lower than 3 MET are considered as mild physical activity,
• between 3 and 6 MET are considered to be moderate and
• 6 MET or above are vigorous activities.
These cut-off thresholds were originally defined for calculating physical activity energy
expenditure based on activity logs, where each type of physical activity was assigned a
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category. In the case of tri-axial accelerometers, similar to the one used in the AMoSS
study, the regression for estimating oxygen consumption from wrist accelerometry for
adults was developed by Hildebrand et al. (Hildebrand et al., 2014) as
V˙ O2 = 0.0323 · ENMO + 7.49 (5.1)
where ENMO represents average ENMO in milli g and cut-off thresholds for MET
were estimated as 3 METs = 93.2 milli g and 6 METs = 418.3 milli g. The estimations
were validated in a study on 30 adults completing 8 activities. Following the approach
of da Silva et al. (da Silva et al., 2014) the average time per day in moderate and
vigorous activities were included in this study in addition to distribution-based activity
level measures.
5.3.3 Summary of psychomotor features
Based on the above-defined analysis methods, the features described in Table 5.2 were
selected as potentially contributing to the psychomotor clusters of symptoms.
Table 5.2: Psychomotor activity features, selected for further analysis.
Feature Description
LEVEL_AVG Average level of ENMO activity
LEVEL_GAMMA_K Shape parameter of Gamma distribution fit into ENMO activity
LEVEL_GAMMA_THETA Scale parameter of Gamma distribution fit into ENMO activity
TIME_MODERATE Time spent in moderate-intensity activities (3-6 MET)
TIME_VIGOROUS Time spent in vigorous activities (>6 MET)
5.4 Disorganisation symptoms cluster
Behavioural disorganisation is one of the most interesting features of mental health, and
it includes many aspects, impulsive behaviour being one of them. As can be seen from the
factor structure of BIS-11 (Barratt and Patton, 1995), impulsivity includes components of
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behaviour instability on different temporal scales, from seconds and minutes (attention) to
days (non-planning). The following sections propose criteria for assessing the structural
organisation of activity on each of these scales, using biomedical community accepted
analysis methods.
5.4.1 Multiscale entropy analysis
One of the most popular methods for measuring signal disorganisation is entropy (Rich-
man and Moorman, 2000; Sung et al., 2005; Iverson et al., 2005). In the case of actigraphic
data, entropy is capable of characterising the stability of motor activity, or the highest-
resolution temporal scale of impulsivity. Most of the research described previously used
simple sample-based measures of entropy, and demonstrated that it could be useful in
the context of mental health (Hornero et al., 2006; Hauge et al., 2011). However, due
to the fact that simple entropy measures are dependent on sampling frequency and dis-
organisation may exist on different time scales, the Multiscale Entropy Analysis (MSE)
provides a more comprehensive assessment method.
MSE (Costa et al., 2005) applies the Sample Entropy (HSE) (Richman and Moorman,
2000) calculation to a range of scales, each representing the down-sampled original signal.
Sample Entropy (HSE) provides an efficient way to estimate disorganisation from time
series data. HSE is a signal complexity estimation, derived from the negative logarithm
of the conditional probability of the appearance of longer patterns in a signal, considering
the presence of a shorter pattern. It is estimated by statistic
HSE(m, r,N) = −ln
[
Am(r)
Bm(r)
]
, (5.2)
where m is the template length, r is the similarity threshold (or quantisation level),
Am(r) is a probability of matching (m + 1)-length template, Bm(r) is a probability of
matching m-length template and N is the length of the record. Two patterns of length
m are considered as similar, if each point of a pattern in one part of the signal is within
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a distance r from the respective point in the other part of the signal.
Sample Entropy calculation for a specific template and similarity threshold is illus-
trated by Figure 5.1.
Figure 5.1: Example of Sample Entropy calculation for a specific template. Red, green and blue
squares represent measurements of a specific template within a similarity threshold r (shown with
dashed lines). The probability of matching the template of length 3, given the template of length
2, equals to the number of green-red-blue sequences divided by the number of green-red sequences.
Adapted from (Costa et al., 2005).
For a Multiscale Entropy calculation the value of each scale n of MSE is the Sample
Entropy, calculated over the down-sampled original signal (by taking the mean of n
samples).
5.4.2 Activity persistence
To assess the attentional impulsiveness, reflecting an individual’s task-focus, analysis of
continuity of activity was performed, where continuity was measured as the time spent
performing a certain physical activity without interruptions. In order to estimate such
continuity, a change point detection method (BOCPD) was applied to the activity time
series, to find statistically coherent activity segments (see Figure 5.2).
Based on this segmentation, an activity duration distribution was created, which con-
sists of durations of stationary periods of activity (or time spent in individual continuous
activities) as data points. Using the same approach as previously for psychomotor cluster
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Figure 5.2: Example of Bayesian segmentation of one hour of locomotor activity data. On the
top plot one hour of activity is presented in black, and the identified stationary segments as white
and purple overlays. On the bottom plot the durations of identified segments are presented.
analysis, the average duration of activity segment, as well as shape k and scale θ parame-
ters of Gamma distribution were calculated as activity persistence measures for each day
of recording.
5.4.2.1 Scaling of activity (Detrended fluctuation analysis)
Long-range correlations in biological signals were reported to be an important factor for
physical and mental health (Bernaola-Galva´n et al., 2001; Hu et al., 2009; Henry et al.,
2010; Indic et al., 2011; Valenza et al., 2013; Valenza et al., 2014a). For example, changes
in heart rate regimes demonstrate the same functional form with different parameters
between healthy individuals and heart failure patients (Bernaola-Galva´n et al., 2001).
Scaling behaviour of human locomotor activity was also shown to distinguish between
risk and clinical states of bipolar disorder (Indic et al., 2011). Detrended Fluctuation
Analysis (DFA) provides a method for identification of long range correlations in time
106
series and includes the following steps (Peng et al., 1994):
1. Divide the input signal of length N into N/l non-overlapping segments and define
the “local trend” as the ordinate of linear least-squares fit in this segment.
2. Define the detrended signal as the difference between the original signal and the
“local trend”. Calculate the average of variances of detrended signal over all the
boxes F 2d (l).
Figure 5.3: Example of Detrended Fluctuation Analysis calculation for a specific segment length.
In each segment, the local trend is presented as a red line. Adapted from (Peng et al., 1994).
If the resulting signal F 2d (l) is proportional to the lα, the α is called the “scaling
exponent” and defines the presence of long-range correlation in the original signal, with
the value giving information about the signal self-correlations, where
• α = 1/2 for white noise,
• α = 1 for pink noise
• and α = 3/2 for Brownian noise.
The variance across segments is expected to increase with the increased segment
length, and α defines the rate of such increase, which is different for various types of
signals, as described above. Note, that F 2d (l) is a signal statistic dependant on segment
length, thus a number of segments of equal length necessary to calculate it.
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5.4.3 Day-to-day activity patterns variation
Another key factor, contributing to a person’s impulsivity and activity disorganisation,
is motor impulsiveness, defined as a tendency to act on the spur of the moment and
consistency of lifestyle. This behavioural characteristic can potentially be represented
by the stability of day-to-day activity patterns. This study proposes to measure the
behavioural stability directly, by performing day-to-day comparison of 24-hour activity
patterns. Given that activities are not likely to align perfectly between days, the Dynamic
Time Warping (DTW) algorithm (Senin, 2008) was used to measure the distance between
daily activity patterns.
DTW is a dynamic programming algorithm, that calculates optimal matching between
two signals by measuring pairwise distance between all points of these signals and selecting
the optimal matching with a minimal cumulative distance (see Figure 5.4).
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Figure 5.4: Example of matching activity patterns of days X and Y using the Dynamic Time
Warping. Picture a) represents mapping between the activity patterns and picture b) shows
the distance matrix between activity levels on days X and Y (colour) together with the optimal
matching (red line).
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5.4.4 Summary of disorganisation features
Based on the above-defined analysis methods, the features described in Table 5.3 were
selected as potentially contributing to the disorganisation cluster of symptoms.
Table 5.3: Activity disorganisation features, selected for further analysis.
Feature Description
LEVEL_MSE_{N} N th scale of Multiscale Entropy (N = 1..5)
DUR_AVG Average duration of BOCPD segments
DUR_GAMMA_K Shape parameter of Gamma distribution fit into BOCPD length
DUR_GAMMA_THETA Scale parameter of Gamma distribution fit into BOCPD length
DUR_DFA DFA α (scaling exponent) of BOCPD length
LEVEL_DTW Average day-to-day DTW distance of activity level patterns
5.5 Mood cluster
The indirect objective measure of mood, used in this study is the quality of sleep. Despite
being an important feature of depression and mania, it is not objectively assessed in the
context of psychiatric examination. At the same time, the field of sleep analysis is very
well developed and actively uses actigraphic sleep assessment techniques (Ancoli-Israel
et al., 2003; Sadeh, 2011). A number of sleep analysis methods were created for different
types of actigraphs and successfully applied in studies of mental health, including affective
disorders (Wirz-Justice et al., 2001; Wulff et al., 2006; Wirz-Justice, 2007a; Wirz-Justice
et al., 2010; Scott, 2011).
Key sleep characteristics include such measures as sleep onset latency and sleep du-
ration, which require knowledge of bed and wake times. Given that in an ambulatory
environment compliance to manual bed time annotation is low (60% for Fitbit-based
annotation in the AMoSS study), a novel method of automatic bed time annotation
was developed and described in the previous chapter, and estimated bed times used to
calculate sleep characteristics described below.
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5.5.1 Sleep-wake segmentation
Analysis of sleep is based on identification of wakefulness episodes during bed time, in the
case of actigraphic sleep assessment characterised by short motion periods. In order to
identify wake-related motion, sleep/wake segmentation of bed-time actigraphic recording
is performed by an expert or by using an automatic algorithm (Blackwell et al., 2005).
There are several published algorithms to segment sleep/wake states in actigraphy
data. For example, Cole et al. (Cole et al., 1992) proposed an algorithm, based on
a weighted sum of previous and subsequent epochs, and claimed an accuracy of 88%
for distinguishing wakefulness from sleep on a sample of 41 subjects monitored during
1 laboratory night. Sadeh et al. (Sadeh et al., 1994) developed a metric to segment
sleep/wake states, based on four activity features with overall reported agreement with
polysomnographic analysis of 91% − 93% on a sample of 36 subjects monitored dur-
ing 1 laboratory night. However, due to differences in hardware implementations, most
actigraphs implement their own sleep detection algorithms.
In this study the sleep/wake scoring algorithm proposed by Oakley (Oakley, 1997)
for Actiwatch (CamNTech, UK) activity monitoring platform was used. The algorithm
estimates each 15 seconds activity epoch as wake or sleep based on previous and future
values:
A0 = 0.04E−(8−5) + 0.2E−(4−1) + 4E0 + 0.2E+(1−4) + 0.04E+(5−8) (5.3)
where A0 is the score of activity of the current epoch, E0 is the activity counts of the
current epoch and En is the activity counts of the epochs before and after the current
one. The epoch is scored as sleep if A0 exceeds the threshold of 40 counts.
The scoring algorithm relies on conversion of raw tri-axial activity data into the
Actiwatch-compatible counts, using a procedure developed by te Lindert et al. (te Lindert
and Van Someren, 2013) and described in Section 4.4.2.
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5.5.2 Sleep analysis
Sleep analysis uses bed time derived from HMM segmentation and sleep / wake segmenta-
tion from Oakley algorithm to calculate a number of sleep characteristics. Clinical prac-
tice parameters for analysis of sleep were originally described by Rechtschaffen and Kales
(Rechtschaffen and Kales, 1968), and currently maintained by the American Academy of
Sleep Medicine (AASM). The parameters include such characteristics as:
• To bed time: The time the subject gets into bed, as identified by bed/wake
segmentation.
• Out of bed time: The time the subject rose out of bed, as identified by bed/wake
segmentation.
• Time in bed (min): Time between “To bed time” and “Out of bed time”.
• Sleep onset latency (min): Time it took the subject to fall asleep.
• Wake after sleep onset (min): Time scored as wake between “Sleep onset time”
and “Final wake time”.
• Actual sleep time (min): Time scored as sleep between “Sleep onset time” and
“Final wake time”.
• Sleep efficiency (%): “Actual sleep time” divided by ’Time in bed’.
• Number of wake bouts: Number of continuous blocks scored as wake.
• Mean wake bout time (min): Mean duration of wake block.
• Number of sleep bouts: Number of continuous blocks scored as sleep.
• Mean sleep bout time (min): Mean duration of sleep block.
• Mobile time (min): Total duration of epochs with activity (>0).
• Immobile time (min): Total duration of epochs with activity (=0).
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5.5.3 Circadian rhythm
The circadian rhythm in humans is characterised by two main variables, τ describing the
period of circadian clock under zeitgeber-free conditions and ψ characterising phase shift
between the rhythm and a zeitgeber, such as dusk and dawn. Additionally, the change
in day length with season influences the ratio of activity and rest (α : ρ) (Wirz-Justice,
2007b).
There are several methods described in the literature for numerical analysis of circa-
dian rhythms, with the Cosinor method and Lomb-Scargle periodogram being the most
accepted and used in research, where the Lomb-Scargle method is used for unevenly sam-
pled data (Wirz-Justice et al., 2001; Wulff et al., 2006; Refinetti et al., 2007). The Cosinor
method for identification of τ was used in this research, although it should be noted that
in studies of humans it is very difficult to reliably identify τ due to the influence of social
and environmental zeitgebers (Wirz-Justice, 2007b).
For the identification of ψ the most reliable actigraphic measure is the sleep midpoint
(Wirz-Justice, 2007b). This, as well as the activity/rest ratio (α : ρ) is measured from
the HMM based bed/wake identification described in Section 4.5.3.
5.5.4 Circadian amplitude
The activity levels during the least active 5 hours, most active 10 hours and relative
amplitude between those give insight into the circadian amplitude, or distribution of
activity between sleep and wakefulness states, and can be defined as
L5 =
|H5|∑
i=1
xi
|H5| , (5.4)
M10 =
|H10|∑
i=1
xi
|H10| , (5.5)
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RA =
M10− L5
M10 + L5
(5.6)
where xi is the activity measurement, |H5| and |H10| are the numbers of measurements
in the least active 5 and most active 10 hours respectively (Witting et al., 1990; Van
Someren, 1999), thus L5 and M10 values effectively represent the mean activity levels
during these periods.
5.5.5 Non-parametric rest-activity characteristics
Inter-daily Stability (IS) and Intra-daily Variability (IV) are so-called non-parametric
rest-activity characteristics, and were originally proposed to detect day-to-day variations
of activity patterns (IS) and fragmentation of rest-activity rhythms (IV) (Sokolove and
Bushell, 1978; Witting et al., 1990) and calculated using the following equations
IS =
n
p∑
i=1
(xi − x)2
p
n∑
i=1
(xi − x)2
(5.7)
IV =
n
n∑
i=2
(xi − xi−1)2
(n− 1)
n∑
i=1
(xi − x)2
(5.8)
where n is the total number of data, p is the number of data samples per day, xi are
individual measurements, x¯ is the mean of all data and i is the index of a given data
point (Van Someren, 1999).
5.5.6 Summary of mood features
Based on the above-defined analysis methods, the features described in Table 5.4 were
selected as potentially contributing to the mood cluster of symptoms.
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Table 5.4: Activity-based sleep and mood features, selected for further analysis.
Feature Description
IN_BED_TIME The time the subjects gets into bed
OUT_OF_BED_TIME The time the subject got out of bed
TIME_IN_BED Time in bed
SLEEP_ONSET_LATENCY Time it took the subject to fall asleep
WAKE_AFTER_SLEEP_ONSET Wake after sleep onset
ACTUAL_SLEEP_TIME Actual sleep time
SLEEP_EFFICIENCY ’Actual sleep time’ divided by ’Time in bed’ multiplied by 100
NUMBER_OF_WAKE_BOUTS Number of continuous blocks scored as WAKE
MEAN_WAKE_BOUT_TIME Mean wake bout time
MEAN_SLEEP_BOUT_TIME Mean sleep bout time
MOBILE_TIME Total duration of epochs with activity (>0) during sleep
IMMOBILE_TIME Total duration of epochs with no activity during sleep
TAU Cosinor-derived τ
PHI Sleep midpoint as offset to midnight in minutes
L5 Level of activity during the least active 5 hours
M10 Level of activity during the most active 10 hours
RA Relative amplitude between L5 and M10
IS Inter-daily Stability
IV Intra-daily Variability
5.6 Summary
In this chapter, based on the five-cluster model of mental symptoms (Liddle, 2001),
a number of activity features were proposed that have a potential to characterise three
dimensions of the model, including psychomotor, disorganisation and mood cluster symp-
toms. The features were introduced in a principled way, based on clinical practice param-
eters accepted in sleep medicine and physical activity research, as well as drawing on the
body of research on analysis of physical activity and behaviour in the fields of psychiatry
and clinical psychology.
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Chapter 6
Differentiation between disorders
6.1 The problem of diagnosis
One of the main problems in treatment of mental health disorders is the reliability of
diagnosis, when a disorder is not correctly identified in those who have it, or found in
subjects who don’t have it. This problem in the current diagnostic framework of DSM-5
was studied by analysing the test-retest reliability of diagnosis, and for most diagnoses
moderate-to-good inter-rater agreement with inter-class Kappa of 0.40-0.79 was found
(Regier et al., 2013), which is in the range of results achieved in medicine in general
(Kraemer et al., 2012). However, between different mental health institutions the inter-
rater agreement results were substantially different, with Mayo Clinic demonstrating a
Kappa value of 0.73 for diagnosis of bipolar I disorder and the University of Texas at
San Antonio showing a Kappa value of 0.27 for the same disorder. A similar picture
was observed for borderline personality disorder and major depressive disorder (Regier
et al., 2013), and indicates a potentially high subjectivity of diagnosis by some clinical
specialists.
More objective criteria are needed for diagnosis of mental disorders to eliminate the
diagnostic inaccuracy due to varying levels of expertise and qualification of clinical spe-
cialists. The recently proposed DSM-5 cross-cutting symptom assessment tools, based on
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patient-reported measures, aim to partially address this problem and facilitate the shift
towards a more dimensional approach in the diagnosis of mental disorders. In the adult
population, the DSM-5 dimensional cross-cutting symptom assessment questionnaire (23
questions covering 13 domains) demonstrated good-to-excellent test-retest reliability for
all domains (Narrow et al., 2013). But the questionnaire-only assessment is still not ma-
ture enough to provide a reliable tool for diagnostics, and may be prone to subjective
bias due to impaired patient self-perception (Stanley and Wilson, 2006).
Objective assessment of behaviours with mobile and wearable sensors could potentially
facilitate diagnostics by providing accurate and unbiased measures of clinically important
behaviour characteristics. In this chapter the behaviour measures, described previously in
Chapter 5, are evaluated for the capability of distinguishing between the bipolar disorder,
borderline personality disorder and healthy control subjects.
6.2 Data subset selection
For the analysis of diagnostic accuracy of objective activity measures, GENEActiv ac-
celerometer data were analysed together with categorical assignment of subjects to their
diagnostic classes (bipolar disorder, borderline personality disorder and healthy controls)
as ground truth. Given the complex nature of mental disorders, where symptoms may
wax and wane during the course of disease, a relatively asymptomatic short duration pe-
riod, where both GENEActiv data and mood self-ratings were present, was selected from
each participant, following the approach of Huynh et al. (Huynh et al., 2015). Contrary
to Huynh et al. who used a nine day period to capture 2 weekends, this study used a
one week period due to limited data availability, to capture a stable emotional state and
to avoid potential bias due to different ratios of work and free days between different
participants.
By doing so, every group was taken in a relative “normality” state, so that the objec-
tive activity signatures of the analysis period were characteristic for the disorder itself,
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and not a transient clinical state (such as mania or depression in bipolar disorder or
deterioration in borderline personality disorder). Such signatures could be potentially
used as “behavioural markers” of specific mental health conditions for clinical diagnostic
purposes.
6.2.1 Euthymic period identification
In order to identify the objective difference between clinical groups, one week of activity
was selected from each participant, where symptoms were least presented, as identified by
the lowest scores on ASRM and QIDS-SR16, and the least non-wear time was detected by
the non-wear detection algorithm described in Section 4.3.2. The selection of a one week
interval was based on the granularity of mood scoring (weekly), the amount of data avail-
able (up to 3 weeks for most participants), and to avoid the bias due to weekday/weekend
variability in activity characteristics. The selected data subset is described in Table 6.1.
Table 6.1: Demographics and data set characteristics of the AMoSS euthymic data subset.
Superscripts indicate that the distributions are different with p < 0.05 according to Wilcoxon
rank sum test. BD, BPD and HC superscripts refer to bipolar disorder, borderline personality
disorder and healthy controls.
Healthy controls Bipolar disorder Borderline
personality disorder
Demographic characteristics
Number of participants 23 24 15
Gender 18 females 16 females 13 females
Age (Mean±SD) 30.61±9.31 BD 40.04±11.61 HC BPD 32.13±9.58 BD
Height (Mean±SD) 168.87±7.84 170.83±10.48 168.20±8.27
Weight (Mean±SD) 65.97±9.27 BD BPD 80.40±15.20 HC 79.13±18.06 HC
BMI (Mean±SD) 23.15±2.92 BD BPD 27.51±4.53 HC 27.99±6.11 HC
Data set characteristics
ASRM (Mean±SD) 1.43±2.23 2.17±3.05 2.13±2.20
QIDS-SR16 (Mean±SD) 2.00±2.17 BD BPD 5.71±5.40 HC BPD 10.13±6.15 HC BD
GAD-7 (Mean±SD) 1.35±1.85 BD BPD 5.75±4.90 HC BPD 10.20±6.72 HC BD
BIS-11 (Mean±SD) 52.30±7.86 BD BPD 64.96±9.78 HC BPD 78.00±12.85 HC BD
Non-wear time, days (Mean±SD) 0.14±0.11 0.15±0.08 0.11±0.09
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6.2.2 Dealing with imbalanced data set
Recruitment for the AMoSS project was still ongoing at the time of writing, so the AMoSS
data set was not balanced in terms of numbers of participants per clinical group, as well
as age, gender and BMI, as can be seen from Table 6.1. Differences in age, gender and
BMI may influence actigraphic measurements (Tudor-Locke et al., 2010; Tucker et al.,
2011), and number of subjects in group (class) is important for the definition of unbiased
classifiers. In order to compensate for the imbalance in the AMoSS data set two strategies
of re-sampling were employed and described below:
• Under-sampling the majority class (USM): Removing samples from the ma-
jority class until classes are balanced in number of samples and clinical character-
istics.
• Synthetic minority over-sampling technique (SMOTE): Adding synthetic
samples to the minority class until classes are balanced.
6.2.2.1 Under-sampling the majority class
Under-sampling the majority class provides an opportunity for eliminating samples from
majority classes that are most dissimilar from samples of the minority class, and thus
improving the balance between classes in both demographic characteristics and numbers
of samples. The number of samples in the least populated class (borderline personal-
ity disorder) was selected as the target under-sampling number, and both healthy con-
trols and bipolar disorder classes were under-sampled by eliminating subjects with lowest
(healthy controls) or highest (bipolar disorder) BMI, until the target number of samples
was achieved. The resulting BMI limits were set as > 22.5 for healthy controls and < 29
for bipolar disorder classes, resulting in the data subset described in Table 6.2.
It can be seen that after USM re-samping the imbalance in group demographic char-
acteristics was eliminated and the difference only remains in self-rated mood symptoms,
that are specific to a particular disorder. It can also be seen that a QIDS-SR16 rating of
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borderline personality disorder group exceeds the clinical threshold for moderate depres-
sion (> 10) at least for some participants. However, this self-reported low mood does not
represent the actual clinical condition of depression, and characteristic of the euthymia
state in borderline personality disorder as described by Stanley and Wilson (Stanley and
Wilson, 2006).
Table 6.2: Demographics and data set characteristics of the AMoSS euthymic data subset after
under-sampling the majority class to match cohorts. Superscripts indicate that the distributions
are different with p < 0.05 according to the Wilcoxon rank sum test. BD, BPD and HC super-
scripts refer to bipolar disorder, borderline personality disorder and healthy controls.
Healthy controls Bipolar disorder Borderline
personality disorder
Demographic characteristics
Number of participants 15 15 15
Gender 13 females 10 females 13 females
Age (Mean±SD) 30.20±6.67 37.40±11.95 32.13±9.58
Height (Mean±SD) 166.80±8.03 171.40±11.17 168.20±8.27
Weight (Mean±SD) 69.31±9.33 72.49±11.75 79.13±18.06
BMI (Mean±SD) 24.83±1.93 24.57±2.34 27.99±6.11
Data set characteristics
ASRM (Mean±SD) 1.67±2.58 1.80±3.36 2.13±2.20
QIDS-SR16 (Mean±SD) 1.87±2.64 BD BPD 4.40±4.64 HC BPD 10.13±6.15 HC BD
GAD-7 (Mean±SD) 1.33±1.91 BD BPD 3.87±2.83 HC BPD 10.20±6.72 HC BD
BIS-11 (Mean±SD) 52.07±9.29 BD BPD 64.29±10.34 HC BPD 78.00±12.85 HC BD
Non-wear time, days (Mean±SD) 0.13±0.12 0.16±0.09 0.11±0.09
6.2.2.2 Synthetic Minority Over-sampling Technique
Given the cost of acquiring new samples for the AMoSS data set, it is also beneficial to
estimate the accuracy of classification using a complete set of data, and account for the
imbalance in numbers of participants in each class by adding synthetic samples to minority
classes. The Synthetic Minority Over-sampling Technique (Chawla et al., 2002) is a
widely accepted technique for dealing with imbalanced data sets by generating synthetic
samples and includes the following steps:
1. Unsupervised classification of complete data set is performed using k-nearest neigh-
bours algorithm (five nearest neighbours proposed in the original algorithm and used
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in this work).
2. Synthetic samples are introduced at a random position along the line segments
joining a minority sample with randomly selected nearest neighbours until the target
number of samples is reached.
For the AMoSS euthymic data subset, the under-represented class of borderline per-
sonality disorder (15 subjects) was over-sampled to match the number of subjects in the
bipolar disorder class (24 subjects). The healthy controls class was not over-sampled as
the number of subjects in this class (23) was close to the number of bipolar disorder sub-
jects. The transformation was performed in feature space, so demographic characteristics
of the data set did not change.
6.3 Data analysis approach
The data analysis approach of this chapter included the steps of feature selection and
classification, performed in Leave One Out Cross Validation (LOOCV) folds to avoid the
curse of dimensionality issues related to over-estimation of classification accuracy when
the number of features is comparable to the number of samples. On each step of cross
validation the best features were selected, a classifier trained on the best features of the
training set, and classification performance estimated on the testing set. For the subset
of features, where best classification accuracy was achieved, the prevalence of features in
classification folds was also reported. All features were normalised before the analysis by
subtracting the mean and dividing by standard deviation.
6.3.1 Dimensionality reduction methods
In order to find the best features for separation between disorders, a number of dimen-
sionality reduction techniques were used. There are two types of dimensionality reduction
approaches in existence, including feature extraction and feature selection.
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Feature extraction attempts to find the best features by transforming existing features
into a lower dimensional space, and feature selection refers to methods of finding optimal
subsets of existing features without transformation. Feature extraction methods may be
agnostic to the type of problem, for example Linear Discriminant Analysis, or use domain
specific knowledge to derive new meaningful features from existing ones.
Feature selection methods attempt to find the best subset of existing features without
transformation, and can be broadly divided into filters and wrappers (Guyon and Elisseeff,
2003), where filters optimise some measure of feature usefulness and wrappers use the
predictive model itself as a measure of feature selection quality.
In the following analysis a number of state-of-the-art dimensionality reduction meth-
ods were evaluated, from simple feature ranking technique to more complex wrapper
methods. Based on features identified by these techniques, classifiers were built and
their predictive power was estimated in terms of classification accuracy, specificity and
sensitivity.
6.3.1.1 Na¨ıve feature ranking method
Na¨ıve feature ranking method sorts all available features according to their p values for
differentiating between target classes, and sequentially adds top rated features to the “op-
timal” subset. This filter method takes into account only the relevance of the features to
a particular classification target, but ignores potential cross-correlation between features.
In this study the best features to distinguish between target classes were selected by
ordering features according to the absolute value of a standardised u-statistic of two-
sample unpaired Wilcoxon rank-sum test.
6.3.1.2 Minimum Redundancy Maximum Relevance
Multivariate minimum-Redundancy-Maximum-Relevance (mRMR) criterion takes into
account both individual relevance of features to target class, as well as the complimen-
tarity of selected subsets of features (Peng et al., 2005). This filter method allows the
121
selection of features that are predictive for the target class (maximum relevance), but at
the same time orthogonal to each other (minimum redundancy), according to Equations
6.3, 6.1 and 6.2. The relevance criterion is given by
maxD(S, c), D =
1
S
∑
xi∈S
I(xi; c), (6.1)
where S is a feature set with features xi and c is a target class (with c = 0 indicating
normal, and c = 1 otherwise). The redundancy criterion is given by
minR(S), R =
1
|S|2
∑
xi,xj∈S
I(xi;xj) (6.2)
where S is a feature set with features xi and xj, and mutual information is defined as
I(x; y) =
∫∫
p(x, y)log
p(x, y)
p(x)p(y)
dxdy, (6.3)
where I(x; y) is the mutual information between variables x and y. p(x), p(y) and
p(x, y) are probability densities of these variables.
The relevance and redundancy criteria were combined using Mutual Information Dif-
ference scheme and incremental search was then used to find features which satisfy the
above criteria. For the application of mRMR, features were discretized into five states
between values of Mean±SD, where SD is one of -1, -0.5, 0.5, 1 as suggested by Peng et
al. (Peng et al., 2005).
6.3.1.3 Least Absolute Shrinkage and Selection Operator
The Least Absolute Shrinkage and Selection Operator (LASSO) was proposed by Robert
Tibshirani as a new method for regression estimation in linear models (Tibshirani, 1996).
LASSO minimises L2 norm (residual sum of squares) subject to L1 constraint on the
model as
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min
β0,β
(
1
2N
N∑
i=1
(yi − β0 − xTi β)2 + λ
p∑
j=1
|βj|
)
, (6.4)
where N is the number of observations, yi is the response at observation i, xi is
the data vector of observation i, p is the length of data vector, λ is the regularisation
parameter, and β0 and β are scalar and p-length vectors of regression coefficients.
As a result, it may produce regression model coefficients that are exactly 0, or ir-
relevant for the model. For feature selection LASSO was used as a wrapper method,
maximising cross-validation accuracy of classification with selected features.
6.3.2 Classification techniques
To analyse the capability of selected features to differentiate between subject classes
(and disorders), a number of classification techniques were used and described below. All
feature selection and classification experiments were performed for pair-wise separation
between study groups and using LOOCV to estimate unbiased classification performance.
6.3.2.1 Logistic regression
Binary logistic regression can be used to predict responses based on independent variables,
with the additional benefit of providing a probabilistic result. The logistic regression
method is based on fitting the logistic function into data to achieve best separation
between target classes. The logistic function is specified as
F (x) =
1
1 + e−
(
β0+
∑m
i=1 βixi
) (6.5)
where xi are the explanatory variables, βi are the coefficients of regression model and
F (x) is interpreted as the probability of dependant variable belonging to the “success”
class.
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6.3.2.2 Support Vector Machines
The Support Vector Machines (SVM) classifier attempts to create a hyperplane with the
largest distance to the nearest points in a feature space to separate target classes (Cortes
and Vapnik, 1995). This is achieved by maximising the expression
[
1
n
n∑
i=1
max(0, 1− yi(w · xi + b))
]
+ λ||w||2, (6.6)
where xi are data points of feature vector of length n, yi are +1 or −1 indicating to
which class xi belongs, w and b are model parameters to optimise and λ is the parameter
defining the misclassification tradeoff. The example of SVM classification is presented in
Figure 6.1.
Figure 6.1: Decision boundary of SVM classifier. Filled and empty dots represent two different
classes with support vectors selected in red. The solid line represents the maximum-margin
hyperplane and dashed lines represent margins.
The SVM classifier allows for more flexibility in definition of class boundaries com-
pared to logistic regression by using a so-called “kernel trick”. With the kernel trick, if
linear separation in the original feature space is not possible, features can be mapped into
a higher dimensional space using the kernel function. The separation is then performed
in a higher dimensional space.
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The Gaussian Radial Basis Function (RBF) kernel used by this study, and in order
to optimise the RBF kernel parameters α (scaling factor) and C (box constraint), on the
first fold of cross-validation an additional LOOCV sub-fold was performed where α and
C were identified using grid search.
6.4 Analysis results
Presented in this chapter exploratory analysis of differences between clinical groups aims
to identify the most important features for separation between the diagnostic categories,
using the proposed dimensional framework. Differences between groups are described
first and subsequently the proposed features are assessed for their classification accuracy.
6.4.1 Comparison between cohorts
Comparison between the proposed behavioural features of mental disorders, correspond-
ing to psychomotor, disorganisation and mood symptom dimensions is presented in Table
6.3. The comparison was performed on a USM data subset, thus the influence of imbal-
ance in age and BMI between study groups was minimised.
The bipolar disorder participants were characterised by slightly elevated levels of
physical activity as described by the time in moderate and vigorous activities, slightly
lower entropy of activity and longer segments of continuous activity. Time to bed of
bipolar disorder participants was slightly earlier, but all sleep characteristics comparable
to healthy controls and patterns of activity were better aligned between days as shown
by lower DTW distance between daily activity patterns.
Interestingly, no statistically significant difference in objective activity features was
identified between healthy controls and bipolar disorder patients. It is consistent with
the definition of bipolar disorder, where symptoms are present only during episodes of
mania and depression, but contradicts with previous research findings, where differences
in behaviour were reported also during euthymic state (Indic et al., 2011; Rock et al.,
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Table 6.3: Group differences between objective features of mental health as described by di-
mensional framework. To minimise the influence of cohorts imbalance, the data are shown after
under-sampling the majority classes (15 subjects in each group with no significant differences
in demographic characteristics). Superscripts indicate that the distributions are different with
p < 0.05 according to the Wilcoxon rank sum test. BD, BPD and HC superscripts refer to
bipolar disorder, borderline personality disorder and healthy controls.
Healthy controls Bipolar disorder
Borderline
personality
disorder
Psychomotor dimension
LEVEL_AVG 0.03±0.01 0.03±0.01 0.03±0.01
LEVEL_GAMMA_K 0.17±0.04 0.19±0.06 0.15±0.04
LEVEL_GAMMA_THETA 0.19±0.09 0.22±0.19 0.18±0.07
TIME_MODERATE 111.99±26.26 124.41±31.32 105.86±26.12
TIME_VIGOROUS 7.72±5.53 11.95±18.62 7.70±10.22
Disorganisation dimension
LEVEL_MSE_1 0.09±0.04 BPD 0.08±0.05 BPD 0.06±0.04 HC BD
LEVEL_MSE_2 0.12±0.03 0.11±0.04 0.10±0.02
LEVEL_MSE_3 0.13±0.03 0.12±0.04 0.11±0.02
LEVEL_MSE_4 0.14±0.03 0.13±0.04 0.12±0.03
LEVEL_MSE_5 0.14±0.03 0.14±0.05 0.13±0.03
DUR_AVG 1.02±0.11 1.06±0.20 1.04±0.13
DUR_GAMMA_K 0.73±0.04 0.72±0.07 0.71±0.05
DUR_GAMMA_THETA 1.42±0.22 1.52±0.47 1.50±0.30
DUR_DFA 0.62±0.05 0.63±0.04 0.66±0.03
LEVEL_DTW 170.29±15.67 167.53±20.63 180.49±16.94
Mood dimension (sleep)
IN_BED_TIME -58.83±85.25 -91.49±50.99 BPD 0.78±100.43 BD
OUT_OF_BED_TIME 477.39±59.19 BPD 438.11±42.47 BPD 540.58±97.87 HC BD
TIME_IN_BED 536.47±49.59 529.85±46.48 540.04±64.13
SLEEP_ONSET_LATENCY 31.64±20.37 26.82±16.26 29.38±15.15
WAKE_AFTER_SLEEP_ONSET 48.51±15.84 47.63±14.35 BPD 62.63±19.05 BD
ACTUAL_SLEEP_TIME 456.07±46.44 455.16±49.52 447.78±55.06
SLEEP_EFFICIENCY 85.54±3.30 86.23±3.49 BPD 83.20±3.34 BD
NUMBER_OF_WAKE_BOUTS 52.92±12.68 48.36±11.64 BPD 62.80±21.43 BD
MEAN_WAKE_BOUT_TIME 0.91±0.28 0.98±0.22 1.01±0.20
MEAN_SLEEP_BOUT_TIME 9.58±2.29 10.39±2.59 8.57±2.65
MOBILE_TIME 214.00±36.82 199.73±35.25 BPD 242.46±64.36 BD
IMMOBILE_TIME 290.83±38.11 303.31±52.17 268.21±48.98
TAU 1.01±0.01 1.01±0.01 1.00±0.01
PHI 209.28±69.07 173.31±40.76 BPD 270.68±93.83 BD
L5 2.79±2.18 BPD 2.82±1.37 BPD 3.88±1.54 HC BD
M10 116.14±27.72 134.15±46.86 113.21±30.26
RA 0.95±0.03 BPD 0.95±0.02 BPD 0.93±0.04 HC BD
IS 0.02±0.01 0.01±0.01 0.02±0.01
IV 0.75±0.14 0.71±0.17 0.75±0.08
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2014). The lack of statistically significant differences may be due to combined effect of
the small number of subjects, short (one week) period of analysis and successful disorder
management strategy of bipolar patients.
The borderline disorder participants were characterised by slightly lower levels of day-
time activity, significantly lower entropy of activity, later times of going to bed and longer
bed times with lower sleep efficiency and higher levels of activity during the least active 5
hours. Also, the variability of daily activity patterns was slightly higher for the borderline
personality disorder patients.
It can be seen that most differences between disorders were observed in mood di-
mension features, related to patterns of circadian rhythms, night time activity and sleep.
Significant differences between borderline personality disorder group and both bipolar
disorder and healthy controls were reported in wake up times, levels of activity during
the least active 5 hours and relative amplitude of day-night activity.
6.4.2 Importance of objective features
The importance of objective features for separation between diagnostic categories was
assessed using three feature selection algorithms, including the simple ranking of features
according to their relevance to target using the p-value of Wilcoxon rank-sum (RANK),
mRMR criteria and LASSO, with results presented in Table 6.4.
If using simple relevance criteria (RANK), most of the top features for separation
between clinical groups are concentrated in the dimension of mood, while the criteria
that take into account complimentarity of features (mRMR) or select features for best
separation between groups using cross-validation (LASSO) propose top features belonging
to different dimensions of symptoms, suggesting the validity of the dimensional approach.
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Table 6.4: Ranking of features for separation between clinical groups using Wilcoxon rank-sum
test criteria, mRMR and LASSO, with top five features in the ranking selected in bold font.
Healthy controls
vs. bipolar
disorder
Healthy controls
vs. borderline
personality
disorder
Bipolar disorder
vs. borderline
personality
disorder
RANK mRMR LASSO RANK mRMR LASSO RANK mRMR LASSO
Psychomotor dimension
LEVEL_AVG 11 19 18 23 28 32 16 24 7
LEVEL_GAMMA_K 13 24 7 25 20 23 11 22 13
LEVEL_GAMMA_THETA 21 3 11 33 8 18 32 4 18
TIME_MODERATE 8 6 2 26 23 24 17 7 5
TIME_VIGOROUS 29 7 24 21 2 11 25 13 19
Disorganisation dimension
LEVEL_MSE_1 33 22 4 2 6 1 6 3 20
LEVEL_MSE_2 31 29 29 13 17 8 20 16 26
LEVEL_MSE_3 32 33 30 16 30 25 21 28 31
LEVEL_MSE_4 30 17 32 15 32 28 26 33 32
LEVEL_MSE_5 25 34 16 18 34 26 27 34 11
DUR_AVG 26 11 13 28 24 29 34 31 14
DUR_GAMMA_K 15 27 12 22 26 19 30 30 21
DUR_GAMMA_THETA 22 31 31 24 33 14 33 26 15
DUR_DFA 17 9 19 6 4 3 14 8 4
LEVEL_DTW 27 4 22 7 11 20 15 20 9
Mood dimension (sleep)
IN_BED_TIME 12 14 33 11 13 33 5 10 22
OUT_OF_BED_TIME 1 16 1 4 19 4 1 1 1
TIME_IN_BED 23 25 34 29 25 34 23 23 33
SLEEP_ONSET_LATENCY 14 13 6 34 31 21 24 27 23
WAKE_AFTER_SLEEP_ONSET 34 8 14 5 21 5 8 21 27
ACTUAL_SLEEP_TIME 28 32 27 27 22 30 28 32 34
SLEEP_EFFICIENCY 16 30 21 12 18 6 3 18 6
NUMBER_OF_WAKE_BOUTS 10 12 28 14 29 9 7 15 8
MEAN_WAKE_BOUT_TIME 2 5 17 9 16 31 29 11 24
MEAN_SLEEP_BOUT_TIME 3 1 15 20 15 12 12 25 12
MOBILE_TIME 4 23 3 19 7 15 9 5 28
IMMOBILE_TIME 18 26 5 17 1 10 18 2 16
TAU 19 10 9 10 14 7 13 17 10
PHI 5 2 25 8 3 13 2 6 2
L5 9 20 26 1 5 27 10 14 29
M10 6 28 23 31 10 16 19 19 25
RA 20 15 20 3 9 2 4 9 3
IS 7 18 8 32 27 22 22 29 17
IV 24 21 10 30 12 17 31 12 30
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6.4.3 Accuracy of separation between study groups
The accuracy of separation between the diagnostic categories is presented in Table 6.5. If
a certain feature selection and classification strategy demonstrated superior performance
compared to others, it was selected in bold. For USM data balancing strategy simple
RANK feature selection demonstrated the best results, indicating that very few highly
correlated features were the most relevant for classification.
As expected from the cohort differences described in Section 6.4.1, the best clas-
sification accuracy of 80% was achieved for separation between bipolar and borderline
personality disorder groups, with 80% sensitivity and specificity when a mRMR feature
selection was used. The features used for classification were:
• OUT_OF_BED_TIME
• IMMOBILE_TIME
• LEVEL_MSE_1
• LEVEL_GAMMA_THETA
• MOBILE_TIME
Notably, this result persists for both SVM and logistic regression classifiers, indicating
linear separation between classes. Classification accuracy drops only marginally when
using SMOTE balancing strategy.
A classification accuracy of 70% with 67% specificity and 73% sensitivity was achieved
for separation between healthy controls and borderline personality disorder patients using
RANK feature selection strategy. The features used for classification were:
• L5
• LEVEL_MSE_1
• RA
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Table 6.5: Summary of classification accuracy for separation between AMoSS clinical groups
using different data set balancing, feature selection and classification strategies, with best results
selected in bold font.
Data set balancing strategy
USM SMOTE
Feature selection
RANK mRMR LASSO RANK mRMR LASSO
Healthy controls vs. bipolar disorder
Logistic regression
Accuracy 0.60 0.57 0.50 0.62 0.45 0.60
Specificity 0.53 0.53 0.47 0.54 0.46 0.58
Sensitivity 0.67 0.60 0.53 0.70 0.43 0.61
SVM
Accuracy 0.67 0.53 0.53 0.57 0.45 0.64
Specificity 0.67 0.53 0.60 0.42 0.42 0.54
Sensitivity 0.67 0.53 0.47 0.74 0.48 0.74
Healthy controls vs. borderline personality disorder
Logistic regression
Accuracy 0.67 0.57 0.67 0.72 0.64 0.72
Specificity 0.67 0.47 0.67 0.75 0.67 0.75
Sensitivity 0.67 0.67 0.67 0.70 0.61 0.70
SVM
Accuracy 0.70 0.60 0.67 0.72 0.66 0.72
Specificity 0.67 0.33 0.67 0.71 0.62 0.71
Sensitivity 0.73 0.87 0.67 0.74 0.70 0.74
Bipolar disorder vs. borderline personality disorder
Logistic regression
Accuracy 0.77 0.80 0.73 0.77 0.77 0.77
Specificity 0.73 0.80 0.67 0.79 0.79 0.79
Sensitivity 0.80 0.80 0.80 0.75 0.75 0.75
SVM
Accuracy 0.80 0.80 0.77 0.79 0.79 0.79
Specificity 0.67 0.80 0.60 0.75 0.75 0.75
Sensitivity 0.93 0.80 0.93 0.83 0.83 0.83
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• OUT_OF_BED_TIME
• WAKE_AFTER_SLEEP_ONSET
With synthetic samples the accuracy of classification marginally improved to 72%
when using RANK and LASSO feature selection. Again, the logistic regression classifier
demonstrated similar accuracy as a SVM classifier.
For separation between healthy controls and bipolar disorder participants the accuracy
of classification was 67% with 67% specificity and sensitivity when using RANK feature
selection strategy. The features used for classification were:
• OUT_OF_BED_TIME
• MEAN_WAKE_BOUT_TIME
• MEAN_SLEEP_BOUT_TIME
• MOBILE_TIME
• PHI
The accuracy of classification dropped to 64% when using SMOTE oversampling.
6.5 Discussion and conclusions
The analysis in this chapter covered two main topics. First, differences between objective
behaviour characteristics of clinical cohorts were identified by analysing the behaviour
characteristics of euthymic periods of activity. Second, the capability of activity features
to differentiate between disorders was evaluated by analysing the cross-validated classifi-
cation accuracy of diagnostic groups with different data set balancing, feature selection
and classification strategies.
For both patient groups, bipolar disorder and borderline personality disorder, the
mood dimension, represented by sleep characteristics, appears to be the most important
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factor separating between groups. For borderline personality disorder patients many
of the sleep characteristics are significantly different compared to both healthy controls
and bipolar disorder patients (see Table 6.3). While there are no individually significant
features of difference between healthy controls and bipolar disorder patients, after feature
selection the top features appear to belong to mood dimension.
Comparing performance of different classifiers and feature selection strategies, it can
be observed that accuracy of simple logistic regression is similar to a nonlinear approach
like an SVM classification, indicating homogenity of diagnostic groups, with linear sepa-
ration possible between classes.
Finally, an interesting observation to make is that bipolar disorder patients are more
different to borderline personality disorder than healthy controls in terms of the activity
metrics defined in this chapter. This could be explained by a well-executed disorder
management strategy, where bipolar disorder patients actively adhere to a healthy and
regular life routine, as demonstrated by low inter-daily variability and differences between
successive daily activity patterns.
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Chapter 7
Differentiation between clinical states
7.1 The problem of deterioration
In many psychiatric disorders symptoms may wax and wane over time, and relapse is a
continual threat (Sierra et al., 2009; Dawson et al., 2010). For example, in the case of
bipolar disorder patients they may slide into a manic or depressive state, in borderline
personality disorder there may be attempts at suicide or self-harm, or psychotic relapse
in schizophrenia. Clinical deterioration poses a significant problem and may happen
undetected due to impaired patient insight, and can lead to hospitalisation (Lieb et al.,
2004; Green, 2006; Pompili et al., 2013).
It was demonstrated that recognition of the early warning signs of upcoming clinical
episodes are helpful for timely treatment, and helps to achieve better patient outcomes
(Birchwood, 2000; Morriss, 2004; Blum et al., 2008). However, the treatment strategies
that allow the incorporation of recognition of early warning signs into the management
of disorder require close collaboration between patient, family, primary and specialist
care (Falloon et al., 1996; Mueser et al., 2002; Mueser et al., 2003). Organising such an
interaction is a complex and costly task, and not always possible in a particular patient’s
circumstances.
The current practice of early warning signs identification includes patients’ self-observations
133
facilitated by family, and sometimes also involves clinical specialists using web-based
mood self-reporting tools, such as True Colours Self-Management platform (Miklowitz
et al., 2012). Self-reports are known to suffer from compliance issues, especially if insight
or motivation are impaired, as often happens in mental disorders. In such situations am-
bient symptoms monitoring using using a mobile and wearable sensors may be of great
benefit.
In this chapter the difference in objective activity features between clinically relevant
mood states will be analysed to assess the feasibility of objective mood state identification.
The task of identification of clinically relevant mood states was approached here as a
classification of weekly objective behaviour indicators.
7.2 Data subset selection
To identify the objective mood features, the high quality data collected with GENEActiv
wearable sensors were used. Such data cover both day and night activity, but are available
only for a short period of time from each participant, usually from one to three weeks
of continuous recording with one or two data acquisition sessions per participant. Given
the DSM-5 diagnostic criteria for mania and depression, where for a clinical episode to
be detected it has to be present for one (mania) or two (depression) weeks, and the fact
that the frequency of episodes in bipolar disorder is low (four episodes per year in a rapid
cycling variant, present in approximately 10% of patients), the probability of capturing
a mood episode together with euthymia from a single participant with GENEActiv data
acquisition is low. The GENEActiv data can be used therefore only to compare cohorts
and not to build personalised regression models, due to the limited number of weekly
observations per subject.
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7.2.1 Distinct mood state identification
In order to perform the analysis, one week periods were selected from data, where mood
self-assessment was available and objective GENEActiv activity data present. Using
standard diagnostic thresholds of QIDS-16SR and ASRM, the four mood states for clas-
sification were defined as
• euthymia, where the ASRM score is below 6 and QIDS-16SR is below 11,
• depression, where QIDS-16SR is above 10,
• mania, where ASRM is above 5, and
• mixed state, where both QIDS-16SR is above 10 and ASRM above 5.
From the analysis in Chapter 6 it can be seen that for the borderline personality
disorder patients the connection between the objectively-assessed behaviours and self-
reported emotional state is not reliable. Therefore for the present classification only the
groups of healthy controls and bipolar disorder patients were used.
Following the approach of Section 6.2, from each participant single weeks of activity
were selected, where no more then 10% of GENEActiv data were missing and subjective
mood score was reported on both QIDS-16SR and ASRM scales.
A total of 109 episodes were identified with statistical characteristics presented in
Table 7.1. There were no mixed state episodes, so the mixed state was excluded from
further analysis and binary classification was performed to separate euthymia, depression
and mania. It is necessary to mention that the selected weeks do not necessarily represent
clinically significant episodes of disorder, as the individual symptoms manifestation may
not match the DSM-5 diagnostic criteria.
7.2.2 Dealing with imbalanced data set
It can be seen that the mood states data set was unbalanced towards euthymia periods,
with the number of weeks five to ten times in excess of the number of weeks with mania
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Table 7.1: Demographics and data set characteristics of the AMoSS mood classification data
subset. Superscripts indicate that the distributions are different with p < 0.05 according to the
Wilcoxon rank sum test. EU, DEP, MAN and MIX superscripts refer to euthymia, depression,
mania and mixed states.
Euthymia Mania Depression Mixed state
Number of weeks, total 109 10 16 0
healthy controls 54 4 0 0
bipolar disorder 55 6 16 0
Demographic characteristics
Number of unique subjects 37 6 7 0
Gender 27 females 3 females 5 females 0 females
Age (Mean±SD) 34.84±10.59 28.00±3.29 30.43±5.83 N/A
Height (Mean±SD) 170.46±7.14 171.50±2.74 172.29±2.29 N/A
Weight (Mean±SD) 73.62±12.24 66.00±12.05 71.29±16.13 N/A
BMI (Mean±SD) 25.49±4.90 22.56±4.82 24.08±5.68 N/A
Data set characteristics
ASRM (Mean±SD) 1.31±1.57 MAN 10.20±3.79 EU DEP 0.81±1.28 MAN N/A
QIDS-16SR (Mean±SD) 3.17±2.47 DEP 3.10±3.11 DEP 17.50±5.82 EU MAN N/A
GAD-7 (Mean±SD) 2.89±3.43 DEP 4.90±4.38 DEP 12.94±6.76 EU MAN N/A
BIS-11 (Mean±SD) 58.15±10.82 DEP 64.80±16.37 67.06±9.33 EU N/A
Non-wear time, days (Mean±SD) 0.17±0.13 0.20±0.15 0.19±0.06 N/A
and depression. Additionally, the data on depressive state represented a high percentage
of recordings from female participants. Therefore the re-sampling strategies described in
detail in Section 6.2.2 were used.
7.2.2.1 Under-sampling the majority class
The strategy for USM re-sampling was selected to minimise the imbalance in gender and
age, therefore samples of male participants at an older age (> 40) were discarded, keeping
at the same time at least one week of data from each unique subject to avoid the data
subset being dominated by a few participants with relatively large amount of acquired
data, and to analyse all possible subject-specific predictors of mood. The resulting subset
is described in Table 7.2.
7.2.2.2 Synthetic Minority Over-sampling Technique
For SMOTE re-sampling, the minority classes of mania and depression were oversampled
to match the number of participants in the euthymia class, with no change in demographic
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Table 7.2: Demographics and data set characteristics of the AMoSS GENEActiv mood data
subset after USM. Superscripts indicate that the distributions are different with p < 0.05 ac-
cording to Wilcoxon rank sum test. EU, DEP, MAN and MX superscripts refer to euthymia,
depression, mania and mixed states.
Euthymia Mania Depression Mixed state
Number of weeks, total 10 10 10 0
healthy controls 7 4 0 0
bipolar disorder 3 6 10 0
Demographic characteristics
Number of unique subjects 10 6 7 0
Gender 5 females 3 females 5 females 0 females
Age (Mean±SD) 31.70±10.06 30.00±9.55 30.71±9.36 N/A
Height (Mean±SD) 170.40±6.31 170.00±7.07 171.71±4.82 N/A
Weight (Mean±SD) 77.60±18.72 72.33±19.14 78.29±18.79 N/A
BMI (Mean±SD) 27.04±7.71 25.34±7.90 26.84±7.67 N/A
Data set characteristics
ASRM (Mean±SD) 1.60±1.43 MAN 10.20±3.79 EU DEP 0.90±1.45 MAN N/A
QIDS-16SR (Mean±SD) 2.50±1.78 DEP 3.10±3.11 DEP 15.60±5.08 EU MAN N/A
GAD-7 (Mean±SD) 1.60±1.96 DEP 4.90±4.38 11.60±6.69 EU N/A
BIS-11 (Mean±SD) 58.40±8.76 64.80±16.37 67.50±10.09 N/A
Non-wear time, days (Mean±SD) 0.20±0.15 0.20±0.15 0.17±0.06 N/A
or data set characteristics after the re-sampling process.
7.3 Data analysis approach
The data analysis approach followed the general structure of cohorts differentiation anal-
ysis described in Section 6.3, including the following steps:
1. Data set re-sampling (using USM and SMOTE strategies) described in detail in
Sections 6.2.2 and 7.2.2.
2. Feature selection using three alternative methods, including RANK (see Section
6.3.1.1), mRMR (see Section 6.3.1.2) and LASSO (see Section 6.3.1.3).
3. Classification using LR (see Section 6.3.2.1) and SVM (see Section 6.3.2.2) classi-
fiers. For classification LOOCV hold out strategy was used.
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7.4 Analysis results
The analysis results of this chapter explore the differences in objective behaviour features
of mental (emotional) states. The differences in objective state features are presented
first, followed by the assessment of their classification accuracy.
7.4.1 Comparison between states
Objectively collected features were analysed to compare their distributions in three pre-
viously described clinically important mood states, including depression, euthymia and
mania, with results presented in Table 7.3. The comparison was performed on a USM
data subset.
The manic state was characterised by a significantly different distribution of activity
levels as characterised by the parameters of fitted Gamma distribution. Also, almost all
disorganisation cluster characteristics were significantly different for mania compared to
euthymia state, including higher levels of MSE, decreased duration of continuous activity
segments, and decreased DTW distance between daily activity patterns. Also, consistent
with theoretical expectations, the manic state was characterised by decreased time in
bed, sleep time and immobile time.
The depressed state was characterised (compared to euthymia state) by significantly
decreased average levels of daily activity, decreased levels of MSE (only for the first two
scales), increased time-to-wake after sleep onset, increased wake bout time and differences
in non-parametric circadian rhythm characteristics, including the M10, RA, IS and IV.
As expected, the difference between the manic and depressed states was more pro-
nounced compared to the difference between each of these states and euthymia.
Interestingly, the disorganisation cluster characteristics were more pronounced in dif-
ferentiating between the euthymia and manic state, while sleep and circadian rhythm
characteristics were more often significant between the euthymia and depressed states.
Psychomotor characteristics were approximately equally relevant for both mania and de-
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Table 7.3: State differences between objective features of mental health. Superscripts indicate
that the distributions are different with p < 0.05 according to Wilcoxon rank sum test. EU, DEP
and MAN superscripts refer to euthymia, depression and mania.
Euthymia Mania Depression
Psychomotor dimension
LEVEL_AVG 0.03±0.01 DEP 0.03±0.01 DEP 0.02±0.01 EU MAN
LEVEL_GAMMA_K 0.18±0.06 MAN 0.23±0.06 EU DEP 0.17±0.04 MAN
LEVEL_GAMMA_THETA 0.18±0.11 MAN DEP 0.12±0.02 EU 0.12±0.03 EU
TIME_MODERATE 116.05±33.85 DEP 127.36±24.64 DEP 92.21±38.94 EU MAN
TIME_VIGOROUS 8.17±10.55 MAN DEP 3.20±1.69 EU 2.43±2.48 EU
Disorganisation dimension
LEVEL_MSE_1 0.08±0.04 MAN DEP 0.11±0.01 EU DEP 0.04±0.06 EU MAN
LEVEL_MSE_2 0.11±0.03 MAN DEP 0.13±0.02 EU DEP 0.09±0.03 EU MAN
LEVEL_MSE_3 0.12±0.03 MAN 0.15±0.02 EU DEP 0.10±0.03 MAN
LEVEL_MSE_4 0.13±0.03 MAN 0.16±0.02 EU DEP 0.11±0.03 MAN
LEVEL_MSE_5 0.13±0.03 MAN 0.17±0.03 EU DEP 0.12±0.04 MAN
DUR_AVG 1.06±0.15 MAN 0.93±0.10 EU 1.10±0.22
DUR_GAMMA_K 0.72±0.06 MAN 0.77±0.04 EU DEP 0.69±0.06 MAN
DUR_GAMMA_THETA 1.52±0.35 MAN 1.23±0.19 EU DEP 1.66±0.48 MAN
DUR_DFA 0.62±0.04 0.62±0.04 0.63±0.04
LEVEL_DTW 171.59±16.28MAN DEP 158.39±16.83 EU DEP 182.03±15.25 EU MAN
Mood dimension (sleep)
IN_BED_TIME -69.65±78.76 -29.75±61.19 -76.15±63.02
OUT_OF_BED_TIME 478.20±63.19 461.58±77.35 473.25±129.62
TIME_IN_BED 548.10±55.11 MAN 491.57±52.04 EU DEP 549.65±95.73 MAN
SLEEP_ONSET_LATENCY 26.19±17.18 21.32±11.13 29.35±25.38
WAKE_AFTER_SLEEP_ONSET 54.37±19.21 DEP 52.00±14.83 DEP 72.87±24.62 EU MAN
ACTUAL_SLEEP_TIME 467.29±51.08 MAN 418.00±43.43 EU 447.17±102.79
SLEEP_EFFICIENCY 85.57±4.54 DEP 85.36±3.50 80.77±8.08 EU
NUMBER_OF_WAKE_BOUTS 54.70±13.04 54.74±13.55 56.86±16.75
MEAN_WAKE_BOUT_TIME 0.99±0.28 DEP 0.95±0.24 DEP 1.28±0.25 EU MAN
MEAN_SLEEP_BOUT_TIME 9.42±2.35 8.57±2.69 8.96±3.13
MOBILE_TIME 221.14±41.24 213.89±45.95 230.55±50.68
IMMOBILE_TIME 300.78±43.50 MAN 256.36±33.50 EU DEP 289.75±86.68 MAN
TAU 1.00±0.02 1.50±1.58 1.00±0.01
PHI 204.28±65.87 215.91±64.70 198.55±89.98
L5 3.46±2.14 3.11±1.07 3.67±1.41
M10 118.95±34.43 DEP 122.58±24.53 DEP 90.81±32.21 EU MAN
RA 0.94±0.03 DEP 0.95±0.02 DEP 0.91±0.04 EU MAN
IS 0.01±0.01 DEP 0.01±0.01 DEP 0.02±0.01 EU MAN
IV 0.74±0.15 DEP 0.77±0.13 0.84±0.08 EU
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pression.
7.4.2 Importance of objective features
The importance of objective features for identification of mood states was assessed using
three feature selection algorithms, including the simple ranking of features according to
their relevance to target using the p-value of Wilcoxon rank-sum (RANK), mRMR criteria
and LASSO, with results presented in Table 7.4.
Similarly to the difference between disorders, the top rated features for separation
between disorders were observed mostly in the mood (sleep) cluster. Features selection
methods that take into account complementarity of features tend to select subsets of
features belonging to different clusters, including psychomotor, disorganisation and mood.
7.4.3 Accuracy of separation between mood states
The accuracy of separation between the mood states is presented in Table 7.5. If certain
feature selection and classification strategies demonstrated superior performance com-
pared to others, they were selected in bold.
As expected from the cohort differences presented in Table 7.3 and theoretical consid-
erations, the best results in separation between mood states (using the USM re-sampling
strategy) were achieved for separation between mania and depression (90% accuracy with
90% specificity and 90% sensitivity). The LASSO feature selection method demonstrated
the best results (with SVM classification), however all other methods have shown higher
performance compared to other classification experiments.
Interestingly, for SMOTE oversampling, all feature selection algorithms and classifica-
tion methods allowed the achievment of perfect separation between mania and depression.
The best classification accuracy of 85% with 100% specificity and 70% sensitivity for
separation between euthymia and depression was achieved using LASSO feature selection
and SVM classification (USM re-sampling).
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Table 7.4: Ranking of features for separation between mood states using the Wilcoxon rank-sum
test criteria, mRMR and LASSO, with the top five features in the ranking selected in bold font.
Euthymia vs.
mania
Euthymia vs.
depression
Mania vs.
depression
RANK mRMR LASSO RANK mRMR LASSO RANK mRMR LASSO
Psychomotor dimension
LEVEL_AVG 24 4 23 32 10 14 16 13 17
LEVEL_GAMMA_K 25 27 15 15 18 18 25 17 6
LEVEL_GAMMA_THETA 31 8 16 17 7 19 29 5 14
TIME_MODERATE 18 26 18 33 32 23 21 30 18
TIME_VIGOROUS 32 5 24 13 5 24 24 4 26
Disorganisation dimension
LEVEL_MSE_1 29 31 19 22 20 7 8 7 27
LEVEL_MSE_2 23 33 9 20 6 25 11 32 7
LEVEL_MSE_3 21 16 25 27 14 26 12 19 28
LEVEL_MSE_4 16 22 26 31 12 27 13 24 29
LEVEL_MSE_5 14 30 10 34 9 20 17 33 30
DUR_AVG 5 21 12 24 34 28 23 16 8
DUR_GAMMA_K 15 29 17 10 28 4 30 34 15
DUR_GAMMA_THETA 8 7 27 19 17 29 34 23 31
DUR_DFA 17 25 20 11 21 5 9 20 9
LEVEL_DTW 10 15 13 12 8 10 19 31 11
Mood dimension (sleep)
IN_BED_TIME 7 11 28 3 3 2 6 3 1
OUT_OF_BED_TIME 2 1 1 7 29 30 14 25 21
TIME_IN_BED 13 13 8 25 25 11 31 21 22
SLEEP_ONSET_LATENCY 33 20 14 28 23 6 20 11 12
WAKE_AFTER_SLEEP_ONSET 27 28 21 2 16 21 3 8 32
ACTUAL_SLEEP_TIME 9 10 4 21 26 31 26 28 33
SLEEP_EFFICIENCY 22 3 22 8 4 8 27 14 19
NUMBER_OF_WAKE_BOUTS 11 9 29 18 30 15 18 6 23
MEAN_WAKE_BOUT_TIME 1 6 2 1 1 1 1 1 2
MEAN_SLEEP_BOUT_TIME 19 32 30 29 27 32 15 22 24
MOBILE_TIME 12 19 5 23 19 33 28 12 5
IMMOBILE_TIME 30 14 31 30 22 12 5 10 13
TAU 6 2 6 9 2 3 22 2 3
PHI 4 18 32 6 24 34 4 9 34
L5 34 34 33 16 11 16 10 27 20
M10 3 12 3 26 31 22 32 26 10
RA 26 23 34 14 33 13 33 18 25
IS 28 24 7 4 13 17 2 15 4
IV 20 17 11 5 15 9 7 29 16
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Table 7.5: Summary of LOOCV classification accuracy for separation between AMoSS partic-
ipants’ mood states using different data set balancing, feature selection and classification strate-
gies, with best results selected in bold font.
Data set balancing strategy
USM SMOTE
Feature selection
RANK mRMR LASSO RANK mRMR LASSO
Euthymia vs. mania
Logistic regression
Accuracy 0.80 0.50 0.75 0.82 0.75 0.83
Specificity 0.80 0.60 0.80 0.73 0.76 0.74
Sensitivity 0.80 0.40 0.70 0.91 0.73 0.93
SVM
Accuracy 0.70 0.60 0.75 0.82 0.87 0.83
Specificity 0.90 0.20 0.80 0.68 0.73 0.72
Sensitivity 0.50 1.00 0.70 0.95 0.98 0.94
Euthymia vs. depression
Logistic regression
Accuracy 0.80 0.70 0.80 0.82 0.85 0.82
Specificity 0.80 0.70 0.90 0.85 0.89 0.84
Sensitivity 0.80 0.70 0.70 0.78 0.82 0.80
SVM
Accuracy 0.75 0.60 0.85 0.84 0.90 0.86
Specificity 0.70 0.40 1.00 0.87 0.97 0.94
Sensitivity 0.80 0.80 0.70 0.79 0.81 0.75
Mania vs. depression
Logistic regression
Accuracy 0.85 0.80 0.85 1.00 1.00 1.00
Specificity 0.80 0.90 0.80 1.00 1.00 1.00
Sensitivity 0.90 0.70 0.90 1.00 1.00 1.00
SVM
Accuracy 0.85 0.80 0.90 1.00 1.00 1.00
Specificity 0.80 0.80 0.90 1.00 1.00 1.00
Sensitivity 0.90 0.80 0.90 1.00 1.00 1.00
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The best classification accuracy of 80% with 80% specificity and sensitivity for sepa-
ration between euthymia and mania was achieved using simple RANK feature selection
and logistic regression classification.
The results demonstrated for SMOTE re-sampling consistently superseded the results
for USM.
7.5 Discussion and conclusions
The analysis of this chapter investigated the differences between objective characteristics
of activity in different clinically relevant mood states and the possibility to identify these
mood states using only data collected from passive activity sensors using classification
techniques.
The first important result is that the classification accuracy demonstrated in identi-
fication of clinical states substantially (by approximately 10%) exceeds the classification
accuracy achieved in separation between different disorders, presented in Chapter 6. This
agrees with the expectation of increased symptom manifestation during clinical episodes,
while indicating that the clinical states of patients should be carefully considered when
differentiating between mental disorders using short-term recordings. Secondly, the the-
oretical expectation of observing higher differences between mania and depression rather
than any of these states and euthymia was also confirmed in practice.
It is interesting to note that while mood (sleep) characteristics are important features
for classification in all cases, the manic state appears to demonstrate elevated character-
istics from the disorganisation cluster of symptoms and the depression state has more
pronounced changes in sleep characteristics, while psychomotor cluster symptoms are
equally relevant in both cases.
These results justify the selected dimensional approach to characterising mental health
and indicate the need and importance of further research in this area. Using appropriate
change point detection techniques on collected objective behaviour data could potentially
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allow for early identification of behaviour abnormalities related to changes in clinical state.
The main limitation of presented research is in limited number of clinical episodes
captured with GENEActiv recordings. This, together with the fact that the number of
subjects were comparable with the number of captured episodes, led the choice of the
analysis using binary classification as opposed to regression between the mood scores and
values of behaviour features. Such regression however, could be attempted once more
clinical mood episodes are captured.
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Chapter 8
Personalised mood modelling
8.1 Diversity of individual symptoms
As was demonstrated in Chapter 7, different mood states can be distinguished from each
other based on behavioural characteristics, calculated from physical activity time series.
But a universal description of a mental state in terms of these behaviour characteristics
is hardly possible due to the diversity of possible symptom combinations and behaviour
impairments. For example, the borderline personality disorder patients are known to
rate their mood and behaviour as very depressed, however no sign of depression may be
obvious to an external observer (Westen et al., 1992). This makes the task of creating a
universally valid association between behaviour and mood almost impossible.
While the symptoms that characterise mental illnesses are well defined, the exact
patterns of symptom combinations may vary from person to person, as described by the
DSM-5 diagnostic criteria (American Psychiatric Association, 2013). More important is
the fact that prodrome and early warning signs of mental disorder episodes may also vary
quite significantly between different patients (Molnar et al., 1988; Keitner et al., 1996;
Perry et al., 1999; Birchwood, 2000; Klosterko¨tter et al., 2001; Jackson et al., 2003; Berk
et al., 2007; Goossens et al., 2010; Sierra et al., 2009).
Early research by Molnar et al. (Molnar et al., 1988) on 20 bipolar patients con-
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cluded that the duration and symptoms of manic and depressive prodrome vary a lot
between individuals, but are consistent for the same individual and the same episode
type. A more extensive study by Keitner et al. (Keitner et al., 1996) on 74 bipolar pa-
tients identified that 78% of patients reported prodromal depressive symptoms and 87%
reported prodromal manic symptoms (while according to family reports these numbers
were even higher). Cognitive, mood, behavioural, neurovegatative and social symptoms
were reported in different combinations.
The systematic review of manic and depressive prodromes by Jackson et al. (Jackson
et al., 2003) identified that at least 80% of individuals with mood disorder can detect
symptoms of prodrome. The most important early symptom of mania was sleep distur-
bance and early symptoms of depression were inconsistent. Importantly, the randomised
control trial on efficacy of teaching patients to recognise early symptoms of relapse per-
formed by Perry et al. (Perry et al., 1999) identified that such teaching was associated
with important clinical improvements, in particular at the time of first manic relapse.
All these facts indicate the importance of creating personalised models of mood deteri-
oration for each individual specifically, that would account for inter-individual differences
in prodrome symptomatology. This problem can be solved by identifying the relationship
between objective behaviours and mood for each subject individually and building person-
alised regression models to reconstruct the respective scoring system (such as QIDS-16SR,
ASRM or GAD-7) using collected objective activity data.
In this chapter regression models have been constructed to identify the relationship
between objective activity features and reported subjective mood state. If accurate, such
models may allow the meaningful tracking of patients and identification of early warning
signs of deterioration.
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8.2 Data subset selection
8.2.1 Selection of participants
Unfortunately the GENEActiv data collected in the AMoSS study cannot be used to
build a personalised regression model due to the limited number of weekly observations
per subject. Despite the fact that correlation between GENEActiv and mobile phone
collected data is limited, mostly because activity during sleep cannot be captured with a
mobile phone, longitudinal changes in day time behaviours can be inferred from mobile
phone data and personalised regression models can be built using data from participants’
smart phones, where data acquisition was continuous for a period of up to one year.
From all collected data the individuals were selected who captured at least 12 mood
points (or three months), where data including phone-derived physical activity and self-
reported mood was captured simultaneously. Additionally, the only subjects who were
retained in the data set were those who had at least two distinct mood states during
the recording, according to thresholds defined earlier in Section 7.2.1. The resulting data
subset is described in Table 8.1 and distributions of self-reported mood scores presented
in Figure 8.1.
Table 8.1: Demographics and data set characteristics of the AMoSS personalised mood regres-
sion data subset. For each mood questionnaire the range is represented as the difference between
maximum and minimum scale values for each participant.
Healthy controls Bipolar disorder
Borderline
personality
disorder
Total
Demographic characteristics
Number of participants 7 24 12 43
Gender 5 females 15 females 11 females 31 females
Phone (Trousers, Jacket, Handbag) 3,0,4 13,3,8 4,1,7 20,4,19
Age (Mean±SD) 25.57±2.88 36.46±9.71 32.00±9.26 33.44±9.56
Height (Mean±SD) 171.14±6.04 171.04±9.64 166.67±8.28 169.84±8.83
Weight (Mean±SD) 62.00±7.16 80.81±16.39 80.75±18.26 77.73±17.06
BMI (Mean±SD) 21.24±2.87 27.50±4.61 29.20±6.94 26.95±5.70
Data set characteristics
Mood points (Mean±SD) 49.14±10.32 51.08±47.75 37.25±19.71 46.91±37.46
ASRM (Mean±SD) 8.57±3.82 9.67±5.06 8.92±4.27 9.28±4.59
QIDS-16SR (Mean±SD) 10.57±4.12 14.33±4.67 14.25±4.00 13.70±4.53
GAD-7 (Mean±SD) 10.43±6.08 13.42±3.86 11.58±2.71 12.42±4.10
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a. b. c.
Figure 8.1: Distribution of self-reported mood scores between participant groups. Figure a)
shows the ASRM scores, b) shows the QIDS-16SR scores and c) shows the GAD-7 scores.
For each collected mood score the preceding week of phone activity data was analysed
to identify objective behaviour features most predictive to subjective mood scores and
regression models were built to estimate severity of mood symptoms (represented by
QIDS-16SR, ASRM and GAD-7 scores) from phone behaviour data.
Note, that due to the personalised nature of regression models, it was possible to
analyse all clinical groups, including borderline personality disorder participants. As
regression models were built for each subject individually, differences between cohorts
were not relevant for the analysis.
8.2.2 Selection of features
Phone data are limited to day-time only collection, capturing activity during the time
when the phone was located on the subject’s body. These data do not allow a perfectly
accurate reconstruction of activity levels, because phones are not constantly attached to
the human body, and may be left at home or located in different pockets, personal carry
bags, or left on tables periodically.
Because of these limitations it was not possible to calculate all activity features de-
scribed in Sections 5.3.3, 5.4.4 and 5.5.6. Psychomotor parameters were excluded as there
are no validated thresholds for moderate and vigorous activity derived for phone-based
activity data. Sleep-related parameters were excluded as sleep analysis was not possible
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to perform using phone data, where the phone was not typically adjacent to a subjects’
body during the sleep period. The excluded features are presented in Table 8.2 and the
features used in further analysis are presented in Table 8.3.
Table 8.2: Phone accelerometer-derived activity features, excluded from the analysis due to
limitations of phone data acquisition.
Feature Description
Psychomotor features
TIME_MODERATE Time spent in moderate-intensity activities (3-6 MET)
TIME_VIGOROUS Time spent in vigorous activities (>6 MET)
Sleep (mood) features
IN_BED_TIME The time the subjects gets into bed
OUT_OF_BED_TIME The time the subject got out of bed
TIME_IN_BED Time in bed
SLEEP_ONSET_LATENCY Time it took the subject to fall asleep
WAKE_AFTER_SLEEP_ONSET Wake after sleep onset
ACTUAL_SLEEP_TIME Actual sleep time
SLEEP_EFFICIENCY ’Actual sleep time’ divided by ’Time in bed’ multiplied by 100
NUMBER_OF_WAKE_BOUTS Number of continuous blocks scored as WAKE
MEAN_WAKE_BOUT_TIME Mean wake bout time
MEAN_SLEEP_BOUT_TIME Mean sleep bout time
MOBILE_TIME Total duration of epochs with activity (>0) during sleep
IMMOBILE_TIME Total duration of epochs with no activity during sleep
TAU Cosinor-derived τ
PHI Sleep midpoint as offset to midnight in minutes
8.3 Data analysis approach
Firstly, daily-calculated objective activity features were pre-processed using smoothing
techniques to produce weekly summaries corresponding to mood self-report.
Secondly, regression models for identification of mood were built for each participant
separately. Objective weekly activity measures (described in Table 8.3) were used as
predictors and self-reported mood scores (total scores of ASRM, QIDS-16SR and GAD-
7) as regression targets.
The quality of regression was evaluated using LOOCV strategy, where all but one data
points were used to build regression model and the accuracy of regression was estimated
149
Table 8.3: Phone accelerometer-derived activity features retained for further analysis of per-
sonalised mood-activity models.
Feature Description
Psychomotor features
LEVEL_AVG Average level of ENMO activity
LEVEL_GAMMA_K Shape parameter of Gamma distribution fit into ENMO activity
LEVEL_GAMMA_THETA Scale parameter of Gamma distribution fit into ENMO activity
Disorganisation features
LEVEL_MSE_{N} N th scale of Multiscale Entropy (N = 1..5)
DUR_AVG Average duration of BOCPD segments
DUR_GAMMA_K Shape parameter of Gamma distribution fit into BOCPD length
DUR_GAMMA_THETA Scale parameter of Gamma distribution fit into BOCPD length
DUR_DFA DFA α (scaling exponent) of BOCPD length
LEVEL_DTW Average day-to-day DTW distance of activity level patterns
Sleep (mood) features
L5 Level of activity during the least active 5 hours
M10 Level of activity during the most active 10 hours
RA Relative amplitude between L5 and M10
using the remaining one (repeating the process for each data point, for each subject).
8.3.1 Smoothing techniques
Data from phone sensors are the subject of quality concerns and behavioural artifacts as
described in Chapter 4, making calculation of daily activity features potentially unreli-
able. To minimise the influence of errors of daily-calculated features on mood regression
models a number of smoothing techniques were applied to the time series of activity fea-
tures with the purpose of reducing the variance in feature values due to feature calculation
error.
The objective activity features were computed for every day, subject to data availabil-
ity. However, mood self-reports were collected once a week and described the subject’s
perception of his / her mental state and behaviour during during the previous week.
Therefore the objective features for regression should aggregate information from seven
days prior to questionnaire delivery and the smoothing techniques described in the follow-
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ing sections were parametrised by using a one week analysis window in order to provide
a meaningful comparison with self-reported data.
As a baseline for comparison of smoothing techniques, the feature values for the last
24 hours before mood assessment were also used.
8.3.1.1 Median filtering
A simple, but robust to outliers, method of smoothing was proposed by Tukey (Tukey,
1977) and uses a running median to calculate the filtered signal. In our case that of
behaviour data with ground truth describing the preceding week, and possible weekly
behaviour regularities, a fixed seven day window length for the filter was selected, with
a smoothing equation defined as
x′i = Median
i
j=i−7{xj}, (8.1)
where xi and x′i are the original and smoothed feature values respectively. The median
filter, along with a number of improvements to enhance robustness and performance in
specific applications is extensively used in image processing (Brownrigg, 1984) and also
adopted in clinical time series data analysis (Davies et al., 2004).
8.3.1.2 Exponential filtering
A well-known phenomena in subjectively recollected reports is the so-called recall bias
(Firth and Torous, 2015), when more recent events are perceived as more important
compared to older ones. This phenomena may affect self-reported mood scores and result
in objectively identified activity features not offering the best explanation for biased self-
reports, despite correctly representing the actual behaviour in the mathematical sense.
The class of filtering techniques that may help address this problem is called exponen-
tial smoothing (Hunter, 1986), where more recent samples are weighted higher compared
to older samples, thus incorporating the potential recall bias into the model. Exponential
smoothing is defined as
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x′i+1 = λxi + (1− λ)x′i, (8.2)
where xi and x′i are the original and smoothed measurements respectively and λ is a
smoothing factor, describing the relative contribution of current and past measurements
and set to 2/(N+1) with N (or filter length) equal to seven days, as for the median filter.
Exponential smoothing is equivalent to an Autoregressive Integrated Moving Average
(ARIMA) (0,1,1) model with no constant term.
Exponential smoothing has proven to be useful in physical activity time series anal-
ysis (Løvendahl and Chagunda, 2010). In addition to basic smoothing described above,
versions to account for trend (double exponential smoothing) and seasonality (triple ex-
ponential smoothing) were proposed (Winters, 1960), but not used in this work due
to increased complexity of the model and necessity for (possibly subject specific) prior
information to infer model parameters.
8.3.1.3 Gaussian Process filtering
The above filtering techniques assume signal stationarity, however it is well-known that
human activity is highly non-stationary and may be self-correlated on different scales.
For example, reduced night sleep may result in increased sleep pressure on the following
day and earlier sleep onset with longer sleep duration on the following night (Birchler-
Pedross et al., 2009). Similarly the external zeitgebers, such as weekly work-rest routine,
are likely to influence daily physical activity (Fuster-Garcia et al., 2015).
A good filtering algorithm should incorporate these non-stationarities. A popular
framework for signal modelling that allows dealing with various kinds of non-stationary
signals in a principled way is offered by Gaussian Processes (GP). A GP is a collection
of random variables, any finite number of which have a joint Gaussian distribution (Ras-
mussen and Williams, 2006). GP defines a family of functions fully specified by mean
function m(x) and covariance function k(x,x′) as
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f(x) = GP(m(x), k(x,x′)),
m(x) = E[f(x)],
k(x,x′) = E[(f(x)−m(x))(f(x′)−m(x′))].
(8.3)
The definition of mean and covariance functions allows the modelling of different
kinds of non-stationarities, with the covariance function being the most interesting topic.
In our case, the signal feature of interest was the dependency of current activity on
activity on previous days. Similarly to the family of exponential smoothing techniques,
many covariance functions were proposed to model different interactions with Gaussian
Processes. However, if interactions are simple or not well defined, the squared exponential
(SE) is most commonly used (Roberts et al., 2013). The SE covariance function is defined
as
kSE(xi, xj) = h
2exp
[
−
(
xi − xj
λ
)2]
, (8.4)
where xi and xj represent the time points of data collection, h is an output-scale
amplitude and λ is an input scale (of time in our case).
8.3.2 Personalised mood regression
The smoothing techniques described in Section 8.3.1, applied to calculated daily activity
features, allow the reduction of potential errors introduced by quality issues of phone-
based activity data.
These activity features are hypothesised to be associated with mood state, however
not all variables may add additional information to the model or even decrease the model’s
accuracy due to the curse of dimensionality. Different features may be important as mood
predictors for different subjects.
Therefore it is essential to select the best features for regression, to characterise the
individual subject. Regression techniques that allow selecting only subsets of variables
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that best describe relationships between predictors and dependent variables are known
as regularised regression methods.
8.3.2.1 Regularised regression
The Least Absolute Shrinkage and Selection Operator (LASSO) of Tibshirani (Tibshirani,
1996) extends the linear regression with the Ordinary Least Squares (OLS) method,
proposed originally by Legendre (Legendre, 1805) and Gauss (Gauss, 1963), by adding
L1 penalty by the number of non-zero regression coefficients.
In multiple linear regression the dependent variable is expressed as a linear combina-
tion of p independent variables:
yi = β0 + β1xi1 + β2xi2 + ...+ βpxip + i, (8.5)
where xij are observations of p independent variables, yi are dependent variables, βi are
regression coefficients, i is the observation error and i indexes the particular observation.
The method of LASSO obtains parameter estimates β by minimising the square of
difference between the dependent variable and estimate, subject to L1 constraint
β = argmin
β
(
1
2N
N∑
i=1
(y′i − yi)2 + λ
p∑
j=1
|βj|
)
, (8.6)
where β is the p-length vector of regression parameter estimates, y′i and yi are the
observed estimated dependent variable values respectively, and N is the number of ob-
servations.
LASSO regression favours zero β coefficients, thus essentially performing feature se-
lection and eliminating non-relevant features from the model. In order to select the best
parametrisation for regression in terms of λ (and therefore the best features), LASSO uses
a cross-validation approach, with 5-fold CV used in this work. Based on cross-validation
results, the value of λ is selected with the minimum MSE (see Figure 8.2). This allows
selecting a parametrisation with the number of features providing the best accuracy.
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Figure 8.2: Example of LASSO lambda parameter selection using the MSE of cross-validated
regression. The green dotted line represents the parametrisation with minimal MSE and blue
dotted line represents the parametrisation with the least number of features and MSE within one
SD from the minimum.
The regression procedure was performed with ASRM, QIDS-16SR and GAD-7 scores
as target variables and objective activity features as predictors. The result of this pro-
cedure including the set of β coefficients for predictors constitute the personalised mood
prediction model.
8.3.2.2 Regression quality estimation
LOOCV cross-validation procedure was applied to estimate the generalisation error of
regression models, where for each subject the accuracy of regression was calculated by
building a number of models on data sets, each excluding one data point, and estimating
the model performance on this data point (for each data point).
The model performance was estimated using the Mean Squared Error (MSE)
MSE =
1
N
N∑
i=1
(y′i − yi)2, (8.7)
and the Mean Absolute Error (MAE)
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MAE =
1
N
N∑
i=1
|y′i − yi|, (8.8)
where y′i and yi are the observed estimated dependent variable values respectively,
and N is the number of observations.
The MAE estimate was chosen as it provides the estimate error in units of the original
mood scale and is easily interpretable by clinical experts, for example the study by Tsanas
et al. used MAE to estimate the quality of the model for the prediction of Parkinson’s
disorder symptom scoring based on voice analysis (Tsanas et al., 2010).
8.4 Analysis results
8.4.1 Smoothing techniques
To minimise the features calculation error, time series of daily objective activity behaviour
features for all subjects were processed by three different methods of data smoothing.
The example plot of smoothing results for a single activity feature of a single subject is
presented in Figure 8.3.
To estimate the quality of smoothing, LASSO regression was performed using data
produced by all three methods of smoothing and also the original data from last 24 hours
before mood score was acquired. The MAE of regression was calculated using LOOCV
approach for each subject, where N-1 data points were used to build regression model
and the error was estimated on the remaining data point, with results presented in Table
8.4.
Table 8.4: Comparison of time series smoothing techniques using the MAE of time series pre-
diction across all participants. The MAE for each subject was calculated using LOOCV approach.
No statistically significant differences were found between smoothing methods.
Last 24 hours Median smoothing Exponentialsmoothing
Gaussian Process
smoothing
ASRM (Mean±SD) 2.13±1.63 2.14±1.74 2.05±1.45 2.23±1.98
QIDS-16SR (Mean±SD) 2.65±1.47 2.68±1.44 2.80±1.74 2.67±1.36
GAD-7 (Mean±SD) 2.51±1.31 2.53±1.39 2.61±1.46 2.55±1.42
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Figure 8.3: Comparison of time series smoothing techniques for a single activity feature
(LEVEL_AVG, defined in Section 5.3.1) of a single subject. Note, that in the case of
LEVEL_AVG smoothing of daily average activity is equivalent to smoothing of the original
activity signal.
It can be seen that no single method is superior comparing to all others, with the
simple last 24 hours value providing slightly better regression results for QIDS-16SR and
GAD-7 models, and exponential smoothing providing better results for ASRM models.
The GP smoothing provides a similar fit to the other methods, but also has the attractive
property of being able to extrapolate the measurements and fill in missing data. Due to
simplicity of the model and similarity of results, the last 24 hours activity method was
selected for reporting the regression results.
8.4.2 Personalised regression models
For each subject and each questionnaire (ASRM, QIDS-16SR and GAD-7) regression
models were identified as described in Section 8.3.2.1 and using the objective activity
features acquired in the last 24 hours before mood score was collected (see example
results at Figure 8.4).
Across all subjects and using the features of the last 24 hours the regression MAE was
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Figure 8.4: Example of results of mood regression model for a single subject. Regression was
performed for all self-reported mood scores and smoothed activity features of a single subject.
2.13±1.63 for ASRM, 2.65±1.47 for QIDS-16SR and 2.51±1.31 for GAD-7 questionnaires
as described in Table 8.4.
Between different study groups the accuracy of prediction models was similar, with
healthy controls demonstrating the lowest MAE for all mood characteristics as presented
in Table 8.5, and significantly lower MAE comparing to bipolar disorder and borderline
personality disorder groups for QIDS-16SR scores.
Pearson’s correlation between the self-reported and estimated mood scores was on
average between 0.27 and 0.54 for all questionnaires and participants groups with the
highest values of 0.54±0.35 for QIDS-16SR of bipolar disorder participants and the lowest
values of 0.27±0.33 for ASRM of healthy controls, with no significant difference between
groups.
The number of features providing the best LASSO regression performance for per-
sonalised mood models was also not significantly different between the groups using the
Wilcoxon rank sum test. The average number of features was between 1.6 and 2.97 for all
questionnaires and participants groups, with the highest values of 2.97±3.24 for GAD-7
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of healthy controls and the lowest values of 1.60±2.12 for ASRM of healthy controls.
Table 8.5: Results of mood score prediction across all participant groups and mood question-
naires. MAE represents the prediction error, r is a Pearson’s correlation coefficient between the
target and predicted time series and N is the number of features used for the model. Superscripts
indicate that the distributions are different with p < 0.05 according to the Wilcoxon rank sum
test. BD, BPD and HC superscripts refer to bipolar disorder, borderline personality disorder and
healthy controls, so a BD superscript in the healthy control column indicates that the parameter
was significantly different between healthy controls and bipolar patients only.
Healthy controls Bipolar disorder
Borderline
personality
disorder
ASRM
MAE (Mean±SD) 1.38±0.85 2.16±1.87 2.49±1.40
MSE (Mean±SD) 3.72±3.41 10.71±19.79 11.63±11.97
r (Mean±SD) 0.27±0.33 0.39±0.29 0.35±0.29
N (Mean±SD) 1.60±2.12 2.27±2.15 2.37±2.63
QIDS-16SR
MAE (Mean±SD) 1.36±0.38 BD BPD 2.68±1.44 HC 3.32±1.50 HC
MSE (Mean±SD) 2.82±1.22 BD BPD 13.62±14.01 HC 19.92±16.42 HC
r (Mean±SD) 0.36±0.29 0.54±0.35 0.40±0.39
N (Mean±SD) 2.87±2.79 2.75±2.76 2.47±2.37
GAD-7
MAE (Mean±SD) 1.77±1.43 2.72±1.39 2.52±0.97
MSE (Mean±SD) 9.14±16.54 BPD 13.46±13.51 10.54±7.06 HC
r (Mean±SD) 0.39±0.29 0.39±0.29 0.31±0.34
N (Mean±SD) 2.97±3.24 2.74±2.48 1.94±1.94
The objective activity features most often selected as predictors in personalised re-
gression models are presented in Table 8.6. For ASRM models the feature most often
selected for the models was the difference between activity of successive days measured
using the Dynamic Time Warping (LEVEL_DTW). For QIDS-16SR and GAD-7 models
the shape parameter of activity duration distribution (DUR_GAMMA_K) was the most
prevalent feature.
To estimate the possible influence of phone usage styles on the regression results,
MAE of regression was compared between users keeping phone in trousers pocket, jacket
pocket and handbag, regardless of grouping into disorder categories. The only signifi-
cant difference in MAE was found for GAD-7 questionnaire between trousers pocket and
handbag (see Table 8.7).
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Table 8.6: Prevalence of features selected by LASSO regression as the percentage of personalised
regression models where each feature was used. The most prevalent features are selected in bold
text.
ASRM (%) QIDS-16SR (%) GAD-7 (%)
LEVEL_AVG 13.95 18.60 6.98
LEVEL_GAMMA_K 23.26 23.26 16.28
LEVEL_GAMMA_THETA 20.93 23.26 16.28
LEVEL_MSE_1 20.93 23.26 9.30
LEVEL_MSE_2 6.98 11.63 11.63
LEVEL_MSE_3 11.63 16.28 4.65
LEVEL_MSE_4 9.30 18.60 4.65
LEVEL_MSE_5 11.63 16.28 13.95
DUR_AVG 9.30 9.30 6.98
DUR_GAMMA_K 18.60 37.21 27.91
DUR_GAMMA_THETA 6.98 20.93 2.33
DUR_DFA 16.28 32.56 16.28
LEVEL_DTW 27.91 30.23 16.28
L5 25.58 20.93 20.93
M10 9.30 9.30 6.98
RA 6.98 20.93 6.98
Table 8.7: Comparison of mood score prediction accuracy depending on the phone usage pattern.
Superscripts indicate that the distributions are different with p < 0.05 according to the Wilcoxon
rank sum test. T, J and H superscripts refer to trousers pocket, jacket pocket and handbag
respectively.
Trousers pocket Jacket pocket Handbag
ASRM (Mean±SD) 2.25±1.53 1.76±1.09 2.07±1.86
QIDS-16SR (Mean±SD) 3.02±1.64 1.79±0.48 2.44±1.34
GAD-7 (Mean±SD) 2.92±1.34 H 3.07±1.69 1.97±1.04 T
8.5 Discussion and conclusions
As was discussed in Section 6.1, the reliability of diagnosis in psychiatry can be quite
low and for most diagnoses moderate-to-good inter-rater agreement between different
experts was found (Regier et al., 2013). The correlation between different psychiatric
scales depends on the type of scale, for ASRM and MRS r=0.72 (Altman et al., 1997)
and for QIDS-16SR and HAM-D24 r=0.84.
Therefore, despite the average correlation between predicted values of psychiatric
questionnaires and self-reported scores was in the range of 0.27 and 0.54, it presents
an important and promising result, indicating the possibility for identification of more
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powerful features, given that the most predictive features of mood, such as sleep char-
acteristics (as identified in Chapter 7), were not included in mood prediction models of
this chapter. The MAE of scores estimation was in the range of 1.36 to 3.32 points, this
corresponds to the ranges reserved in psychiatric questionnaires for a unique identifiable
mood state (4-5 points) (as described in Table 3.6), and indicating that clinically relevant
results are possible to achieve.
Given that for the analysis of this chapter many of important features, in particular
related to sleep, were excluded due to the limitations of data acquisition using mobile
phones, improvements in results may be produced by improvements in data acquisition
techniques, such as using wearable technology, once the compliance issues described in
Section 4.5.3 are resolved.
An interesting observation from the comparison of smoothing techniques is that using
the value of objective behaviour features in the last 24 hours directly preceding the
collection of subjective behaviour evaluation provides slightly more accurate (although
not statistically significant) regression models. This phenomena was expected because
weekly self-reports may tend to over-emphasise more recent feelings from the last 24
hours or less (Baranowski, 1988; Stone and Shiffman, 2002; Bowling, 2005; Saunders et al.,
2015), and indicates the potential inaccuracies of evaluating symptoms using subjectively
assessed mood, which can be prone to artifacts related to mood sampling timing.
Under such circumstances the objective measures of behaviour may provide a more
precise (comparing to questionnaires) tool for assessment of symptomatic behaviours and
early detection of clinical episodes of disorder, as well as more accurate estimation for
the episode duration, important for both diagnostic and treatment purposes.
161
Chapter 9
Fusing activity and physiological data
to improve classification
9.1 Introduction
As was shown in Section 2.4, physiological signals may be helpful in assessing mental
health symptoms that are associated with autonomous nervous system activation, specif-
ically in the anxiety dimension but potentially also including reality distortion, mood
and other domains, where symptoms include strong subjective experiences. Electroder-
mal activity (EDA) and heart rate (HR) were found to be useful in studies of mental
disorders (Carney et al., 2001; McCraty et al., 2001; Agelink et al., 2002; Cohen et al.,
2003), since HRV has been shown to be a good proxy for the state of the autonomous
nervous system (Ba¨r et al., 2008) and EDA is known to be linked with parasympathetic
nervous system activation (Boucsein, 2012).
The HR signal has attracted increasing attention from the psychophysiological re-
search community due to the ability to characterise both branches of ANS and the avail-
ability of standardised analysis techniques, where variability analysis plays the most sig-
nificant role (Rechlin et al., 1994; Friedman and Thayer, 1998; Agelink et al., 2002; Cohen
et al., 2003; Valkonen-Korhonen et al., 2003; Valenza et al., 2014b). Heart rate variability
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is also known to be affected by medication (O’Regan et al., 2015), potentially providing
an indirect measure of treatment compliance. This thesis therefore presents a preliminary
analysis of the potential for including heart rate based metrics as an objective marker of
psychiatric health.
9.1.1 Experimental foundations
Studies using HR and EDA signals in the area of mental health cover a wide range of
conditions, including panic disorder, depression, schizophrenia and bipolar disorder, with
most of the studies performed on a small number of subjects. A number of projects that
are most relevant to this research are described below.
McCraty et al. (McCraty et al., 2001) analysed the HRV in patients with panic
disorder. 24-hour ECG records from panic disorder patients (N = 38, age 38 ± 7.65
years) and normal controls (N = 38, age 38 ± 7.86 years) were analysed and both time
(mean, RMSSD) and frequency (HF, LF, VLF, ULF) HRV characteristics were collected.
It was found that the VLF and LF power were significantly lower in panic disorder
patients compared to normal controls.
Carney et al. (Carney et al., 2001) studied clinical depression in post myocardial
infarction patients. Patients with (N = 307, age 57.1 ± 12.3 years) and without (N =
366, 60.9 ± 11.1 years) depression had a 24-hour ambulatory ECG before their hospital
discharge. Four HRV indices were calculated, including the power in ULF, VLF, LF and
HF bands. All HRV indices were significantly lower in patients with depression compared
to patients without depression.
Agelink et al. (Agelink et al., 2002) analysed differences in heart rate variability
between moderate (N = 16, age 44.3 ± 12.6 years) and severe (N = 16, age 53.5 ± 15.8
years) major depression patients, as well as normal controls (N = 64, age 46.6 ± 11.9
years). For HRV analysis, the coefficient of variation (CV), RMSSD and the power
in LF and HF bands were calculated. Patients with severe major depression showed
significantly higher heart rate and lower CV, RMSSD and HF, compared to controls, while
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in moderately depressed patients the HRV characteristics were lower, but not significantly.
Heart rate variability in bipolar disorder was studied by Cohen et al. (Cohen et al.,
2003). Euthymic bipolar patients (N = 39, age 38.4 ± 12.8 years), and matched by sex
and age, normal controls (N = 39, age 39.5 ± 12.8 years) were recruited for the study.
ECG recordings were taken at resting state and HRV indices were calculated, including
mean and standard deviation of beat-to-beat intervals, power in VLF, LF, HF bands and
total power (TP, 0.01− 0.40 Hz). It was found that bipolar patients are characterised by
markedly low HRV, independent of specific drug treatments.
Valenza et al. (Valenza et al., 2013) analysed the heart rate in bipolar patients (N = 3,
ages 38, 55 and 37 years) in the PSYCHE project. Up to 6 data acquisition sessions were
performed for each subject in different emotional states and classification accuracy of
severe clinical mood states from 68.31% to 97.96% (depending on a subject) was achieved
using 5-fold cross validation for intra-subject analysis using heart rate features.
Lanata et al. (Lanata et al., 2015) performed analysis of RR-intervals of bipolar
patients (N = 10, age not reported) using Sample Entropy and reported the decreased
entropy in depression and mania states compared to euthymia (significance tests not
performed).
Valenza et al. (Valenza et al., 2014a) performed RR-intervals analysis of bipolar
patients (N = 8, age not reported) using Multiscale Entropy and Detrended Fluctuation
Analysis and identified statistically significant differences between features in depression,
hypomania and euthymic states.
However, it is important to point out that many of the above studies failed to do two
crucial things. First, they did not attempt to classify patients and therefore provide any
indication of the potential accuracy of these features to diagnose or monitor patients.
Second, they performed very limited out of sample analysis in order to provide a notion
of generalisation of the approaches in diagnosing or monitoring patients outside the very
small cohorts analysed.
The question therefore remains if these signals are complimentary to behaviour anal-
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ysis described in this thesis, and what would be the predictive accuracy of HR for diag-
nosis. In order to address this point, in this chapter an analysis of HR and actigraphy is
presented for a new patient population, specifically for schizophrenia, where changes in
locomotor activity and HR have been shown to be indicative of the disease. This validates
the methods on an external population and provides an evaluation of the potential for
combining physiology with actigraphy for monitoring mental health.
9.1.2 The case of schizophrenia
Schizophrenia is a chronic illness, affecting about one percent of the population. It is
characterised by delusions, hallucinations, disorganisation of speech and behaviour. On-
set of schizophrenia usually occurs in early adult years and during the course of the
disorder symptoms may wax and wane, or remain relatively stable. Common complica-
tions include depression and suicide (about 50% of patients attempt and approximately
10% succeed), usually early in the course of the illness (American Psychiatric Associa-
tion, 2013). The broad range and diverse combinations of symptoms make differential
diagnosis of schizophrenia a complex task that requires a good knowledge of a patient’s
history. In addition, the early detection of psychotic relapse/exacerbation often depends
on patient self-report which is a particular challenge in an illness in which insight is fre-
quently impaired. Psychotic relapse is a continual threat, largely because of high rates
of non-adherence in medication taking. Objective measures which could alert clinicians
and caregivers to early signs of relapse would have enormous public health significance.
Walther et al. (Walther et al., 2009) performed a quantitative activity analysis in
patients with different schizophrenia subtypes, including paranoid (N=18, age 39.60±9.64
years), catatonic (N=6, age 45.50±12.19 years) and disorganised (N=9, age 36.23±10.26
years). Activity was monitored for 24 hours every two seconds, but only data during
wakefulness were included in the main analysis. Three activity parameters were extracted:
the mean number of activity counts per hour (AL), the percentage of epochs with non-
zero activity (mobility index, MI), and the mean duration of immobility periods (MIP).
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Only schizophrenia subtype and type of anti-psychotic were found to have significant
effect on AL, MI and MIP.
Hauge et al. (Hauge et al., 2011) analysed differences in locomotor activity of schizophre-
nia patients (N=24, age 47.4±11.1 years), depressed patients (N=25, age 42.9±10.7 years)
and healthy subjects (N=32, age 38.2±13.0 years) in two settings: a) one minute epochs
recorded over five hours, and b) one hour epochs recorded over two weeks. Sample En-
tropy and Fourier analysis were applied and have shown significantly different profiles of
activity between all three groups.
Wulff et al. (Wulff et al., 2012) analysed sleep and circadian rhythm disruption in
schizophrenia outpatients (N=20, age 38.8±8.6 years) in comparison to healthy unem-
ployed individuals (N=21, age 37.5±9.6 years). Activity and light exposure were recorded
every two minutes over six weeks. Activity data were analysed using rest-activity char-
acteristics, cosinor and periodogram analysis. Significant disruption in the sleep and
rest-activity cycle was detected in all schizophrenia patients, independently of mood,
mental state and anti-psychotic treatment.
Ba¨r et al. (Ba¨r et al., 2008) studied the HRV in schizophrenia patients. ECG data
were collected for 2 hours from unmedicated patients with schizophrenia (N = 40, age
34.7 ± 7.1 years) and matched healthy controls (N = 58, age 33.8 ± 8.4 years). Heart
rate as well as the time domain (RMSSD) and frequency domain (VLF, LF, HF power)
indices of HRV were calculated. The heart rate was significantly higher and the HF power
was lower for the schizophrenia patients group.
Rachow et al. (Rachow et al., 2011) analysed the interrelation of skin conductivity
levels and cardiac autonomic dysfunction with 18 unmedicated schizophrenia patients and
18 matched controls. They found significantly increased HR (consistent with results of
Ba¨r), decreased Root Mean Square of the Successive Differences (RMSSD) in heart beats
and decreased complexity (measured with compression entropy) of HR of schizophrenia
patients in comparison to controls.
Studies of Walther et al., Hauge et al. and Wulff et al. demonstrated the usefulness
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of actigraphy (Walther et al., 2009; Hauge et al., 2011; Wulff et al., 2012), and studies by
Ba¨r et al. and Rachow et al. have shown that the heart rate is also a useful signal in the
analysis of schizophrenia (Ba¨r et al., 2008; Rachow et al., 2011). This chapter presents
the analysis of physical activity (Osipov et al., 2013), as well as combined analysis of
physical activity and HR (Osipov et al., 2015) for differentiation between schizophrenia
and healthy controls using two different data sets described below.
9.2 Description of the data sets
9.2.1 The Nuffield data set
The first data set was provided by the Nuffield Department of Clinical Neurosciences, Uni-
versity of Oxford and included only actigraphy information from schizophrenia patients
and matched healthy controls. Motor activity and light exposure of schizophrenia pa-
tients (N=20, age 38.8±8.6 years) and unemployed controls (N=21, age 37.5±9.6 years),
were monitored at home for a maximum of 6 weeks (see Table 9.1). For data collection,
Actiwatch-L actigraph by CamNTech (Cambridge, UK) was used. The device was con-
tinuously worn on the non-dominant wrist with exception of short watch-off intervals due
to shower or medical procedures. Actiwatch-L was configured for data collection with
one or two minutes epochs.
Table 9.1: Demographics and data set characteristics of the Nuffield schizophrenia data set.
Healthy controls Schizophrenia
Number of participants 21 20
Gender 8 female 5 female
Age (Mean±SD) 37.5±9.6 38.8±8.6
Medication N/A All medicated
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9.2.2 Proteus data set
The second data set was provided by Proteus Digital Health (Redwood City, CA) and
included both physical activity and heart rate data, collected from schizophrenia patients
and healthy controls. Outpatients with diagnosis of schizophrenia (N = 16, age 45.1±12.3
years), medicated and in relative symptomatic remission and healthy control subjects
(N = 19, age 51.7 ± 8.8 years) without a history of mental disorders were included in
the analysis (see Table 9.2). Accelerometry and the heart rate of study participants
were monitored for a maximum of four weeks using an adhesive patch manufactured by
Proteus Digital Health (Redwood City, CA) (see Figure 9.1). The device was continuously
worn on the body and configured for the acquisition of ECG-derived heart rate (every 10
minutes as a mean HR at 15 second intervals) and locomotor activity (every 5 minutes
as a mean acceleration at 15 second intervals).
Table 9.2: Demographics and data set characteristics of the Proteus schizophrenia data set.
Healthy controls Schizophrenia
Number of participants 19 16
Gender 25% female 42% female
Age (Mean±SD) 51.7±8.8 45.1±12.3
Medication N/A All medicated
Length of disease (years) N/A 6.4±3.4
Symptoms No history of mental disorders All in relative symptomatic remission
Schizophrenia patients were prescribed anti-psychotic medication, including Olanza-
pine, Risperidone, Aripiprazole, Perphenazine, Fluphenazine, Ziprasidone, Haloperidol
and Quetiapine.
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Figure 9.1: Adhesive activity and heart rate monitoring patch used in the study (Proteus Digital
Health, Redwood City, CA, USA). Adopted from the company marketing materials.
9.3 Data analysis approach
9.3.1 Data pre-processing
9.3.1.1 The Nuffield data set
Because actigraphic data were collected with different epoch lengths (one and two min-
utes) and record duration, the data were pre-processed for analysis according to the
following rules:
1. Records were re-sampled for two minutes epoch according to the Actiwatch-L User
Manual (CamNtech Ltd, 2008).
2. Records with less than 20 complete days (median length of unemployed controls
category) were excluded from analysis.
3. Records were inspected visually and periods without significant missing data (watch-
off intervals) were selected.
4. First and last days of every record were discarded as transition periods.
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5. Periods of missing data were taken as zero activity. These periods usually represent
periods of bathing. Although correction with a non-zero value may at first seem
appropriate, it is unclear how a relevant non-zero value could be picked, since we
may just be picking an activity value that is similar to normality when the patient
is abnormal, or vice versa. A value of zero is unique and simply indicates that
something different is happening. Removing the values and concatenating the data
either side of the removed segment would not be appropriate as this would affect
the meaning of the temporally-related metrics we used.
9.3.1.2 The Proteus data set
Locomotor activity data (recorded in arbitrary units, ranged from zero to one) and heart
rate data (recorded in beats per minute, bpm) were collected with a variable recording
rate and length. Since most analysis algorithms require evenly sampled data, the data
were processed according to the following rules:
1. Data points with an interval, exceeding 1.5 × data collection rate (15 minutes for
HR and 7.5 minutes for activity) were labelled as low quality and removed.
2. HR values lower than 20 bpm were labelled as low quality and removed, based on
normative values of the human heart rate (Jensen-Urstad et al., 2007).
3. HR data were re-sampled to exactly 10 minute intervals using zero-order hold
(sample-and-hold) interpolation. Sample-and-hold interpolation approximates the
next value in time series by replicating the previous value.
4. Locomotor activity data were re-sampled to exactly 5 minute intervals using zero-
order hold (sample-and-hold) interpolation.
5. For analysis, where synchronous activity and heart rate data were necessary, activity
data were down-sampled to 10 minute intervals using linear interpolation. Linear
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interpolation approximates the value in time series as a mean of previous and the
next value.
6. The data from the device are influenced by motion artifacts, and high levels of activ-
ity are correlated to motion, including all data would reduce our ability to separate
the independent influences of physiology and motion on the classifier performance.
To avoid this bias, an automated quality assessment on the HR data was performed
and subjects with more than 10% artifacts removed, consistent with Li et al. (Li
et al., 2008). From complete recordings, the 10 days with the lowest percentage of
missing data for that subject were selected. Recordings, where more than 10% of
data were missing or were of low quality, were discarded.
9.3.2 Analysis methods
The Nuffield data set was analysed using Multiscale Entropy characteristics. For the
analysis of Proteus data set four feature groups were selected, representing different di-
mensions of schizophrenia symptoms, and are described in the next sections (9.3.2.1
through 9.3.2.4).
9.3.2.1 Statistical characteristics
Both locomotor activity and HR have been shown to be affected in schizophrenia (Walther
et al., 2009; Hauge et al., 2011; Ba¨r et al., 2008; Rachow et al., 2011), so statistical char-
acteristics of HR and activity were calculated, including mean, median, mode, standard
deviation (STD) and inter-quartile range (IQR).
9.3.2.2 Rest-activity characteristics
Recent studies indicate that circadian rhythm disruption plays a significant role in schizophre-
nia (Wulff et al., 2012), so the rest-activity characteristics of HR and activity, including
levels during the Least Active 5 hours, Most Active 10 hours, Relative Amplitude (see
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Section 5.5.4), as well as Inter-day Stability and Intra-day Variability (see Section 5.5.5)
were included in the analysis.
9.3.2.3 Multiscale Entropy
Activity disorganisation is one of the diagnostic criteria for schizophrenia (American
Psychiatric Association, 2000). Hauge et al. (Hauge et al., 2011) indicated that entropy
can be used to estimate such disorganisation. For the analysis of the Nuffield data
set, Multiscale Entropy (MSE) analysis (see Section 5.4.1) was applied to actigraphy
and values of entropy at scales from two minutes up to 12 hours were used as features
directly. For the analysis of the Proteus data set MSE of activity and HR was included in
the analysis and first five scales were calculated and coefficients of a 3rd degree polynomial
fitted in a least squares sense into these scales, were used as features for further analysis.
9.3.2.4 Transfer Entropy
To estimate the possible coupling between locomotor and cardiovascular activity, Transfer
Entropy (TE) between HR and activity signals were calculated as follows
TX→Y = H(yi|y(l)i−t)−H(yi|y(l)i−t, y(k)i−τ ) (9.1)
where i is a given point in time, τ and t are the time lags in X and Y , and k and l
are the block lengths of past values in X and Y .
TE estimates directional coupling between signals and measures the reduction of un-
certainty, given past knowledge of a secondary signal in comparison with knowledge of a
primary signal only. The algorithm is parametrised by primary and secondary signal lags
(or the amount of history to take into account) (Schreiber, 2000).
Values of k and l were taken as k = 1 and l = 1 as recommended by Lee et al. (Lee
et al., 2012). The Darbellay-Vajda signal partitioning scheme (Darbellay and Vajda,
1999; Lee et al., 2012) was used for probability density function estimation. Coefficients
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of a 3rd degree polynomial, fitted in a least squares sense into the TE values with t = 1
and τ = {1, 2, 3, 4, 5}, were used as features for further analysis.
9.3.2.5 Feature selection and classification
For the analysis of the Nuffield data set the best features to distinguish between schizophre-
nia and healthy controls subject categories were selected by ordering MSE values ac-
cording to the absolute value of the standardised u-statistic of a two-sample unpaired
Wilcoxon test (RANK). For Proteus data set, a multivariate minimum-Redundancy-
Maximum-Relevance (mRMR) criterion (see Section 6.3.1.2) was used to identify the
most important features for classification (Peng et al., 2005).
For classification into schizophrenia and normal controls categories, a Support Vector
Machine (SVM) with a Gaussian Radial Basis Function (RBF) kernel (see Section 6.3.2.2)
was used (Cortes and Vapnik, 1995), σ = 4, selected using grid search. Due to the limited
number of samples in both schizophrenia and control classes, LOOCV was performed for
the analysis of the Nuffield data set and 2-fold cross-validation with repeated random
sub-sampling (Kohavi, 1995) was used to estimate the classification performance in the
Proteus data set, where samples were randomly separated into the training and testing set
and 1000 classification experiments performed to estimate the classification performance.
For the Proteus data set, to evaluate the influence of combination of physiological
and locomotor activity features, three feature selection and classification experiments
were performed:
• Using HR features alone.
• Using locomotor activity features alone.
• Using HR, locomotor activity and Transfer Entropy features.
To evaluate the models, Receiver Operating Characteristic (ROC) curves were created
and the Area Under Curve (AUC) was calculated for each model.
173
9.4 Comparative results of activity, HR, and a combi-
nation of both
9.4.1 The Nuffield data set
Classification results for separation between schizophrenia and healthy control classes
varied depending on the number of features. The best accuracy of 95.12% was achieved
using the best 22 features, 90.24% using two or six best features and usage of only the
SampEn on a scale of two minutes provided 87.8% classification accuracy as presented in
Table 9.3.
Table 9.3: Ordering of the best entropy features and characteristics of classifier, using the top
25 selected features (scales of MSE calculation, h is hours and m is minutes). Wilcoxon rank-
sum test results for features, different with 5% significance level with Bonferroni correction for
multiple testing, are denoted by †.
Nr. MSE scale p-value Accuracy Specificity Sensitivity
1 0h 2m 0.000011 † 0.878049 0.800000 0.952381
2 0h 4m 0.000020 † 0.902439 0.800000 1.000000
3 10h 34m 0.024065 0.878049 0.800000 0.952381
4 0h 6m 0.000087 † 0.878049 0.800000 0.952381
5 11h 38m 0.040606 0.853659 0.800000 0.904762
6 11h 8m 0.055192 0.902439 0.850000 0.952381
7 11h 54m 0.065947 0.902439 0.850000 0.952381
8 11h 52m 0.092512 0.878049 0.850000 0.904762
9 6h 28m 0.000665 † 0.853659 0.800000 0.904762
10 11h 26m 0.103075 0.853659 0.800000 0.904762
11 11h 30m 0.103075 0.853659 0.800000 0.904762
12 6h 50m 0.000882 † 0.829268 0.750000 0.904762
13 10h 38m 0.114543 0.804878 0.750000 0.857143
14 11h 56m 0.123827 0.829268 0.750000 0.904762
15 11h 22m 0.127043 0.829268 0.750000 0.904762
16 5h 50m 0.001277 † 0.804878 0.750000 0.857143
17 7h 16m 0.001530 † 0.853659 0.750000 0.952381
18 8h 16m 0.001528 † 0.853659 0.800000 0.904762
19 11h 6m 0.158986 0.853659 0.800000 0.904762
20 10h 2m 0.162880 0.853659 0.750000 0.952381
21 13h 16m 0.162880 0.902439 0.800000 1.000000
22 13h 8m 0.166847 0.951220 0.900000 1.000000
23 5h 22m 0.001828 † 0.902439 0.850000 0.952381
24 7h 30m 0.001828 † 0.951220 0.900000 1.000000
25 10h 10m 0.187772 0.951220 0.900000 1.000000
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9.4.2 The Proteus data set
After pre-processing, four records of schizophrenia subjects with an amount of missing
data exceeding the 10% threshold were discarded. The missing data were probably caused
by the poor contact of adhesive wearable sensor with patient’s skin and motion artifacts,
and not related to the diagnosis of the patient. A total of 12 records of schizophrenia
patients and 19 records of normal controls were processed for further analysis, with results
presented in Tables 9.4 and 9.5.
Table 9.4: Accuracy of Proteus data set classification using locomotor activity, physiology and
combined features subsets.
Accuracy Sensitivity Specificity Nr. features
Heart rate alone 78.5% 82.3% 72.2% 2
Locomotor activity alone 85.5% 85.3% 85.9% 5
Combined features 95.3% 98% 91.1% 4
Table 9.5: Features of HR and locomotor activity of schizophrenia and control subjects (Mean
± STD, arbitrary units for activity and bpm for HR) together with mRMR ranking. The items
different with 1% significance level according to two-sided Wilcoxon rank sum test marked with
bold font and †.
Heart Rate Activity
Schizophrenia Controls Rank Schizophrenia Controls Rank
Mean 82.01± 10.46 76.11± 6.19 4 0.04± 0.02 0.06± 0.01 15†
Median 79.33± 10.83 74.70± 7.10 27 0.01± 0.00 0.02± 0.00 17
Mode 72.27± 12.71 69.23± 8.19 20 0.01± 0.00 0.01± 0.00 2†
STD 13.95± 2.70 14.11± 2.23 21 0.08± 0.03 0.13± 0.03 1†
IQR 18.50± 5.00 19.71± 4.25 29 0.02± 0.02 0.03± 0.01 8
L5 1952.19± 249.99 1831.15± 162.50 12 1.17± 0.51 1.61± 0.33 9†
M10 4311.61± 599.30 4016.32± 322.46 7 7.15± 2.71 10.05± 5.25 13
RA 0.38± 0.03 0.37± 0.02 18 0.71± 0.08 0.70± 0.06 33
IS 0.30± 0.14 0.36± 0.12 23 0.16± 0.04 0.18± 0.03 16
IV 0.60± 0.21 0.70± 0.23 19 1.23± 0.13 1.23± 0.23 28
MSE(1) < 0.01 < 0.01 5 < 0.01 < 0.01 31
MSE(2) −0.02± 0.12 0.05± 0.13 24 −0.02± 0.04 −0.01± 0.03 35
MSE(3) 0.09± 0.34 −0.20± 0.36 14 0.13± 0.13 0.12± 0.09 26
MSE(4) 1.78± 0.38 2.35± 0.34 3† 0.30± 0.11 0.31± 0.09 30
TE(1) < 0.01 < 0.01 10 < 0.01 < 0.01 32
TE(2) 0.02± 0.04 0.00± 0.03 22 0.00± 0.06 0.01± 0.04 36
TE(3) −0.07± 0.11 −0.01± 0.07 6 0.01± 0.17 0.00± 0.13 25
TE(4) 0.19± 0.15 0.11± 0.05 11† 0.18± 0.11 0.17± 0.12 34
When using HR derived features only, ordered by the mRMR algorithm, the two best
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features (including mean and MSE(4)) resulted in a 78.5% classification accuracy with
82.3% sensitivity and 72.2% specificity with an AUC of 0.85.
When using locomotor activity features only, ordered by the mRMR algorithm, the
five best features, (STD, mode, IQR, IS and L5) resulted in a 85.5% classification accuracy
with 85.3% sensitivity and 85.9% specificity with an AUC of 0.9. Note, that despite of
previous finding (Hauge et al., 2011) the MSE of activity was not identified as one of
predictive features.
When HR, locomotor activity and Transfer Entropy features (ordered by the mRMR
algorithm) were used to train an SVM, the four best features, (STD of locomotor ac-
tivity, mode of locomotor activity, MSE(4) of HR and mean of HR) resulted in a 95.3%
classification accuracy with 98% sensitivity and 91.1% specificity with an AUC of 0.99.
The use of SVN classifier could potentially provide over-fitted results, however the use
of cross validation with repeated random sub-sampling (as described in Section 9.3.2.5)
provides a guarantee that our results are reliable estimate of classifier accuracy based on
selected features.
9.5 Discussion and conclusions
Using a machine learning framework, it was possible to achieve classification accuracy of
95.12% using locomotor features alone (the Nuffield data set) and 85.5% (the Proteus
data set). The combination of HR and locomotor activity features provided the best
classification accuracy with almost a 10% increase in accuracy above using locomotor
features alone (85.5% versus 95.3%) and almost 17% improvement on using heart rate
related features alone (78.5% versus 95.3%).
The optimal features set in the Proteus data set included different feature classes,
representing levels of HR, locomotor activity and Multiscale Entropy dynamics across
the time scales of HR. Consistent with previous results and theoretical expectations (Ba¨r
et al., 2008; Rachow et al., 2011), HR was found to be elevated in schizophrenia patients
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and the level of locomotor activity decreased. Despite the fact that HR elevation is
not significant, it was an independent characteristic of schizophrenia group, as found by
mRMR feature selection. The STD of locomotor activity was both significantly different
and important from the point of view of classification, as well as the 4th coefficient of a
polynomial fit of Multiscale Entropy for HR.
However, these results should be taken with caution. Recent analysis O’Regan et al.
(O’Regan et al., 2015) performed on 4750 participants organised in four groups, includ-
ing depressed and on antidepressants (N=80, 59.4±0.75), depressed and not on antide-
pressants (N=317, age 60.04±0.43), not depressed and on antidepressants (N=185, age
62.6±0.62) and without depression and not on antidepressants (N=4107, age 61.7±0.13),
identified that depressed patients not taking antidepressants did not differ significantly
from controls.
But even if the heart rate-based measures reflect purely the influence of medica-
tion, then an alternative approach to using this information can be taken. The models
based upon heart rate only can be used as a measure of medication adherence and the
actigraphy-based model can be used for evaluation the effectiveness of a therapy (if the
former model indicates the medication is being taken). Disentangling the two would re-
quire a carefully controlled study involving both compliant and non-compliant responders
and non responders to treatment.
As indicated by Teicher in his review of actigraphy and motion analysis use in psychi-
atry (Teicher, 1995), accurate monitoring of activity levels and circadian rhythms has a
potential to aid clinicians in diagnosis, however very few studies examined sensitivity and
specificity of these features. The analysis of this chapter aimed to fill this gap and added
another promising dimension by fusing the HR-based measures of ANS function with
locomotor activity analysis and showed that physiological and physical activity signals
provide complimentary information for classification of mental health.
While the above analysis was performed on a data set including only schizophrenia
patients and controls, and mood disorders symptoms related to the HR changes will be
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different, the results are encouraging and suggest that continuous HR acquisition may be
an important signal to include in future studies and models of mood disorders.
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Chapter 10
Conclusions and future work
10.1 Validity of the approach
In this work a novel approach to psychiatric diagnosis and disorder management was pre-
sented, where assessment of symptoms was performed using objectively collected physical
activity and derived behaviour features.
10.1.1 The need for objective mental health metrics
In current clinical practice, the diagnosis of mental disorders is primarily based on pa-
tient self-reports and infrequent clinical observations (American Psychiatric Association,
2013). This often leads to erroneous conclusions and may result in unnecessary medica-
tion, incorrect treatment and decreased quality of life for patients (Regier et al., 2013).
Improvements in the diagnostic process, including the introduction of more objective di-
agnostic criteria suitable for ambulatory assessment is a promising avenue for improving
mental health care, and is recognised as a necessary further step in development of the
psychiatric field (Singh and Rose, 2009; Insel et al., 2010; Phillips and Kupfer, 2013).
The approach adopted by this thesis was based on the dimensional symptoms frame-
work described by Peter Liddle (Liddle, 2001) and summarised earlier in Table 2.1. In
this framework five dimensions of symptoms are defined, including reality distortion, dis-
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Table 10.1: Signals for objective assessment of mental health symptoms.
Signal Symptom cluster Dimension
Physical activity Disorganised and bizarre behaviour, Disorganisation
Decreased voluntary motor activity, Psychomotor
Motor agitation, Psychomotor
Decreased or increased need for sleep, Mood
Inappropriate affect Disorganisation
Heart rate Feelings of unease, fear or dread, Anxiety
Overactivity of the sympathetic Anxiety
nervous system
Electrodermal activity Feelings of unease, fear or dread, Anxiety
Overactivity of the sympathetic Anxiety
nervous system
organisation, psychomotor, mood and anxiety dimensions. The research of this thesis
started with the observation that at least three of these dimensions include symptom
clusters with manifestations in physical activity or behaviour, thus the usage of phys-
iological signals may give an insight into these symptoms, as can be seen from Table
10.1.
With the latest developments in quantified-self domain and wearable technologies it
may be possible to objectively assess human behaviours (and symptoms) continuously
and nearly in real-time, providing the patient and the clinician with a powerful tool for
accurate diagnosis and management of mental disorders, free from subjective perception
bias and accurately capturing the complete temporal picture of symptoms.
10.1.2 The approach of this thesis
This thesis approached the topic of objective mental health from the perspective of iden-
tifying “quantifiable symptoms” of disorders and clinical states, based on an accepted set
of clinical practice definitions (American Psychiatric Association, 2013). These defini-
tions were converted into hypothesised mathematical descriptions of objectively collected
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physical activity data (activity features), based on state-of-the-art methods from sleep
and physical activity research, as well as the latest developments in psychophysiology.
Models were built to reproduce existing clinical scores using the above mentioned
features, and a number of machine learning techniques were assessed for creating accurate
models to (a) distinguish between the disorder and healthy state and (b) identify clinical
state within the disorder.
Physical activity data were selected for this analysis due to its descriptive power,
which were capable of characterising different groups of symptoms, and simplicity of
acquisition, with different modalities available for capturing locomotor activity signals,
including research grade wearable sensors and consumer mobile phones with acceleration
sensors.
The resulting framework followed the dimensional model of symptomatology and has
a potential benefit of not only being diagnostically accurate, but also providing intuitively
clear and actionable information for both clinical specialists and patients.
10.1.3 Summary of main contributions
Chapter 3 describes a platform for the collection of activity and behaviour data for the
purpose of mental health symptoms analysis used by the AMoSS study. This client-
server platform was developed and deployed by the author, and used to collect data
from mobile phones of patients with mental disorders and healthy controls (a total of
150 subjects) in an ambulatory environment and for the duration of more then one
year, representing a substantial improvement compared to previous studies, where data
acquisition was limited to three months (see Table 3.1). The ongoing technical support
of participants was provided by study assistants from non-technical backgrounds, thus
proving the possibility of using smart-phone and wearable devices as clinical tools outside
of research settings.
Chapters 4 and 5 of this work proposed a set of activity data pre-processing methods
and a principled framework for computational analysis of mental health symptoms by
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mathematical description of symptomatic behaviours. To the author’s knowledge, this
is the first attempt to define such a framework based on a dimensional approach to
psychiatric symptomatology, as opposed to the modality-based (activity, HR, EDA) or
phenomena-based (entropy, activity level) approaches of other studies. Based on solid
foundations of accelerometry data analysis from population-level physical activity studies,
this work built a framework for the extraction of high level behaviour features, such as
the characteristics of sleep or stability of 24-hour activity patterns, using modern signal
processing and machine learning techniques.
Chapter 6 assessed the difference between health and disorder, the main question of
psychiatric diagnosis. Correctly identifying a disorder is important for providing ade-
quate treatment and achieving best patient outcomes. However, it is often difficult to
distinguish between different conditions, given that insight in patients is often impaired
and correct diagnosis requires a good anamnesis. Objective examination of symptomatic
activity patterns may help to distinguish between specific conditions that are difficult to
assess using self-reports. In this study the differences between healthy subjects, bipo-
lar and borderline personality disorder patients were analysed, and an accuracy of 70%
was achieved for separation between healthy controls and borderline personality disorder,
67% for separation between healthy controls and bipolar disorder, and 80% for separation
between bipolar disorder and borderline personality disorder using LOOCV. Note, that
these results were achieved using only one least symptomatic week of activity data.
Chapter 7 analysed the difference in objective behaviour characteristics between clin-
ical states, specifically mood states in bipolar disorder where mood tends to be well
expressed and represents the main characteristic of the illness. Early identification of de-
terioration in mood is critical for management of this disorder, but may be a complicated
task due to infrequent contact with clinical specialists in the course of ambulatory ob-
servations and due to impaired patient insight. This study demonstrates that behaviour
correlates may allow for the identification of clinically significant emotional states with
85% accuracy for differentiation between euthymic state and depression, 80% for differ-
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entiation between euthymic state and mania and 90% for differentiation between mania
and depression using LOOCV. Thus, it was demonstrated that using symptomatic data
can provide for a potentially better separation between patients in different emotional
states and clinical conditions.
By building personalised models of mood described in Chapter 8 it was possible to
achieve a mean average error of prediction of ASRM scores of 2.13±1.63 points, QIDS-
16SR scores of 2.65±1.47 points and GAD-7 scores of 2.51±1.31 points, i.e. at the
granularity level of clinical state identification with psychiatric questionnaires, and over-
all average correlation of self-reported and estimated mood scores between 0.27 and 0.54,
although below the reported correlation between different psychiatric scales (r=0.72 for
ASRM and MRS and r=0.84 for QIDS-16SR and HAM-D24) (Altman et al., 1997),
indicates a promising opportunity for replicating self-reports with behavioural or phys-
iological measurements once data from wearable devices are available to evaluate the
complete symptoms assessment framework.
Chapter 9 added physiology into the picture of objective mental health symptoms by
analysing combined locomotor activity and heart rate in schizophrenia. The combination
of HR and locomotor activity features provided classification accuracy with almost a
10% increase above using locomotor features alone (85.5% versus 95.3%) and almost 17%
above using HR related features alone. The optimal features set included different feature
classes, representing levels of HR, locomotor activity and Multiscale Entropy dynamics
across the time scales of HR. While this analysis was performed on a data set including
only schizophrenia patients and controls, and mood disorders symptoms related to the
HR changes will be different, the results are encouraging and suggest that continuous HR
acquisition may be an important signal to include in future studies and models of mood
disorders. Even if the physiological measures reflect purely the influence of medication,
then they may be used as a method for identifying medication adherence, separate to the
effectiveness of the treatment (measured by actigraphy).
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10.2 Current study limitations
The problems of defining objective physiological features for psychological phenomena
and assessing mental state using objective measurements were described by Hinton in
1966 (Hinton, 1966), but are still valid today as discussed in Section 2.1.2. The present
study addresses many of these problems, but due to the nature of the analysed phenomena
has certain limitations, described in detail below.
10.2.1 Link between behaviour and psychological phenomena
Psychological constructs (such as mood) were often based solely on subjectively-reported
phenomena and direct behaviour-based measures were not possible to define, therefore
indirect correlates were used. For mood, this thesis adopted sleep quality as the best
known predictor, based on prior research on the relationship between sleep and mood
(Kahn et al., 2013), diagnostic criteria (American Psychiatric Association, 2013) and
dimensional symptoms framework (Liddle, 2001). This link is not direct and may be
influenced by many external factors, such as work-rest routine and physical illness. How-
ever, a person’s sleep when adversely affected by external factors may in turn lead to
mood changes, and substantial further research is needed on the nature of these inter-
connections. This is beyond the scope of the presented thesis.
Other psychological constructs with no direct behaviour correlate that may show bias
during reporting, include syndromes of flat and labile affect, as well as most subjective
experiences, such as fatigue, elevated or low mood, and hopelessness. In most cases there
are no defined objective measures for these phenomena to allow continuous ambulatory
monitoring of symptom severity, and the subjective bias can be disorder specific.
Even if a psychological construct has a direct measurable behaviour equivalent, ques-
tionnaire based assessments do not consistently provide a reliable ground truth. It was
reported for example that physical activity levels, as assessed by individuals themselves
or external observers, do not provide a reliable estimation of the actual physical activity
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(Ham et al., 2007; Rosenberg et al., 2015). For retrospective mood self-reports, there was
positive and negative recall bias identified, as well as recall inaccuracies depending on
diagnosis and clinical state (Ebner-Priemer et al., 2006; Ben-Zeev et al., 2009). Inaccura-
cies in subjective self-reports are also associated with age and mild cognitive impairments
(Weston et al., 2011).
10.2.2 Unreliable methods of measurement
Development of micro-electro-mechanical sensor technologies, miniaturisation of electron-
ics and improvement of battery life made continuous behaviour and physiology data ac-
quisition feasible. However research grade instrumentation is not currently suitable for
long-term use (for example the GENEActiv device needs to be connected to a computer
in order to download acquired data) and consumer-grade devices still suffer from lim-
ited usability, with smart phones not collecting activity data during the night and Fitbit
wearable sensors being used only 60% of the time, with only 60% of nights covered during
usage periods (only 36% of nights assessed). Moreover, the low cost of consumer devices
may lead to higher inter-device quality variance.
There are promising new developments in behaviour-sensing taking place in the field
of smart watch technology that could provide easy-to-use instruments addressing mul-
tiple user needs, and therefore leading to better compliance with usage. Smart watch
technology development is still at an early stage, with the need to re-charge every two
days being the main limiting usability factor (based on the author’s experience).
10.2.3 Ill-defined psychological constructs
Existing definitions of symptoms are mostly based on subjective impressions about pa-
tient behaviours, and are often vague and difficult to reformulate in measurable terms,
especially if behaviour is assessed continuously and non-invasively in an ambulatory envi-
ronment. For example, the behavioural construct of “impulsivity” is widely acknowledged
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as an important characteristic in many mental disorders and clinical states, including the
attention deficit hyperactivity disorder, borderline personality disorder and mania, and
defined as
“behaviour without adequate thought, the tendency to act with less fore-
thought than do most individuals of equal ability and knowledge, or a
predisposition toward rapid, unplanned reactions to internal or external
stimuli without regard to the negative consequences of these reactions”
It is clear that such a definition is ambiguous and subjective (“adequate thought” is not
defined), and also not specific. The existing objective impulsivity measures, including the
Balloon Analogue Risk Task (BART) (Lejuez et al., 2002), Cued Go No-Go (Marczinski
and Fillmore, 2003) and Immediate and Delayed Memory Tasks (IMT/DMT) (Dougherty
et al., 2002), are suitable only for laboratory settings and address mostly attentional and
immediate reaction aspects of impulsivity. The most comprehensive Barratt Impulsive-
ness Scale (BIS-11) (Barratt and Patton, 1995) covers all factors contributing to a persons’
impulsivity, but is based on self-reporting of otherwise not measured behaviours.
A similar construct defined for the assessment of schizophrenia is “behaviour disorgan-
isation” with a dedicated cluster allocated to it in the dimensional symptoms framework
of Liddle (Liddle, 2001). The link between impulsivity and disorganisation is not very
well understood, and was never assessed in a principled manner, making the definition of
objective behaviour measures of impulsivity and disorganisation potentially unreliable.
The test-retest reliability of a diagnosis based on DSM-5 criteria for most diagnoses
has moderate-to-good inter-rater agreement with an inter-class Kappa of 0.40-0.79 (Regier
et al., 2013). Diagnostic criteria for many mental disorders, although well understood
by clinicians, often do not help in distinguishing diagnostic entities due to differences
in possible symptom manifestations and dependence on clinical states. For example for
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bipolar disorder and borderline personality disorder current clinical practice is reported
to be inadequate to reliably distinguish between the two (Saunders et al., 2015).
10.2.4 Influence of external factors
As was previously discussed in the context of sleep, external factors may influence be-
haviour measures. This problem may not be of the highest importance for the analysis of
mental health, as mainly slow variations and semi-permanent changes in behaviour char-
acteristics are symptomatic, and therefore the appropriate filtering techniques introduced
in Chapter 8 may address the issue. However, in some real-world scenarios, such as for
example a patient going on vacation, changes in behaviour may not be easily distinguish-
able from symptoms of manic episode. Further research is necessary on the introduction
of context information into the behaviour and mood models, for example mobile phones
with in-built location sensing may be able to help in this regard.
10.2.5 Difference in individual characteristics
Even if all of the issues above are properly addressed, there is a substantial difference
in individual behaviour manifestation of mood states. The important limitation of the
current study is therefore the limited number of subjects and data points for clinical states
assessment that may not reflect the complete picture of possible symptomatic behaviours.
Despite being perhaps the most comprehensive project of its kind, the AMoSS study
includes only 50 patients with bipolar disorder and 30 patients with borderline personality
disorder (less for the presented analysis, which deals with a less complete data set). This
cohort does not represent the complete spectrum of possible symptom manifestations,
and may not provide a substantial number of clinically validated disorder episodes. The
current study is therefore of an exploratory nature, assessing the the viability of the de-
scribed approaches and providing useful information for future researchers on promising
techniques and research directions. Despite these limitations, to the author’s knowl-
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edge the study in this thesis provides the most in-depth study of automated psychiatric
symptom evaluation so far published.
10.3 Future work
The most important problem in the field of objective mental health analysis is the growing
number of studies with a small number of subjects, where data were collected in different
conditions, including ambulatory and hospital, with participants often being medicated
and in different phases of their illness. Furthermore, activity and physiology information
has often been collected using different methods, and analysis techniques varied greatly,
making the task of results generalisation almost impossible.
These limitation serve as a prompt for the collection of large scale data sets that
could be shared by researchers in the field, including patients representing the complete
spectrum of symptoms and allowing application of different analysis methods to compare
results in well-controlled conditions. Such collection is already feasible using a range of
consumer devices, such as smart phones, fitness trackers and smart watches. Once such
data sets become available, the results of this work may be further validated and objective
activity features related to specific symptoms of mental health.
Study cohorts should allow stratification by age, gender, medication and sociodemo-
graphic status to allow eliminating confounding factors and more precisely identifying be-
haviours related to disorder within certain population or treatment regimen. Compliance
remains to be an issue, specifically in mental health patients, thus the data acquisition
modalities shall be usable and useful outside of the research context, and not carrying
stigma on study participants. The example of such devices are smart watches, where
technology allows for collection of a range of potentially useful signals continuously and
improving on conventional watches, thus bringing a direct benefit to participants.
These data sets should include not only information about locomotor activity (and
if it is included - it must go beyond simple step counts), but also physiological data,
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such as heart rate and variability (which show the capability for improvement of diagnos-
tic results), and electrodermal activity, for complete assessment of individual symptom
correlations.
Given the range of possible individual symptoms of mental disorders, essentially cov-
ering all possible aspects of individual behaviours and social interaction patterns, it is
important to also acquire and analyse non-conventional potential symptom correlates,
such as information about social networking (including both mobile text messaging and
online social networking) and geo-location data, to analyse possible deviations from in-
dividual normal behaviour patterns.
Such information may also be used as an important source of information about pos-
sible confounding factors, influencing the accuracy of actigraphic analysis. For example,
knowing that an individual has changed his base location (for example while going on
holiday) we may expect that his or her model of normality will change as well, and in-
troduce this information into the diagnostic model to improve the accuracy of analysis
results.
Last, but not least, is the need for improved accuracy and reliability of data acquisi-
tion instrumentation, including both technical characteristics and perceived user benefit,
which transforms into compliance. Unified data formats should become available as well
as reference data processing algorithms, making possible comparison of results between
different studies. The use of proprietary algorithms to process actigraphy make it difficult
to create analysis methods that work on more than one (version of) a particular device.
Further advances in the field will be problematic without close cooperation between
clinical experts and data scientists to identify more specific and objective behaviour pat-
terns, relevant to particular symptoms of mental health. This would allow the develop-
ment of computational data analysis methods to identify activity or behaviour features,
that are characteristic specifically to these symptoms. Thus, experimental psychiatry and
biomedical data analysis should develop hand-in-hand, and, it is to be hoped, contribute
to the development of the emerging field of “computational psychiatry”.
189
Bibliography
Activinsights Ltd. (2012). GENEActiv Instruction Manual v. 1.2. Avail-
able at: http://www.geneactiv.org/wp-content/uploads/2014/03/geneactiv_
instruction_manual_v1.2.pdf.
Adams, R. P. and MacKay, D. J. C. (2007). Bayesian Online Changepoint Detection.
Technical report, University of Cambridge, Cambridge, UK. Available at: https:
//hips.seas.harvard.edu/files/adams-changepoint-tr-2007.pdf.
Afonso, P., Figueira, M. L., and Paiva, T. (2013). Sleep-wake patterns in schizophrenia
patients compared to healthy controls. The World Journal of Biological Psychiatry,
15(7):517–524.
Agelink, M., Boz, C., Ullrich, H., and Andrich, J. (2002). Relationship between major
depression and heart rate variability: Clinical consequences and implications for
antidepressive treatment. Psychiatry Research, 113(1–2):139–149.
Akiskal, H. S., Bourgeois, M. L., Angst, J., Post, R., Mo¨ller, H.-J., and Hirschfeld, R.
(2000). Re-evaluating the prevalence of and diagnostic composition within the broad
clinical spectrum of bipolar disorders. Journal of Affective Disorders, 59:S5–S30.
Altman, E. G., Hedeker, D., Peterson, J. L., and Davis, J. M. (1997). The Altman
self-rating mania scale. Biological Psychiatry, 42(10):948–955.
Altschule, M. D. (1953). Bodily physiology in mental and emotional disorders. Grune &
Stratton, New York.
190
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV-TR). American Psychiatric Publishing, Arling-
ton, VA.
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition (DSM-5). American Psychiatric Publishing, Arlington, VA.
Ancoli-Israel, S., Cole, R., Alessi, C., Chambers, M., Moorcroft, W., and Pollak, C. P.
(2003). The role of actigraphy in the study of sleep and circadian rhythms. Sleep,
26(3):342–392.
Andreasen, N. C. (1988). Brain imaging: Applications in psychiatry. Science,
239(4846):1381–1388.
Angst, J., Gamma, A., Benazzi, F., Ajdacic, V., Eich, D., and Ro¨ssler, W. (2003). Toward
a re-definition of subthreshold bipolarity: Epidemiology and proposed criteria for
bipolar-II, minor bipolar disorders and hypomania. Journal of Affective Disorders,
73(1-2):133–146.
Angst, J. and Marneros, A. (2001). Bipolarity from ancient to modern times. Journal of
Affective Disorders, 67(1-3):3–19.
Appelhans, B. and Luecken, L. (2006). Heart rate variability as an index of regulated
emotional responding. Review of General Psychology, 10(3):229–240.
Arau´jo, T., Nunes, N., Quintao, C., and Gamboa, H. (2012). Localized electroencephalog-
raphy sensor and detection of evoked potentials. 2nd International Workshop on
Computing Paradigms for Mental Health, pages 41–46.
Aristotle (1984). The complete works of Aristotle, volume 2. Princeton University Press,
Princeton, NJ.
Aritake-Okada, S., Higuchi, S., Suzuki, H., Kuriyama, K., Enomoto, M., Soshi, T., Ki-
tamura, S., Watanabe, M., Hida, A., Matsuura, M., Uchiyama, M., and Mishima,
191
K. (2010). Diurnal fluctuations in subjective sleep time in humans. Neuroscience
Research, 68(3):225–231.
Armstrong, N., Price, J., and Geddes, J. (2015). Serious but not solemn: Rebalancing the
assessment of risks and benefits of patient recruitment materials. Research Ethics,
11(2):98–107.
Baillarger, J. G. F. (1880). De la folie a` double forme, volume 6. impr. Donnaud.
Ba¨r, K., Wernich, K., Boettger, S., and Cordes, J. (2008). Relationship between car-
diovagal modulation and psychotic state in patients with paranoid schizophrenia.
Psychiatry Research, 157(1–3):255–257.
Baranowski, T. (1988). Validity and reliability of self-report measures of physical activity:
An information-processing perspective. Research Quarterly for Exercise and Sport,
59(4):314–327.
Bard, P. (1928). A diencephalic mechanism for the expression of rage with special refer-
ence to the sympathetic nervous system. American Journal of Physiology, 84:490–
515.
Bardram, J. E., Frost, M., Sza´nto´, K., Faurholt-Jepsen, M., Vinberg, M., and Kessing,
L. V. (2013). Designing mobile health technology for bipolar disorder. In Proceedings
of the SIGCHI Conference on Human Factors in Computing Systems - CHI ’13, page
2627, New York, New York, USA. ACM Press.
Bardram, J. E., Frost, M., Sza´nto´, K., and Marcu, G. (2012). The MONARCA self-
assessment system. In Proceedings of the 2nd ACM SIGHIT Symposium on Inter-
national health informatics - IHI ’12, page 21, New York, New York, USA. ACM
Press.
Barratt, E. S. and Patton, J. H. (1995). Barratt Impulsiveness Scale-11. In Handbook of
psychiatric measures. American Psychiatric Association, Washington DC.
192
Beck, A. T., Steer, R. A., and Carbin, M. G. (1988). Psychometric properties of the Beck
Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review,
8(1):77–100.
Bellivier, F., Geoffroy, P.-A., Etain, B., and Scott, J. (2015). Sleep- and circadian rhythm-
associated pathways as therapeutic targets in bipolar disorder. Expert Opinion on
Therapeutic Targets, 19(6):747–763.
Ben-Zeev, D., McHugo, G. J., Xie, H., Dobbins, K., and Young, M. A. (2012). Comparing
retrospective reports to real-time/real-place mobile assessments in individuals with
schizophrenia and a nonclinical comparison group. Schizophrenia Bulletin, 38(3):396–
404.
Ben-Zeev, D., Young, M. A., and Madsen, J. W. (2009). Retrospective recall of affect
in clinically depressed individuals and controls. Cognition and Emotion, 23(5):1021–
1040.
Benca, R. M. (1992). Sleep and psychiatric disorders. Archives of General Psychiatry,
49(8):651.
Benca, R. M., Okawa, M., Uchiyama, M., Ozaki, S., Nakajima, T., Shibui, K., and
Obermeyer, W. H. (1997). Sleep and mood disorders. Sleep Medicine Reviews,
1(1):45–56.
Benedetti, F. and Terman, M. (2013). Much ado about. . . a moody clock. Biological
Psychiatry, 74(4):236–7.
Benson, P. J., Beedie, S. A., Shephard, E., Giegling, I., Rujescu, D., and St Clair, D.
(2012). Simple viewing tests can detect eye movement abnormalities that distinguish
schizophrenia cases from controls with exceptional accuracy. Biological Psychiatry,
72(9):716–24.
193
Berger, A. M., Wielgus, K. K., Young-McCaughan, S., Fischer, P., Farr, L., and Lee,
K. A. (2008). Methodological challenges when using actigraphy in research. Journal
of Pain and Symptom Management, 36(2):191–199.
Berk, M., Conus, P., Lucas, N., Hallam, K., Malhi, G. S., Dodd, S., Yatham, L. N.,
Yung, A., and McGorry, P. (2007). Setting the stage: from prodrome to treatment
resistance in bipolar disorder. Bipolar Disorders, 9(7):671–8.
Berle, J. O., Hauge, E. R., Oedegaard, K. J., Holsten, F., and Fasmer, O. B. (2010). Acti-
graphic registration of motor activity reveals a more structured behavioural pattern
in schizophrenia than in major depression. BMC Research Notes, 3(1):149.
Bernaola-Galva´n, P., Ivanov, P., Nunes Amaral, L., and Stanley, H. (2001). Scale
invariance in the nonstationarity of human heart rate. Physical Review Letters,
87(16):168105.
Bernaola-Galva´n, P., Oliver, J. L., Hackenberg, M., Coronado, A. V., Ivanov, P. C., and
Carpena, P. (2012). Segmentation of time series with long-range fractal correlations.
The European Physical Journal. B, 85(6).
Bertolote, J. M. and Fleischmann, A. (2002). A global perspective in the epidemiology
of suicide. Suicidology, 7(2):6–8.
Birchler-Pedross, A., Schro¨der, C. M., Mu¨nch, M., Knoblauch, V., Blatter, K., Schnitzler-
Sack, C., Wirz-Justice, A., and Cajochen, C. (2009). Subjective well-being is mod-
ulated by circadian phase, sleep pressure, age, and gender. Journal of Biological
Rhythms, 24(3):232 –242.
Birchwood, M. (2000). Schizophrenia: early warning signs. Advances in Psychiatric
Treatment, 6(2):93–101.
Birket-Smith, M., Hasle, N., and Jensen, H. (1993). Electrodermal activity in anxiety
disorders. Acta Psychiatrica Scandinavica, 88(5):350–355.
194
Bishop, C. M. (2006). Pattern Recognition and Machine Learning, volume 4. Springer,
New York, New York, USA.
Blackwell, T., Ancoli-Israel, S., Gehrman, P. R., Schneider, J. L., Pedula, K. L., and
Stone, K. L. (2005). Actigraphy scoring reliability in the study of osteoporotic frac-
tures. Sleep, 28(12):1599–1605.
Blum, N., St John, D., Pfohl, B., Stuart, S., McCormick, B., Allen, J., Arndt, S., and
Black, D. W. (2008). Systems Training for Emotional Predictability and Problem
Solving (STEPPS) for outpatients with borderline personality disorder: A random-
ized controlled trial and 1-year follow-up. The American Journal of Psychiatry,
165(4):468–78.
Botella, C., Moragrega, I., Ban˜os, R., and Garc´ıa-Palacios, A. (2011). Online predictive
tools for intervention in mental illness: the OPTIMI project. Studies in Health
Technology and Informatics, 163:86–92.
Boucsein, W. (2012). Electrodermal Activity. Springer US, Boston, MA.
Bowling, A. (2005). Mode of questionnaire administration can have serious effects on
data quality. Journal of Public Health, 27(3):281–91.
Breso´, A., Mart´ınez-Miranda, J., and Garc´ıa-Go´mez, J. M. (2014). Leveraging adaptive
sessions based on therapeutic empathy through a virtual agent. In Proceedings of the
6th International Conference on Agents and Artificial Intelligence (ICAART 2014)
- Doctoral Consortium.
Bromundt, V., Wirz-Justice, A., Kyburz, S., Opwis, K., Dammann, G., and Cajochen,
C. (2013). Circadian sleep-wake cycles, well-being, and light therapy in borderline
personality disorder. Journal of Personality Disorders, 27(5):680–96.
Brownrigg, D. R. K. (1984). The weighted median filter. Communications of the ACM,
27(8):807–818.
195
Burton, C., McKinstry, B., Szentagotai Ta˘tar, A., Serrano-Blanco, A., Pagliari, C., and
Wolters, M. (2013). Activity monitoring in patients with depression: A systematic
review. Journal of Affective Disorders, 145(1):21–8.
Busschaert, C., De Bourdeaudhuij, I., Van Holle, V., Chastin, S. F., Cardon, G., and
De Cocker, K. (2015). Reliability and validity of three questionnaires measuring
context-specific sedentary behaviour and associated correlates in adolescents, adults
and older adults. The international journal of behavioral nutrition and physical
activity, 12(1):117.
Cacioppo, J. (1991). Psychophysiological approaches to the evaluation of psychother-
apeutic process and outcome, 1991: Contributions from social psychophysiology.
Psychological Assessment, 3(3):321–336.
Cacioppo, J. T., Tassinary, L. G., and Berntson, G. (2007). Handbook of psychophysiology.
Cambridge University Press, Cambridge, UK.
CamNtech Ltd (2008). The Actiwatch User Manual V 7.2.
Cannon, M., Jones, P., Gilvarry, C., Rifkin, L., McKenzie, K., Foerster, A., and Murray,
R. M. (1997). Premorbid social functioning in schizophrenia and bipolar disorder:
Similarities and differences. American Journal of Psychiatry, 154(11):1544–1550.
Carney, R. M., Blumenthal, J. A., Stein, P. K., Watkins, L., Catellier, D., Berkman,
L. F., Czajkowski, S. M., O’Connor, C., Stone, P. H., and Freedland, K. E. (2001).
Depression, heart rate variability, and acute myocardial infarction. Circulation,
104(17):2024–2028.
Carpenter, B. E. (1990). Kao Lien’s eight treatises on the nurturing of life. Tezukayama
University Review, 67:38–51.
Catellier, D. J., Hannan, P. J., Murray, D. M., Addy, C. L., Conway, T. L., Yang, S., and
196
Rice, J. C. (2005). Imputation of missing data when measuring physical activity by
accelerometry. Medicine and Science in Sports and Exercise, 37(11 Suppl):S555–62.
Chapman, J. J., Brown, W. J., and Burton, N. W. (2015). Defining a valid day of
accelerometer monitoring in adults with mental illness. Mental Health and Physical
Activity.
Chawla, N. V., Bowyer, K. W., Hall, L. O., and Kegelmeyer, W. P. (2002). SMOTE: Syn-
thetic Minority Over-sampling Technique. Journal of Artificial Intelligence Research,
16:321–357.
Chen, Y. W. and Dilsaver, S. C. (1996). Lifetime rates of suicide attempts among subjects
with bipolar and unipolar disorders relative to subjects with other Axis I disorders.
Biological Psychiatry, 39(10):896–9.
Clifford, G. D., Tsanas, A., Guy, G., and Saunders, K. (2015). Automated Monitoring of
Symptoms Severity (AMoSS) Study Protocol. Technical report. Available by request.
Cohen, H., Kaplan, Z., Kotler, M., Mittelman, I., Osher, Y., and Bersudsky, Y. (2003).
Impaired heart rate variability in euthymic bipolar patients. Bipolar Disorders,
5(2):138–143.
Cohen, S., Tyrrell, D. A., and Smith, A. P. (1991). Psychological stress and susceptibility
to the common cold. New England Journal of Medicine, 325(9):606–612.
Cole, R. J., Kripke, D. F., Gruen, W., Mullaney, D. J., and Gillin, J. C. (1992). Automatic
sleep/wake identification from wrist activity. Sleep, 15(5):461–469.
Cortes, C. and Vapnik, V. (1995). Support-vector networks. Machine Learning,
20(3):273–297.
Costa, M., Goldberger, A., and Peng, C.-K. (2005). Multiscale entropy analysis of bio-
logical signals. Physical Review E, 71(2):021906.
197
Curone, D., Bertolotti, G. M., Cristiani, A., Secco, E. L., and Magenes, G. (2010). A
real-time and self-calibrating algorithm based on triaxial accelerometer signals for
the detection of human posture and activity. IEEE Transactions on Information
Technology in Biomedicine, 14(4):1098–105.
da Silva, I. C., van Hees, V. T., Ramires, V. V., Knuth, A. G., Bielemann, R. M., Ekelund,
U., Brage, S., and Hallal, P. C. (2014). Physical activity levels in three Brazilian
birth cohorts as assessed with raw triaxial wrist accelerometry. International Journal
of Epidemiology, 43(6):1959–68.
Dahl, A. A. (1985). Borderline disorders–the validity of the diagnostic concept. Psychi-
atric Developments, 3(2):109–52.
Darbellay, G. A. and Vajda, I. (1999). Estimation of the information by an adaptive
partitioning of the observation space. IEEE Transactions on Information Theory,
45(4):1315–1321.
Darwin, C. (1872). The expression of the emotions in man and animals. The American
Journal of the Medical Sciences, 232(4):477.
Davies, P., Fried, R., and Gather, U. (2004). Robust signal extraction for on-line moni-
toring data. Journal of Statistical Planning and Inference, 122(1-2):65–78.
Dawson, M. E., Schell, A. M., Rissling, A., Ventura, J., Subotnik, K. L., and Nuechterlein,
K. H. (2010). Psychophysiological prodromal signs of schizophrenic relapse: A pilot
study. Schizophrenia Research, 123(1):64–67.
Depue, R. A., Krauss, S., Spoont, M. R., and Arbisi, P. (1989). General behavior in-
ventory identification of unipolar and bipolar affective conditions in a nonclinical
university population. Journal of Abnormal Psychology, 98(2):117–26.
Dougherty, D. M., Marsh, D. M., and Mathias, C. W. (2002). Immediate and delayed
198
memory tasks: A computerized behavioral measure of memory, attention, and im-
pulsivity. Behavior Research Methods, Instruments and Computers, 34(3):391–398.
Ebner-Priemer, U. W., Kuo, J., Welch, S. S., Thielgen, T., Witte, S., Bohus, M., and
Linehan, M. M. (2006). A valence-dependent group-specific recall bias of retrospec-
tive self-reports: A study of borderline personality disorder in everyday life. The
Journal of Nervous and Mental Disease, 194(10):774–9.
El-Amrawy, F. and Nounou, M. I. (2015). Are Currently Available Wearable Devices
for Activity Tracking and Heart Rate Monitoring Accurate, Precise, and Medically
Beneficial? Healthcare Informatics Research, 21(4):315–320.
Enders, C. K. (2006). A primer on the use of modern missing-data methods in psycho-
somatic medicine research. Psychosomatic Medicine, 68(3):427–36.
Falloon, I. R., Kydd, R. R., Coverdale, J. H., and Laidlaw, T. M. (1996). Early detec-
tion and intervention for initial episodes of schizophrenia. Schizophrenia Bulletin,
22(2):271–82.
Falret, J.-P. (1854). Me´moire sur la folie circulaire. Bulletin de I’Academie de Medicine,
19:382–415.
Faulkner, G. and Biddle, S. (2013). Standing on top of the world: Is sedentary behaviour
associated with mental health? Mental Health and Physical Activity, 1(6):1–2.
First, M. B., Gibbon, M., Spitzer, R. L., Williams, J. B. W., and S., B. L. (1997).
Structured Clinical Interview for DSM-IV Axis II Personality Disorders. (SCID-II).
American Psychiatric Press, Washington, D. C.
First, M. B., Spitzer, R. L., Gibbon, M., and Williams, J. B. W. (1996). Structured Clini-
cal Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). American
Psychiatric Press, Washington, D. C.
199
First, M. B., Spitzer, R. L., Gibbon, M., and Williams, J. B. W. (2002). Structured Clin-
ical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition
With Psychotic Screen (SCID-I/P W/ PSY SCREEN). Biometrics Research, New
York.
First, M. B., Williams, J. B. W., Spitzer, R. L., and Gibbon, M. (2007). Structured
Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-
CT). Biometrics Research, New York.
Firth, J. and Torous, J. (2015). Smartphone apps for schizophrenia: A systematic review.
JMIR mHealth and uHealth, 3(4):e102.
Fleischhacker, W., Meise, U., Gu¨nther, V., and Kurz, M. (1994). Compliance with an-
tipsychotic drug treatment: influence of side effects. Acta Psychiatrica Scandinavica,
89(s382):11–15.
Foster, R. and Wulff, K. (2005). The rhythm of rest and excess. Nature Reviews Neuro-
science, 6(5):407–414.
Fowles, D. (2007). The three arousal model: Implications of Gray’s two-factor learning
theory for heart rate, electrodermal activity, and psychopathy. Psychophysiology,
17(2):87–104.
Franks, J., Hallam-Baker, P., Hostetler, J., Lawrence, S., Leach, P., Luotonen, A., and
Stewart, L. (1999). RFC 2617: HTTP authentication: Basic and digest access
authentication.
Franzen, P. L., Siegle, G. J., and Buysse, D. J. (2008). Relationships between affect,
vigilance, and sleepiness following sleep deprivation. Journal of Sleep Research,
17(1):34–41.
Freedson, P. S. and Miller, K. (2000). Objective monitoring of physical activity using
200
motion sensors and heart rate. Research Quarterly for Exercise and Sport, 71(2
Suppl):S21–9.
Friedman, B. and Thayer, J. (1998). Autonomic balance revisited: Panic anxiety and
heart rate variability. Journal of Psychosomatic Research, 44(1):133–151.
Fung, M. T., Raine, A., Loeber, R., Lynam, D. R., Steinhauer, S. R., Venables, P. H.,
and Stouthamer-Loeber, M. (2005). Reduced electrodermal activity in psychopathy-
prone adolescents. Journal of Abnormal Psychology, 114(2):187–196.
Fuster-Garcia, E., Breso´, A., Mart´ınez-Miranda, J., Rosell-Ferrer, J., Matheson, C., and
Garc´ıa-Go´mez, J. M. (2015). Fusing actigraphy signals for outpatient monitoring.
Information Fusion, 23:69–80.
Gauss, C. F. (1963). Theoria motus corporum celestium, No. 1809; Theory of motion of
the heavenly bodies. Dover, New York.
Geddes, J. R. and Miklowitz, D. J. (2013). Treatment of bipolar disorder. Lancet,
381(9878):1672–82.
Geoffroy, P. A., Boudebesse, C., Bellivier, F., Lajnef, M., Henry, C., Leboyer, M., Scott,
J., and Etain, B. (2014). Sleep in remitted bipolar disorder: A naturalistic case-
control study using actigraphy. Journal of Affective Disorders, 158:1–7.
Gerard, R. W. (1949). Physiology and psychiatry. The American Journal of Psychiatry,
106:161–173.
Gietzelt, M., Wolf, K.-H., Marschollek, M., and Haux, R. (2008). Automatic self-
calibration of body worn triaxial-accelerometers for application in healthcare. In 2008
Second International Conference on Pervasive Computing Technologies for Health-
care, pages 177–180. IEEE.
Goossens, P. J. J., Kupka, R. W., Beentjes, T. A. A., and van Achterberg, T. (2010).
Recognising prodromes of manic or depressive recurrence in outpatients with bipo-
201
lar disorder: A cross-sectional study. International Journal of Nursing Studies,
47(10):1201–7.
Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D.,
Smith, S. M., Dawson, D. A., Pulay, A. J., Pickering, R. P., and Ruan, W. J. (2008).
Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality
disorder: Results from the Wave 2 National Epidemiologic Survey on Alcohol and
Related Conditions. The Journal of Clinical Psychiatry, 69(4):533–45.
Gravenhorst, F., Muaremi, A., Gruenerbl, A., Arnrich, B., and Troester, G. (2013).
Towards a mobile galvanic skin response measurement system for mentally disordered
patients. In Proceedings of the 8th International Conference on Body Area Networks,
pages 432–435. ACM.
Greco, A., Lanata`, A., Valenza, G., Rota, G., Vanello, N., and Scilingo, E. P. (2012). On
the deconvolution analysis of electrodermal activity in bipolar patients. In Annual
International Conference of the IEEE Engineering in Medicine and Biology Society.
IEEE Engineering in Medicine and Biology Society., volume 2012, pages 6691–4.
IEEE.
Greco, A., Valenza, G., Lanata’, A., Rota, G., and Scilingo, E. (2014). Electrodermal
activity in bipolar patients during affective elicitation. IEEE Journal of Biomedical
and Health Informatics, 18(6):1865–1873.
Green, M. F. (2006). Cognitive impairment and functional outcome in schizophrenia and
bipolar disorder. The Journal of Clinical Psychiatry, 67(10):e12.
Greene, T. (2007). The Kraepelinian dichotomy: The twin pillars crumbling? History of
Psychiatry, 18(3):361–379.
Gruenerbl, A., Osmani, V., Bahle, G., Carrasco, J. C., Oehler, S., Mayora, O., Haring,
C., and Lukowicz, P. (2014). Using smart phone mobility traces for the diagnosis
202
of depressive and manic episodes in bipolar patients. In Proceedings of the 5th Aug-
mented Human International Conference, pages 1–8, New York, New York, USA.
ACM Press.
Gruner, O. C. (1970). A treatise on the canon of medicine of Avicenna, incorporating a
translation of the first book. Kelley, New York.
Grunerbl, A., Muaremi, A., Osmani, V., Bahle, G., Ohler, S., Troester, G., Mayora, O.,
Haring, C., and Lukowicz, P. (2014). Smart-phone based recognition of states and
state changes in bipolar disorder patients. IEEE Journal of Biomedical and Health
Informatics, 19(1):140–148.
Guidi, A., Vanello, N., Bertschy, G., Gentili, C., Landini, L., and Scilingo, E. (2014).
Automatic analysis of speech F0 contour for the characterization of mood changes
in bipolar patients. Biomedical Signal Processing and Control, 17:29–37.
Guyon, I. and Elisseeff, A. (2003). An introduction to variable and feature selection. The
Journal of Machine Learning Research, 3:1157–1182.
Haiminen, N., Mannila, H., and Terzi, E. (2007). Comparing segmentations by applying
randomization techniques. BMC Bioinformatics, 8(1):171.
Ham, S. A., Reis, J. P., Strath, S. J., Dubose, K. D., and Ainsworth, B. E. (2007). Dis-
crepancies between methods of identifying objectively determined physical activity.
Medicine and Science in Sports and Exercise, 39(1):52–8.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery,
and Psychiatry, 23:56–62.
Hare, R. and Quinn, M. (1971). Psychopathy and autonomic conditioning. Journal of
Abnormal Psychology, 77(3):223–235.
203
Hauge, E., Berle, J., and Oedegaard, K. (2011). Nonlinear analysis of motor activity shows
differences between schizophrenia and depression: A study using Fourier analysis and
sample entropy. PloS One, 6(1):e16291.
Helmes, E. and Landmark, J. (2003). Subtypes of schizophrenia: A cluster analytic
approach. Canadian Journal of Psychiatry, 48(10):702–708.
Henry, B. L., Minassian, A., Paulus, M. P., Geyer, M. A., and Perry, W. (2010). Heart
rate variability in bipolar mania and schizophrenia. Journal of Psychiatric Research,
44(3):168–76.
Henry, C., Mitropoulou, V., New, A. S., Koenigsberg, H. W., Silverman, J., and Siever,
L. J. (2001). Affective instability and impulsivity in borderline personality and
bipolar II disorders: Similarities and differences. Journal of Psychiatric Research,
35(6):307–312.
Hersen, M. (2006). Clinician’s handbook of child behavioral assessment. Elsvier Academic
Press, Burlington, MA.
Hildebrand, M., Van Hees, V. T., Hansen, B. H., and Ekelund, U. (2014). Age group com-
parability of raw accelerometer output from wrist- and hip-worn monitors. Medicine
and Science in Sports and Exercise, 46(9):1816–24.
Hinton, J. M. (1966). Physiological measurements in psychiatry. Proceedings of the Royal
Society of Medicine, 59(10):1028–30.
Hornero, R., Aba´solo, D., Jimeno, N., Sa´nchez, C. I., Poza, J., and Aboy, M. (2006). Vari-
ability, regularity, and complexity of time series generated by schizophrenic patients
and control subjects. IEEE Transactions on Biomedical Engineering, 53(2):210–218.
Hu, K., Van Someren, E. J. W., Shea, S. A., and Scheer, F. A. J. L. (2009). Reduction of
scale invariance of activity fluctuations with aging and Alzheimer’s disease: Involve-
204
ment of the circadian pacemaker. Proceedings of the National Academy of Sciences
of the United States of America, 106(8):2490–4.
Hunter, J. S. (1986). The exponentially weighted moving average. Journal of Quality
Technology, 18(4):203–210.
Huynh, C., Guile´, J.-M., Breton, J.-J., and Godbout, R. (2015). Sleep-wake patterns of
adolescents with borderline personality disorder and bipolar disorder. Child Psychi-
atry and Human Development, [Epub].
ICT4Depression Consortium (2013a). ICT4Depression Pilot in Netherlands. Technical
report. Available at: http://www.ict4depression.eu/wp/wp-content/uploads/
2013/10/Results-Dutch-pilot.pdf.
ICT4Depression Consortium (2013b). ICT4Depression Pilot in Sweden. Technical re-
port. Available at: http://www.ict4depression.eu/wp/wp-content/uploads/
2013/10/Results-Swedish-pilot.pdf.
Indic, P., Salvatore, P., Maggini, C., and Ghidini, S. (2011). Scaling behavior of hu-
man locomotor activity amplitude: Association with bipolar disorder. PLoS One,
6(5):e20650.
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C.,
and Wang, P. (2010). Research domain criteria (RDoC): Toward a new classification
framework for research on mental disorders. The American Journal of Psychiatry,
167(7):748–51.
Iverson, G. L., Gaetz, M. B., Rzempoluck, E. J., McLean, P., Linden, W., and Remick,
R. (2005). A new potential marker for abnormal cardiac physiology in depression.
Journal of Behavioral Medicine, 28(6):507–11.
Jackson, A., Cavanagh, J., and Scott, J. (2003). A systematic review of manic and
depressive prodromes. Journal of Affective Disorders, 74(3):209–217.
205
Jackson, S. W. (1969). Galen — on mental disorders. Journal of the History of the
Behavioral Sciences, 5(4):365–384.
James, W. (1884). What is an emotion? Mind, 9(34):188–205.
Javelot, H., Spadazzi, A., Weiner, L., Garcia, S., Gentili, C., Kosel, M., and Bertschy,
G. (2014). Telemonitoring with respect to mood disorders and information and
communication technologies: Overview and presentation of the PSYCHE project.
BioMed Research International, 2014:104658.
Jensen-Urstad, K., Saltin, B., Ericson, M., Storck, N., and Jensen-Urstad, M. (2007).
Pronounced resting bradycardia in male elite runners is associated with high heart
rate variability. Scandinavian Journal of Medicine & Science in Sports, 7(5):274–278.
Jones, S. H., Hare, D. J., and Evershed, K. (2005). Actigraphic assessment of circadian
activity and sleep patterns in bipolar disorder. Bipolar Disorders, 7(2):176–86.
Jones, W. H. S. (1923). Hippocrates, Volume II. Harvard University Press (Loeb Classical
Library), London, Cambridge.
Jung, C. G. (1921). Psychologische Typen. Rascher Verlag, Zurich.
Kahn, M., Sheppes, G., and Sadeh, A. (2013). Sleep and emotions: Bidirectional links and
underlying mechanisms. International Journal of Psychophysiology, 89(2):218–228.
Kappeler-Setz, C., Gravenhorst, F., Schumm, J., Arnrich, B., and Tro¨ster, G. (2011).
Towards long term monitoring of electrodermal activity in daily life. Personal and
Ubiquitous Computing, 17(2):261–271.
Keitner, G. I., Solomon, D. A., Ryan, C. E., Miller, I. W., Mallinger, A., Kupfer, D. J.,
and Frank, E. (1996). Prodromal and residual symptoms in bipolar I disorder.
Comprehensive Psychiatry, 37(5):362–367.
206
Kessler, R. C., Andrews, G., Colpe, L. J., Hiripi, E., Mroczek, D. K., Normand, S. L. T.,
Walters, E. E., and Zaslavsky, A. M. (2002). Short screening scales to monitor pop-
ulation prevalences and trends in non-specific psychological distress. Psychological
Medicine, 32(6):959–76.
Kiecolt-Glaser, J. K., Page, G. G., Marucha, P. T., MacCallum, R. C., and Glaser, R.
(1998). Psychological influences on surgical recovery. Perspectives from psychoneu-
roimmunology. The American Psychologist, 53(11):1209–18.
Kiehl, K. A., Smith, A. M., Hare, R. D., and Liddle, P. F. (2000). An event-related poten-
tial investigation of response inhibition in schizophrenia and psychopathy. Biological
Psychiatry, 48(3):210–221.
Klosterko¨tter, J., Hellmich, M., Steinmeyer, E. M., and Schultze-Lutter, F. (2001). Diag-
nosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry,
58(2):158–64.
Kohavi, R. (1995). A study of cross-validation and bootstrap for accuracy estimation and
model selection. In IJCAI’95 Proceedings of the 14th International Joint Conference
on Artificial Intelligence, pages 1137–1143. Morgan Kaufmann Publishers Inc.
Kraemer, H. C., Kupfer, D. J., Clarke, D. E., Narrow, W. E., and Regier, D. A. (2012).
DSM-5: How reliable is reliable enough? American Journal of Psychiatry, 169(1):13–
15.
Kraepelin, E. (1921). Manic depressive insanity and paranoia. The Journal of Nervous
and Mental Disease, 53(4):350.
Kraepelin, E. (1987). Dementia praecox.
Kroenke, K., Spitzer, R. L., and Williams, J. B. W. (2001). The PHQ-9. Journal of
General Internal Medicine, 16(9):606–613.
207
Lacey, B. and Lacey, J. (1974). Studies of heart rate and other bodily processes in
sensorimotor behavior. In P. A. Obrist, A. H. Black, J. Brener, and L. V. DiCara,
editors, Cardiovascular Psychophysiology, pages 538–564. Aldine Transaction, New
Brunswick, NJ, US.
Lacey, J. (1959). Psychophysiological approaches to the evaluation of psychotherapeutic
process and outcome. In E. A. Rubinstein M. B. Parloff, editor, Research in Psy-
chotherapy, pages 160–208. American Psychological Association, Washington, DC,
US.
Lanata, A., Valenza, G., Nardelli, M., Gentili, C., and Scilingo, E. P. (2015). Complexity
index from a personalized wearable monitoring system for assessing remission in
mental health. IEEE Journal of Biomedical and Health Informatics, 19(1):132–9.
Lang, P. J., Bradley, M. M., and Cuthbert, B. N. (1998). Emotion, motivation, and anx-
iety: Brain mechanisms and psychophysiology. Biological Psychiatry, 44(12):1248–
1263.
Larson, J. A. (1923). The cardio-pneumo-psychogram in deception. Journal of Experi-
mental Psychology, 6(6):420–454.
Lathia, N., Pejovic, V., Rachuri, K. K., Mascolo, C., Musolesi, M., and Rentfrow, P. J.
(2013). Smartphones for large-scale behavior change interventions. IEEE Pervasive
Computing, 12(3):66–73.
Lauderdale, D. S., Knutson, K. L., Yan, L. L., Liu, K., and Rathouz, P. J. (2008).
Self-reported and measured sleep duration: How similar are they? Epidemiology,
19(6):838–45.
Layard, R. (2012). How mental illness loses out in the NHS: A report by The Centre
for Economic Performance’s Mental Health Policy Group. CEP Special Reports
CEPSP26, CEP.
208
Lee, J., Nemati, S., Silva, I., Edwards, B. A., Butler, J. P., and Malhotra, A. (2012).
Transfer entropy estimation and directional coupling change detection in biomedical
time series. Biomedical Engineering Online, 11(1):19.
Legendre, A. M. (1805). Nouvelles me´thodes pour la de´termination des orbites des
come`tes. Courcier, Paris.
Lehman, A. F., Lieberman, J. A., Dixon, L. B., McGlashan, T. H., Miller, A. L., Perkins,
D. O., and Kreyenbuhl, J. (2004). Practice guideline for the treatment of patients
with schizophrenia, second edition. The American Journal of Psychiatry, 161(2
Suppl):1–56.
Lejuez, C. W., Read, J. P., Kahler, C. W., Richards, J. B., Ramsey, S. E., Stuart, G. L.,
Strong, D. R., and Brown, R. A. (2002). Evaluation of a behavioral measure of
risk taking: the Balloon Analogue Risk Task (BART). Journal of Experimental
Psychology., 8(2):75–84.
Li, Q., Mark, R. G., and Clifford, G. D. (2008). Robust heart rate estimation from
multiple asynchronous noisy sources using signal quality indices and a Kalman filter.
Physiological measurement, 29(1):15–32.
Liddle, P. (2001). Disordered mind and brain: The neural basis of mental symptoms.
Cromwell Press, Trowbridge, UK.
Liddle, P. F. (1987). The symptoms of chronic schizophrenia. A re-examination of the
positive- negative dichotomy. The British Journal of Psychiatry, 151(2):145–151.
Lieb, K., Zanarini, M. C., Schmahl, C., Linehan, M. M., and Bohus, M. (2004). Borderline
personality disorder. Lancet, 364(9432):453–61.
Littner, M., Kushida, C. A., Anderson, W. M., Bailey, D., Berry, R. B., Davila, D. G.,
Hirshkowitz, M., Kapen, S., Kramer, M., Loube, D., Wise, M., and Johnson, S. F.
209
(2003). Practice parameters for the role of actigraphy in the study of sleep and
circadian rhythms: An update for 2002. Sleep, 26(3):337–41.
Lobbestael, J., Leurgans, M., and Arntz, A. (2010). Inter-rater reliability of the Struc-
tured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders
(SCID II). Clinical Psychology and Psychotherapy, 18(1):75–9.
Lorber, M. (2004). Psychophysiology of aggression, psychopathy, and conduct problems:
A meta-analysis. Psychological Bulletin, 130(4):531–552.
Lo¨tters, J., Schipper, J., Veltink, P., Olthuis, W., and Bergveld, P. (1998). Procedure
for in-use calibration of triaxial accelerometers in medical applications. Sensors and
Actuators A: Physical, 68(1-3):221–228.
Løvendahl, P. and Chagunda, M. G. G. (2010). On the use of physical activity monitoring
for estrus detection in dairy cows. Journal of Dairy Science, 93(1):249–59.
Lu, S., Zhao, H., Ju, K., Shin, K., and Lee, M. (2008). Can photoplethysmography vari-
ability serve as an alternative approach to obtain heart rate variability information?
Journal of Clinical Monitoring and Computing, 22(1):23–29.
Maj, M. (1998). Critique of the DSM-IV operational diagnostic criteria for schizophrenia.
The British Journal of Psychiatry, 172(6):458–458.
Maj, M. (2005). "Psychiatric comorbidity": An artefact of current diagnostic systems?
The British Journal of Psychiatry, 186(3):182–4.
Marczinski, C. A. and Fillmore, M. T. (2003). Preresponse cues reduce the impairing
effects of alcohol on the execution and suppression of responses. Experimental and
Clinical Psychopharmacology, 11(1):110–117.
Mathers, C. D., Fat, D. M., and Boerma, J. T. (2008). The global burden of disease: 2004
update. World Health Organization.
210
Mayers, A. G. and Baldwin, D. S. (2015). The relationship between sleep disturbance
and depression. International Journal of Psychiatry in Clinical Practice, 10(1):2–16.
McCall, W. V. (2015). A rest-activity biomarker to predict response to SSRIs in major
depressive disorder. Journal of Psychiatric Research, 64:19–22.
McClung, C. A. (2013). How might circadian rhythms control mood? Let me count the
ways... Biological Psychiatry, 74(4):242–9.
McCraty, R., Atkinson, M., Tomasino, D., and Stuppy, W. (2001). Analysis of twenty-
four hour heart rate variability in patients with panic disorder. Biological Psychology,
56(2):131–150.
McCrone, P. (2008). Paying the price: The cost of mental health care in England to 2026.
McElroy, S. L., Kotwal, R., Malhotra, S., Nelson, E. B., Keck, P. E., and Nemeroff, C. B.
(2004). Are mood disorders and obesity related? A review for the mental health
professional. The Journal of Clinical Psychiatry, 65(5):634–51.
McSharry, P., Clifford, G., Tarassenko, L., and Smith, L. (2002). Method for generating
an artificial RR tachogram of a typical healthy human over 24-hours. In Computers
in Cardiology, pages 225–228. IEEE.
Migo, E. M., Haynes, B. I., Harris, L., Friedner, K., Humphreys, K., and Kopelman, M. D.
(2014). mHealth and memory aids: Levels of smartphone ownership in patients.
Journal of Mental Health, 24(5):266–270.
Miklowitz, D. J., Price, J., Holmes, E. A., Rendell, J., Bell, S., Budge, K., Christensen,
J., Wallace, J., Simon, J., Armstrong, N. M., McPeake, L., Goodwin, G. M., and
Geddes, J. R. (2012). Facilitated integrated mood management for adults with
bipolar disorder. Bipolar Disorders, 14(2):185–97.
211
Minassian, A., Henry, B. L., Geyer, M. A., Paulus, M. P., Young, J. W., and Perry, W.
(2010). The quantitative assessment of motor activity in mania and schizophrenia.
Journal of Affective Disorders, 120(1):200–206.
Mohr, D. C., Schueller, S. M., Araya, R., Gureje, O., and Montague, E. (2014). Men-
tal health technologies and the needs of cultural groups. The Lancet Psychiatry,
1(5):326–327.
Molnar, G., Feeney, M. G., and Fava, G. A. (1988). Duration and symptoms of bipolar
prodromes. The American Journal of Psychiatry, 145(12):1576–8.
Moore, P. J., Little, M. A., McSharry, P. E., Geddes, J. R., and Goodwin, G. M. (2012).
Forecasting depression in bipolar disorder. IEEE Transactions on Biomedical Engi-
neering, 59(10):2801–7.
Moore, P. J., Little, M. A., McSharry, P. E., Goodwin, G. M., and Geddes, J. R. (2014).
Correlates of depression in bipolar disorder. Proceedings. Biological Sciences / The
Royal Society, 281(1776):20132320.
Morriss, R. (2004). The early warning symptom intervention for patients with bipolar
affective disorder. Advances in Psychiatric Treatment, 10(1):18–26.
Mueser, K. T., Corrigan, P. W., Hilton, D. W., Tanzman, B., Schaub, A., Gingerich,
S., Essock, S. M., Tarrier, N., Morey, B., Vogel-Scibilia, S., and Herz, M. I. (2002).
Illness management and recovery: A review of the research. Psychiatric Services,
53(10):1272–84.
Mueser, K. T., Torrey, W. C., Lynde, D., Singer, P., and Drake, R. E. (2003). Imple-
menting evidence-based practices for people with severe mental illness. Behavior
Modification, 27(3):387–411.
Murphy, K. P. (2007). Conjugate bayesian analysis of the gaussian distribution. Techni-
212
cal report. Available at: https://www.cs.ubc.ca/~murphyk/Papers/bayesGauss.
pdf.
Narrow, W. E., Clarke, D. E., Kuramoto, S. J., Kraemer, H. C., Kupfer, D. J., Greiner,
L., and Regier, D. A. (2013). DSM-5 field trials in the United States and Canada,
Part III: Development and reliability testing of a cross-cutting symptom assessment
for DSM-5. The American Journal of Psychiatry, 170(1):71–82.
Naslund, J. A., Aschbrenner, K. A., Barre, L. K., and Bartels, S. J. (2015). Feasibility of
popular m-health technologies for activity tracking among individuals with serious
mental illness. Telemedicine Journal and E-health, 21(3):213–6.
Oakley, N. R. (1997). Validation with polysomnography of the Sleepwatch sleep/wake
scoring algorithm used by the Actiwatch activity monitoring system. Bend: Mini
Mitter, Cambridge Neurotechnology. Available by request.
O¨hman, A. (1981). Electrodermal activity and vulnerability to schizophrenia: A review.
Biological Psychology, 12(2–3):87–145.
O’Regan, C., Kenny, R. A., Cronin, H., Finucane, C., and Kearney, P. M. (2015). An-
tidepressants strongly influence the relationship between depression and heart rate
variability: Findings from The Irish Longitudinal Study on Ageing (TILDA). Psy-
chological Medicine, 45(3):623–36.
Ortiz-Tudela, E., Martinez-Nicolas, A., Campos, M., Rol, M. A´., and Madrid, J. A.
(2010). A new integrated variable based on thermometry, actimetry and body po-
sition (TAP) to evaluate circadian system status in humans. PLoS Computational
Biology, 6(11):e1000996.
Osipov, M., Behzadi, Y., Kane, J. M., Petrides, G., and Clifford, G. D. (2015). Objective
identification and analysis of physiological and behavioral signs of schizophrenia.
Journal of Mental Health, 24(5):276–282.
213
Osipov, M., Wulff, K., Foster, R. G., and Clifford, G. D. (2013). Multiscale entropy of
physical activity as an objective measure of activity disorganization in a context of
schizophrenia. In IX Congreso Internacional de Informa´tica en Salud 2013, pages
1–9.
Osmani, V., Maxhuni, A., Gru¨nerbl, A., Lukowicz, P., Haring, C., and Mayora, O.
(2013). Monitoring activity of patients with bipolar disorder using smart phones.
In Proceedings of International Conference on Advances in Mobile Computing &
Multimedia - MoMM ’13, pages 85–92, New York, New York, USA. ACM Press.
Ouzir, M. (2013). Impulsivity in schizophrenia: A comprehensive update. Aggression
and Violent Behavior, 18(2):247–254.
Palmius, N., Osipov, M., Goodwin, G. M., Saunders, K., Bilderbeck, A. C., Tsanas, A.,
and Clifford, G. D. (2014). A multi-sensor monitoring system for objective mental
health management in resource constrained environments. In Appropriate Health-
care Technologies for Low Resource Settings (AHT 2014), pages 4–4. Institution of
Engineering and Technology.
Paradiso, R., Bianchi, A. M., Lau, K., and Scilingo, E. P. (2010). PSYCHE: Personalised
monitoring systems for care in mental health. In Annual International Conference of
the IEEE Engineering in Medicine and Biology Society., volume 2010, pages 3602–5.
Peng, C.-K., Buldyrev, S., Havlin, S., Simons, M., Stanley, H., and Goldberger, A. (1994).
Mosaic organization of DNA nucleotides. Physical Review E, 49(2):1685–1689.
Peng, H., Long, F., and Ding, C. (2005). Feature selection based on mutual information
criteria of max-dependency, max-relevance, and min-redundancy. IEEE Transactions
on Pattern Analysis and Machine Intelligence, 27(8):1226–1238.
Perez-Diaz de Cerio, D., Ruiz Boque, S., Rosell-Ferrer, J., Ramos-Castro, J., and Castro,
J. (2012). A wireless sensor network design for the Help4Mood european project. In
European Wireless, 2012. EW. 18th European Wireless Conference, pages 1–6.
214
Perry, A., Tarrier, N., Morriss, R., McCarthy, E., and Limb, K. (1999). Randomised
controlled trial of efficacy of teaching patients with bipolar disorder to identify early
symptoms of relapse and obtain treatment. BMJ, 318(7177):149–153.
Phillips, M. L. and Kupfer, D. J. (2013). Bipolar disorder diagnosis: Challenges and
future directions. Lancet, 381(9878):1663–71.
Pompili, M., Gonda, X., Serafini, G., Innamorati, M., Sher, L., Amore, M., Rihmer, Z.,
and Girardi, P. (2013). Epidemiology of suicide in bipolar disorders: A systematic
review of the literature. Bipolar Disorders, 15(5):457–490.
Pomrock, Y. and Ginath, Y. (1982). Differences between schizophrenics and normal
controls using chirological (hand) testing. The Israel Journal of Psychiatry and
Related Sciences, 19(1):5–22.
Prociow, P., Wac, K., and Crowe, J. (2012). Mobile psychiatry: Towards improving the
care for bipolar disorder. International Journal of Mental Health Systems, 6(1):5.
Rabiner, L. (1989). A tutorial on hidden Markov models and selected applications in
speech recognition. Proceedings of the IEEE, 77(2):257–286.
Rachow, T., Berger, S., and Boettger, M. (2011). Nonlinear relationship between elec-
trodermal activity and heart rate variability in patients with acute schizophrenia.
Psychophysiology, 48(10):1323–1332.
Rachuri, K. K., Musolesi, M., Mascolo, C., Rentfrow, P. J., Longworth, C., and Aucinas,
A. (2010). EmotionSense: A mobile phones based adaptive platform for experimental
social psychology research. In Proceedings of the 12th ACM international conference
on Ubiquitous computing, Ubicomp ’10, pages 281–290, New York, NY, USA. ACM.
Rasmussen, C. E. and Williams, C. K. I. (2006). Gaussian processes in machine learning,
volume 14 of Lecture Notes in Computer Science. The MIT Press.
215
Rechlin, T., Weis, M., Spitzer, A., and Kaschka, W. (1994). Are affective disorders
associated with alterations of heart rate variability? Journal of Affective Disorders,
32(4):271–275.
Rechtschaffen, A. and Kales, A. (1968). A manual of standardized terminology, techniques
and scoring system for sleep stages of human subjects. UCLA Brain Information
Service, Brain Research Institute, Los Angeles.
Refinetti, R., Corne´lissen, G., and Halberg, F. (2007). Procedures for numerical analysis
of circadian rhythms. Biological Rhythm Research, 38(4):275–325.
Regier, D. A. (2007). Time for a fresh start? Rethinking psychosis in DSM-V. Schizophre-
nia Bulletin, 33(4):843–5.
Regier, D. A., Narrow, W. E., Clarke, D. E., Kraemer, H. C., Kuramoto, S. J., Kuhl, E. A.,
and Kupfer, D. J. (2013). DSM-5 field trials in the United States and Canada, Part
II: Test-retest reliability of selected categorical diagnoses. The American Journal of
Psychiatry, 170(1):59–70.
Rescorla, E. (2000). RFC 2818: HTTP over TLS.
Richman, J. and Moorman, J. (2000). Physiological time-series analysis using approxi-
mate entropy and sample entropy. American Journal of Physiology-Heart and Cir-
culatory Physiology, 278(6):H2039–2049.
Ritschel, L. A. and Kilpela, L. S. (2014). Borderline personality disorder. In The Ency-
clopedia of Clinical Psychology. John Wiley & Sons, Inc., New Jersey, USA.
Roberts, S., Osborne, M., Ebden, M., Reece, S., Gibson, N., and Aigrain, S. (2013).
Gaussian processes for time-series modelling. Philosophical Transactions. Series A,
Mathematical, Physical, and Engineering sciences, 371(1984):20110550.
216
Rock, P., Goodwin, G., Harmer, C., and Wulff, K. (2014). Daily rest-activity patterns in
the bipolar phenotype: A controlled actigraphy study. Chronobiology International,
31(2):290–296.
Roebuck, A., Monasterio, V., Gederi, E., Osipov, M., Behar, J., Malhotra, A., Penzel, T.,
and Clifford, G. D. (2013). A review of signals used in sleep analysis. Physiological
Measurement, 35(1):R1–R57.
Rosa, A. R., Singh, N., Whitaker, E., de Brito, M., Lewis, A. M., Vieta, E., Churchill,
G. C., Geddes, J. R., and Goodwin, G. M. (2014). Altered plasma glutathione levels
in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness
onset despite normal brain-derived neurotrophic factor (BDNF) levels. Psychological
Medicine, 44(11):1–10.
Rosenberg, D. E., Bellettiere, J., Gardiner, P. A., Villarreal, V. N., Crist, K., and Kerr, J.
(2015). Independent associations between sedentary behaviors and mental, cognitive,
physical, and functional health among older adults in retirement communities. The
Journals of Gerontology. Series A, 71(1):78–83.
Rothemund, Y., Ziegler, S., and Hermann, C. (2012). Fear conditioning in psychopaths:
Event-related potentials and peripheral measures. Biological Psychology, 90(1):50–
59.
Rowlands, A. V., Fraysse, F., Catt, M., Stiles, V. H., Stanley, R. M., Eston, R. G., and
Olds, T. S. (2014a). Comparability of measured acceleration from accelerometry-
based activity monitors.
Rowlands, A. V., Olds, T. S., Hillsdon, M., Pulsford, R., Hurst, T. L., Eston, R. G., Gom-
ersall, S. R., Johnston, K., and Langford, J. (2014b). Assessing sedentary behavior
with the GENEActiv: introducing the sedentary sphere. Medicine and science in
sports and exercise, 46(6):1235–47.
217
Rubin, D. B. (1976). Inference and missing data. Biometrika, 63(3):581–592.
Rush, A., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N.,
Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Koc-
sis, J. H., and Keller, M. B. (2003). The 16-Item quick inventory of depressive
symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A
psychometric evaluation in patients with chronic major depression. Biological Psy-
chiatry, 54(5):573–583.
Rush, A. J. J., First, M. B., and Blacker, D., editors (2008). Handbook of psychiatric
measures. American Psychiatric Publishing, Arlington, VA, 2 edition.
Sabia, S., van Hees, V. T., Shipley, M. J., Trenell, M. I., Hagger-Johnson, G., Elbaz, A.,
Kivimaki, M., and Singh-Manoux, A. (2014). Association between questionnaire-
and accelerometer-assessed physical activity: The role of sociodemographic factors.
American Journal of Epidemiology, 179(6):781–90.
Sadeh, A. (2011). The role and validity of actigraphy in sleep medicine: An update. Sleep
Medicine Reviews, 15(4):259–267.
Sadeh, A., Keinan, G., and Daon, K. (2004). Effects of stress on sleep: The moderating
role of coping style. Health Psychology, 23(5):542–5.
Sadeh, A., Sharkey, K., and Carskadon, M. (1994). Activity-based sleep-wake identifica-
tion: An empirical test of methodological issues. Sleep, 17(3):201–207.
Sansone, R. A. and Sansone, L. A. (2011). Gender patterns in borderline personality
disorder. Innovations in Clinical Neuroscience, 8(5):16–20.
Santos, R., Sousa, J., Marques, C. J., Gamboa, H., and Silva, H. (2012). Towards emotion
related feature extraction based on generalized source-independent event detection.
Proceedings of the 2nd International Workshop on Computing Paradigms for Mental
Health (MindCare 2012), pages 71–78.
218
Saunders, K., Bilderbeck, A., Price, J., and Goodwin, G. (2015). Distinguishing bipolar
disorder from borderline personality disorder: A study of current clinical practice.
European Psychiatry, 30(8):965–974.
Sayers, J. (2001). The world health report 2001 - mental health: New understanding,
new hope. Bulletin of the World Health Organization, 79(11):1085.
Scargle, J. D., Norris, J. P., Jackson, B., and Chiang, J. (2013). Studies in astronomical
time series analysis. VI. Bayesian block representations. The Astrophysical Journal,
764(2):167.
Scarpa, A. and Raine, A. (1997). Psychophysiology of anger and violent behavior. Psy-
chiatric Clinics of North America, 20(2):375–394.
Schaefer, C. A., Nigg, C. R., Hill, J. O., Brink, L. A., and Browning, R. C. (2014).
Establishing and evaluating wrist cutpoints for the GENEActiv accelerometer in
youth. Medicine and Science in Sports and Exercise, 46(4):826–833.
Schafer, J. L. and Olsen, M. K. (1998). Multiple imputation for multivariate missing-
data problems: A data analyst’s perspective. Multivariate Behavioral Research,
33(4):545–571.
Schou, M., Baastrup, P. C., Grof, P., Weis, P., and Angst, J. (1970). Pharmacological
and clinical problems of lithium prophylaxis. The British Journal of Psychiatry,
116(535):615–619.
Schreiber, T. (2000). Measuring information transfer. Physical Review Letters, 85(2):461–
464.
Scott, J. (2011). Clinical parameters of circadian rhythms in affective disorders. European
Neuropsychopharmacology, 21 Suppl 4:S671–5.
Senin, P. (2008). Dynamic time warping algorithm review. Information and Computer
Science Department University of Hawaii at Manoa Honolulu, USA, pages 1–23.
219
Shedler, J., Mayman, M., and Manis, M. (1993). The illusion of mental health. American
Psychologist, 48(11):1117–1131.
Sierra, P., Livianos, L., Arques, S., Castello´, J., and Rojo, L. (2009). Prodromal symptoms
to relapse in bipolar disorder. Australian and New Zealand Journal of Psychiatry,
41(5):385–91.
Silva, H., Sousa, J., and Gamboa, H. (2012). Study and evaluation of palmar blood
volume pulse for heart rate monitoring in a multimodal framework. Proceedings of the
2nd International Workshop on Computing Paradigms for Mental Health (MindCare
2012), pages 35–40.
Singh, I. and Rose, N. (2009). Biomarkers in psychiatry. Nature, 460(7252):202–7.
Smeraldi, E., Benedetti, F., Barbini, B., Campori, E., and Colombo, C. (1999). Sus-
tained antidepressant effect of sleep deprivation combined with pindolol in bipolar
depression. A placebo-controlled trial. Neuropsychopharmacology, 20(4):380–5.
Sokolove, P. and Bushell, W. (1978). The chi square periodogram: Its utility for analysis
of circadian rhythms. Journal of Theoretical Biology, 72(1):131–160.
Spitzer, R. L., Kroenke, K., Williams, J. B. W., and Lo¨we, B. (2006). A brief measure for
assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine,
166(10):1092–7.
Stanley, B. and Wilson, S. T. (2006). Heightened subjective experience of depression in
borderline personality disorder. Journal of Personality Disorders, 20(4):307–18.
Steenari, B. M.-R. and Aronen, E. (2002). Actigraph placement and sleep estimation in
children. Sleep, 25(2):235–237.
Steiner, H. (2011). Handbook of developmental psychiatry. World Scientific Publishing
Company, Singapore.
220
Stone, A. A. and Shiffman, S. (2002). Capturing momentary, self-report data: A proposal
for reporting guidelines. Annals of Behavioral Medicine, 24(3):236–243.
Sung, M., Marci, C., and Pentland, A. (2005). Objective physiological and behavioral
measures for identifying and tracking depression state in clinically depressed patients.
Technical report, Massachusetts Institute of Technology. Available at: http://hd.
media.mit.edu/tech-reports/TR-595.pdf.
Swann, A. C. (2009). Impulsivity in mania. Current Psychiatry Reports, 11(6):481–7.
Swartz, A. M., Strath, S. J., Bassett, D. R., O’Brien, W. L., King, G. A., and Ainsworth,
B. E. (2000). Estimation of energy expenditure using CSA accelerometers at hip and
wrist sites. Medicine and Science in Sports and Exercise, 32(9 Suppl):S450–456.
Taillard, J., Lemoine, P., Boule, P., Drogue, M., and Mouret, J. (1993). Sleep and
heart rate circadian rhythm in depression: The necessity to separate. Chronobiology
International, 10(1):63–72.
Tandon, R., Keshavan, M. S., and Nasrallah, H. A. (2008). Schizophrenia, "just the
facts" what we know in 2008. 2. Epidemiology and etiology. Schizophrenia Research,
102(1-3):1–18.
Tandon, R., Nasrallah, H. A., and Keshavan, M. S. (2009). Schizophrenia, "just the facts"
4. Clinical features and conceptualization. Schizophrenia Research, 110(1-3):1–23.
Task Force of the European Society of Cardiology the North American Society of Pac-
ing Electrophysiology (1996). Heart rate variability: Standards of measurement,
physiological interpretation, and clinical use. Circulation, 93(5):1043–1065.
te Lindert, B. H. W. and Van Someren, E. J. W. (2013). Sleep estimates using micro-
electromechanical systems (MEMS). Sleep, 36(5):781–9.
Teicher, M. H. (1995). Actigraphy and motion analysis: New tools for psychiatry. Harvard
Rev Psychiatry, 3:18–35.
221
Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of the
Royal Statistical Society. Series B (Methodological), pages 267–288.
Torous, J., Staples, P., and Onnela, J.-P. (2015). Realizing the potential of mobile
mental health: New methods for new data in psychiatry. Current Psychiatry Reports,
17(8):602.
Tracy, D. J., Xu, Z., Choi, L., Acra, S., Chen, K. Y., and Buchowski, M. S. (2014).
Separating bedtime rest from activity using waist or wrist-worn accelerometers in
youth. PloS One, 9(4):e92512.
Troiano, R. P., Berrigan, D., Dodd, K. W., Maˆsse, L. C., Tilert, T., and McDowell, M.
(2008). Physical activity in the United States measured by accelerometer. Medicine
and Science in Sports and Exercise, 40(1):181–8.
Troiano, R. P., McClain, J. J., Brychta, R. J., and Chen, K. Y. (2014). Evolution
of accelerometer methods for physical activity research. British journal of sports
medicine, 48(13):1019–23.
Trost, S. G. (2001). Objective measurement of physical activity in youth: Current issues,
future directions. Exercise and Sport Sciences Reviews, 29(1):32–6.
Tsanas, A., Little, M. A., McSharry, P. E., and Ramig, L. O. (2010). Accurate tele-
monitoring of Parkinson’s disease progression by noninvasive speech tests. IEEE
Transactions on Biomedical Engineering, 57(4):884–893.
Tsoi, D. T.-Y., Hunter, M. D., and Woodruff, P. W. (2008). History, aetiology, and
symptomatology of schizophrenia. Psychiatry, 7(10):404–409.
Tucker, J. M., Welk, G. J., and Beyler, N. K. (2011). Physical activity in U.S.: Adults
compliance with the Physical Activity Guidelines for Americans. American Journal
of Preventive Medicine, 40(4):454–61.
222
Tudor-Locke, C., Brashear, M. M., Johnson, W. D., and Katzmarzyk, P. T. (2010). Ac-
celerometer profiles of physical activity and inactivity in normal weight, overweight,
and obese U.S. men and women. The International Journal of Behavioral Nutrition
and Physical Activity, 7:60.
Tukey, J. W. (1977). Exploratory data analysis. Analysis, 2(1999):688.
Turner, R., Saatci, Y., and Rasmussen, C. E. (2009). Adaptive sequential Bayesian change
point detection. Technical report. Available at: http://mlg.eng.cam.ac.uk/pub/
pdf/TurSaaRas09.pdf.
Valenza, G., Citi, L., Gentili, C., Lanata, A., Scilingo, E. P., and Barbieri, R. (2015).
Characterization of depressive states in bipolar patients using wearable textile tech-
nology and instantaneous heart rate variability assessment. IEEE Journal of Biomed-
ical and Health Informatics, 19(1):263–74.
Valenza, G., Gentili, C., Lanata`, A., and Scilingo, E. P. (2013). Mood recognition in
bipolar patients through the PSYCHE platform: Preliminary evaluations and per-
spectives. Artificial Intelligence in Medicine, 57(1):49–58.
Valenza, G., Nardelli, M., Bertschy, G., Lanata`, A., Barbieri, R., and Scilingo, E. P.
(2014a). Maximal-radius multiscale entropy of cardiovascular variability: A promis-
ing biomarker of pathological mood states in bipolar disorders. In Annual Interna-
tional Conference of the IEEE Engineering in Medicine and Biology Society., volume
2014, pages 6663–6.
Valenza, G., Nardelli, M., Bertschy, G., Lanata, A., and Scilingo, E. P. (2014b). Complex-
ity modulation in heart rate variability during pathological mental states of bipolar
disorders. In 2014 8th Conference of the European Study Group on Cardiovascular
Oscillations (ESGCO), pages 99–100. IEEE.
Valkonen-Korhonen, M., Tarvainen, M. P., Ranta-Aho, P., Karjalainen, P. A., Partanen,
223
J., Karhu, J., and Lehtonen, J. (2003). Heart rate variability in acute psychosis.
Psychophysiology, 40(5):716–726.
van de Ven, P., Henriques, M. R., Hoogendoorn, M., Klein, M., McGovern, E., Nelson,
J., Silva, H., and Tousset, E. (2012). A mobile system for treatment of depression.
Proceedings of the 2nd International Workshop on Computing Paradigms for Mental
Health (MindCare 2012), pages 47–58.
Van de Water, A. T. M., Holmes, A., and Hurley, D. A. (2011). Objective measurements
of sleep for non-laboratory settings as alternatives to polysomnography - a systematic
review. Journal of Sleep Research, 20(1.1):183–200.
van Hees, V. T., Fang, Z., Langford, J., Assah, F., Mohammad, A., da Silva, I. C. M.,
Trenell, M. I., White, T., Wareham, N. J., and Brage, S. (2014). Autocalibration
of accelerometer data for free-living physical activity assessment using local gravity
and temperature: An evaluation on four continents. Journal of Applied Physiology,
117(7):738–44.
van Hees, V. T., Gorzelniak, L., Dean Leo´n, E. C., Eder, M., Pias, M., Taherian, S.,
Ekelund, U., Renstro¨m, F., Franks, P. W., Horsch, A., and Brage, S. (2013). Sepa-
rating movement and gravity components in an acceleration signal and implications
for the assessment of human daily physical activity. PloS One, 8(4):e61691.
van Hees, V. T., Renstro¨m, F., Wright, A., Gradmark, A., Catt, M., Chen, K. Y., Lo¨f,
M., Bluck, L., Pomeroy, J., Wareham, N. J., Ekelund, U., Brage, S., and Franks,
P. W. (2011). Estimation of daily energy expenditure in pregnant and non-pregnant
women using a wrist-worn tri-axial accelerometer. PloS One, 6(7):e22922.
Van Someren, E. (1999). Bright light therapy: Improved sensitivity to its effects on rest-
activity rhythms in Alzheimer patients by application of nonparametric methods.
Chronobiology International, 16(4):505–518.
224
Vancampfort, D., Knapen, J., Probst, M., Scheewe, T., Remans, S., and De Hert,
M. (2012). A systematic review of correlates of physical activity in patients with
schizophrenia. Acta Psychiatrica Scandinavica, 125(5):352–62.
Ventura, J., Nuechterlein, K. H., Subotnik, K. L., Gutkind, D., and Gilbert, E. A. (2000).
Symptom dimensions in recent-onset schizophrenia and mania: A principal compo-
nents analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Research,
97(2-3):129–135.
Walther, S., Horn, H., and Razavi, N. (2009). Quantitative motor activity differentiates
schizophrenia subtypes. Neuropsychobiology, 60(2):80–86.
Walther, S., Ramseyer, F., Horn, H., Strik, W., and Tschacher, W. (2014). Less struc-
tured movement patterns predict severity of positive syndrome, excitement, and
disorganization. Schizophrenia Bulletin, 40(3):585–91.
Warmerdam, L., Riper, H., Klein, M., van den Ven, P., Rocha, A., Ricardo Henriques, M.,
Tousset, E., Silva, H., Andersson, G., and Cuijpers, P. (2012). Innovative ICT solu-
tions to improve treatment outcomes for depression: The ICT4Depression project.
Studies in Health Technology and Informatics, 181:339–43.
Webster, J. B., Kripke, D. F., Messin, S., Mullaney, D. J., and Wyborney, G. (1982). An
activity-based sleep monitor system for ambulatory use. Sleep, 5(4):389–99.
Weissman, M. M. (1996). Cross-national epidemiology of major depression and bipolar
disorder. The Journal of the American Medical Association, 276(4):293.
Westen, D., Moses, M. J., Silk, K. R., Lohr, N. E., Cohen, R., and Segal, H. (1992).
Quality of depressive experience in borderline personality disorder and major de-
pression: When depression is not just depression. Journal of Personality Disorders,
6(4):382–393.
225
Weston, A., Barton, C., Lesselyong, J., and Yaffe, K. (2011). Functional deficits among
patients with mild cognitive impairment. Alzheimer’s and Dementia, 7(6):611–4.
Widiger, T. A. and Weissman, M. M. (1991). Epidemiology of borderline personality
disorder. Psychiatric Services, 42(10):1015–1021.
Winters, P. R. (1960). Forecasting sales by exponentially weighted moving averages.
Management Science, 6(3):324–342.
Wirz-Justice, A. (2006). Biological rhythm disturbances in mood disorders. International
Clinical Psychopharmacology, 21 Suppl 1:S11–5.
Wirz-Justice, A. (2007a). Chronobiology and psychiatry. Sleep Medicine Reviews,
11(6):423–427.
Wirz-Justice, A. (2007b). How to measure circadian rhythms in humans. Medicographia,
29(1):84–90.
Wirz-Justice, A., Haug, H., and Cajochen, C. (2001). Disturbed circadian rest-activity cy-
cles in schizophrenia patients: An effect of drugs? Schizophrenia Bulletin, 27(3):497
–502.
Wirz-Justice, A., Schro¨der, C. M., Gasio, P. F., Cajochen, C., and Savaskan, E. (2010).
The circadian rest-activity cycle in Korsakoff psychosis. The American Journal of
Geriatric Psychiatry, 18(1):33–41.
Witting, W., Kwa, I., and Eikelenboom, P. (1990). Alterations in the circadian rest-
activity rhythm in aging and Alzheimer’s disease. Biological Psychiatry, 27(6):563–
572.
Wolters, M., Burton, C., Matheson, C., Breso´, A., Szentagotai, A., Martinez-Miranda,
J., Fuster, E., Rosell, J., Pagliari, C., and McKinstry, B. (2013). Help4Mood -
supporting joint sense making in the treatmet of major depressive disorder. Workshop
on Interactive Systems in Healthcare (WISH), Washington DC.
226
Wulff, K., Dijk, D.-J., and Middleton, B. (2012). Sleep and circadian rhythm disruption
in schizophrenia. The British Journal of Psychiatry, 200(4):308–316.
Wulff, K., Gatti, S., Wettstein, J. G., and Foster, R. G. (2010). Sleep and circadian
rhythm disruption in psychiatric and neurodegenerative disease. Nature Reviews.
Neuroscience, 11(8):589–99.
Wulff, K., Joyce, E., Middleton, B., Dijk, D.-J., and Foster, R. G. (2006). The suitability
of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment
of sleep disturbances in schizophrenia: A case report. Chronobiology International,
23(1-2):485–495.
Young, R. C., Biggs, J. T., Ziegler, V. E., and Meyer, D. A. (1978). A rating scale
for mania: reliability, validity and sensitivity. The British Journal of Psychiatry,
133:429–35.
Zaragoza´, I., Rey, B., Botella, C., Ban˜os, R., Moragrega, I., Castilla, D., and Alcan˜iz, M.
(2011). A user-friendly tool for detecting the stress level in a person’s daily life. In
Human-Computer Interaction. Design and Development Approaches. Lecture Notes
in Computer Science, volume 6761, pages 423–431. Springer Berlin Heidelberg.
Zhang, S., Rowlands, A. V., Murray, P., and Hurst, T. L. (2012). Physical activity
classification using the GENEA wrist-worn accelerometer. Medicine and Science in
Sports and Exercise, 44(4):742–8.
Zhang, X., Hu, B., Zhou, L., Moore, P., and Chen, J. (2013). An EEG based pervasive
depression detection for females. In Pervasive Computing and the Networked World.
Lecture Notes in Computer Science, volume 7719, pages 848–861. Springer Berlin
Heidelberg.
227
Appendices
228
Appendix A
The Altman Self-Rating scale for
Mania (ASRM)
A.1 Instructions
1. On this questionnaire are groups of five statements; read each group of statements
carefully.
2. Choose the one statement in each group that best describes the way you have been
feeling for the past week.
3. Circle the number next to the statement you picked.
Please note: The word "occasionally" when used here means once or twice; "often" means
several times or more; "frequently" means most of the time.
A.2 Questions
1. Positive mood:
(a) I do not feel happier or more cheerful than usual.
(b) I occasionally feel happier or more cheerful than usual.
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(c) I often feel happier or more cheerful than usual.
(d) I feel happier or more cheerful than usual most of the time.
(e) I feel happier or more cheerful than usual all of the time.
2. Self-confidence:
(a) I do not feel more self-confident than usual.
(b) I occasionally feel more self-confident than usual.
(c) I often feel more self-confident than usual.
(d) I feel more self-confident than usual.
(e) I feel extremely self-confident all of the time.
3. Sleep patterns:
(a) I do not need less sleep than usual.
(b) I occasionally need less sleep than usual.
(c) I often need less sleep than usual.
(d) I frequently need less sleep than usual.
(e) I can go all day and night without any sleep and still not feel tired.
4. Speech:
(a) I do not talk more than usual.
(b) I occasionally talk more than usual.
(c) I often talk more than usual.
(d) I frequently talk more than usual.
(e) I talk constantly and cannot be interrupted.
5. Activity level:
230
(a) I have not been more active (either socially, sexually, at work, home or school)
than usual.
(b) I have occasionally been more active than usual.
(c) I have often been more active than usual.
(d) I have frequently been more active than usual.
(e) I am constantly active or on the go all the time.
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Appendix B
The Quick Inventory of Depressive
Symptomatology, Self-Report
(QIDS-SR16)
B.1 Instructions
Please circle the one response to each item that best describes you for the past seven
days.
B.2 Questions
1. Falling Asleep:
(a) I never take longer than 30 minutes to fall asleep.
(b) I take at least 30 minutes to fall asleep, less than half the time.
(c) I take at least 30 minutes to fall asleep, more than half the time.
(d) I take more than 60 minutes to fall alseep, more than half the time.
2. Sleep During the Night:
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(a) I do not wake up at night.
(b) I have a restless, light sleep with a few brief awakenings each night.
(c) I wake up at least once a night, but I go back to sleep easily.
(d) I awaken more than once a night and stay awake for 20 minutes or more, more
than half the time.
3. Waking Up Too Early:
(a) Most of the time, I awaken no more than 30 minutes before I need to get up.
(b) More than half the time, I awaken more than 30 minutes before I need to get
up.
(c) I almost always awaken at least one hour or so before I need to, but I go back
to sleep eventually.
(d) I awaken at least one hour before I need to, and can’t go back to sleep.
4. Sleeping Too Much:
(a) I sleep no longer than 7–8 hours/night, without napping during the day.
(b) I sleep no longer than 10 hours in a 24-hour period including naps.
(c) I sleep no longer than 12 hours in a 24-hour period including naps.
(d) I sleep longer than 12 hours in a 24-hour period including naps.
5. Feeling Sad:
(a) I do not feel sad.
(b) I feel sad less than half the time.
(c) I feel sad more than half the time.
(d) I feel sad nearly all of the time.
6. Decreased Appetite:
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(a) There is no change in my usual appetite.
(b) I eat somewhat less often or lesser amounts of food than usual.
(c) I eat much less than usual and only with personal effort.
(d) I rarely eat within a 24-hour period, and only with extreme personal effort or
when others persuade me to eat.
7. Increased Appetite:
(a) There is no change from my usual appetite.
(b) I feel a need to eat more frequently than usual.
(c) I regularly eat more often and/or greater amounts of food than usual.
(d) I feel driven to overeat both at mealtime and between meals.
8. Decreased Weight (Within the Last Two Weeks):
(a) I have not had a change in my weight.
(b) I feel as if I’ve had a slight weight loss.
(c) I have lost 2 pounds or more.
(d) I have lost 5 pounds or more.
9. Increased Weight (Within the Last Two Weeks):
(a) I have not had a change in my weight.
(b) I feel as if I’ve had a slight weight gain.
(c) I have gained 2 pounds or more.
(d) I have gained 5 pounds or more.
10. Concentration/Decision Making:
(a) There is no change in my usual capacity to concentrate or make decisions.
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(b) I occasionally feel indecisive or find that my attention wanders.
(c) Most of the time, I struggle to focus my attention or to make decisions.
(d) I cannot concentrate well enough to read or cannot make even minor decisions.
11. View of Myself:
(a) I see myself as equally worthwhile and deserving as other people.
(b) I am more self-blaming than usual.
(c) I largely believe that I cause problems for others.
(d) I think almost constantly about major and minor defects in myself.
12. Thoughts of Death or Suicide:
(a) I do not think of suicide or death.
(b) I feel that life is empty or wonder if it’s worth living.
(c) I think of suicide or death several times a week for several minutes.
(d) I think of suicide or death several times a day in some detail, or I have made
specific plans for suicide or have actually tried to take my life.
13. General Interest:
(a) There is no change from usual in how interested I am in other people or
activities.
(b) I notice that I am less interested in people or activities.
(c) I find I have interest in only one or two of my formerly pursued activities.
(d) I have virtually no interest in formerly pursued activities.
14. Energy Level:
(a) There is no change in my usual level of energy.
(b) I get tired more easily than usual.
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(c) I have to make a big effort to start or finish my usual daily activities (for
example, shopping, homework, cooking or going to work).
(d) I really cannot carry out most of my usual daily activities because I just don’t
have the energy.
15. Feeling Slowed Down:
(a) I think, speak, and move at my usual rate of speed.
(b) I find that my thinking is slowed down or my voice sounds dull or flat.
(c) It takes me several seconds to respond to most questions and I’m sure my
thinking is slowed.
(d) I am often unable to respond to questions without extreme effort.
16. Feeling Restless:
(a) I do not feel restless.
(b) I’m often fidgety, wringing my hands, or need to shift how I am sitting.
(c) I have impulses to move about and am quite restless.
(d) At times, I am unable to stay seated and need to pace around.
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Appendix C
The Generalised Anxiety Disorder
7-item scale (GAD-7)
C.1 Instructions
Over the last 2 weeks, how often have you been bothered by the following problems?
C.2 Questions
1. Feeling nervous, anxious, or on edge:
(a) Not at all.
(b) Several days.
(c) More than half the days.
(d) Nearly every day.
2. Not being able to stop or control worrying:
(a) Not at all.
(b) Several days.
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(c) More than half the days.
(d) Nearly every day.
3. Worrying too much about different things:
(a) Not at all.
(b) Several days.
(c) More than half the days.
(d) Nearly every day.
4. Trouble relaxing:
(a) Not at all.
(b) Several days.
(c) More than half the days.
(d) Nearly every day.
5. Being so restless that it is hard to sit still:
(a) Not at all.
(b) Several days.
(c) More than half the days.
(d) Nearly every day.
6. Becoming easily annoyed or irritable:
(a) Not at all.
(b) Several days.
(c) More than half the days.
(d) Nearly every day.
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7. Feeling afraid as if something awful might happen:
(a) Not at all.
(b) Several days.
(c) More than half the days.
(d) Nearly every day.
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